Pharmaceutical Benefits Scheme (PBS) | Home · Web viewA 17988 Capsule 50mg 50 0.30 GM 116 – P 2527B Tablet 50mg (twice daily sustained release) 20 0.30 GM 45,604 732,050 P 3484J

35

TABLE 1

2007 COMMUNITY PRESCRIPTION NUMBERS, TOGETHER WITH

GOVERNMENT AND PATIENT COSTS FOR PBS–LISTED DRUGS

Table 1 includes an estimate of community prescription numbers for the 2007 calendar year, costs (government and patient contribution) for the items with a four digit PBS/RPBS code, together with the defined daily dose (DDD) where assigned. There is no cost information available for items with a five digit Amfac drug code. Table 1 exclude the presentation of information on any item with an estimated community use of less than 110 prescriptions in 2007.

The prescription items are arranged by ATC code on generic name, and by form and strength using either the PBS drug code (4 digit plus alpha) or, for non–PBS items, the Amfac drug code (5 digit). Note that in this edition, “Item type” has been added to distinguish between PBS drug code and non–PBS drug code, for instance, P refers to PBS drug code and A refers to Amfac drug code.

An index by 2nd level of the ATC classification follows:

AlimentAry trAct And metAbolism PAge no

A01 STOMATOLOGICAL PREPARATIONS 39

A02 DRUGS FOR ACID RELATED DISORDERS 40

A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS 43

A04 ANTIEMETICS AND ANTINAUSEANTS 45

A05 BILE AND LIVER THERAPY 46

A06 LAXATIVES 47

A07 ANTIDIARRHOEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVES 49

A08 ANTIOBESITY PREPARATIONS, EXCLUDING DIET PRODUCTS 51

A09 DIGESTIVES, INCLUDING ENZYMES 52

A10 ANTIDIABETIC THERAPY 53

A11 VITAMINS 56

36

A12 MINERAL SUPPLEMENTS 57

A14 ANABOLIC AGENTS FOR SYSTEMIC USE 58

blood And blood forming orgAns 59

B01 ANTITHROMBOTIC AGENTS 59

B02 ANTIHAEMORRHAGICS 61

B03 ANTIANAEMIC PREPARATIONS 62

B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS 64

B06 OTHER HAEMATOLOGICAL AGENTS 65

cArdiovAsculAr system

C01 CARDIAC THERAPY 66

C02 ANTIHYPERTENSIVES 68

C03 DIURETICS 69

C04 PERIPHERAL VASODILATORS 71

C05 VASOPROTECTIVES 72

C07 BETA BLOCKING AGENTS 73

C08 CALCIUM CHANNEL BLOCKERS 74

C09 AGENTS ACTING ON THE RENIN–ANGIOTENSIN SYSTEM 76

C10 LIPID MODIFYING AGENTS 80

dermAtologicAls

D01 ANTIFUNGALS FOR DERMATOLOGICAL USE 82

D02 EMOLLIENTS AND PROTECTIVES 84

D03

D04

D05

PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS

ANTIPRURITICS, INCLUDING ANTIHISTAMINES, ANAESTHETICS ETC

86

85

87

D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE 88

D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS 89

D08 ANTISEPTICS AND DISINFECTANTS 91

D09 MEDICATED DRESSINGS 92

D10 ANTI–ACNE PREPARATIONS 93

D11 OTHER DERMATOLOGICAL PREPARATIONS 94

37

genitourinAry system And sex hormones

G01 GYNAECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS 95

G02 OTHER GYNAECOLOGICALS 96

G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM 97

G04 UROLOGICALS 103

systemic hormonAl PrePArAtions, excluding sex hormones

H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES 105

H02 CORTICOSTEROIDS FOR SYSTEMIC USE 106

H03 THYROID THERAPY 107

H04 PANCREATIC HORMONES 108

H05 CALCIUM HOMEOSTASIS 109

generAl Antiinfectives for systemic use

J01 ANTIBACTERIALS FOR SYSTEMIC USE 110

J02 ANTIMYCOTICS FOR SYSTEMIC USE 118

J04 ANTIMYCOBACTERIALS 119

J05 ANTIVIRALS FOR SYSTEMIC USE 120

J07 VACCINES 122

AntineoPlAstic And immuno–modulAting Agents

L01 ANTINEOPLASTIC AGENTS 125

L02 ENDOCRINE THERAPY 131

L03 IMMUNOSTIMULANTS 133

L04 IMMUNO–SUPPRESSIVE AGENTS 134

musculo–skeletAl system

M01 ANTI–INFLAMMATORY AND ANTI–RHEUMATIC PRODUCTS 137

M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN 141

M03 MUSCLE RELAXANTS 142

M04 ANTI–GOUT PREPARATIONS 143

M05 DRUGS FOR TREATMENT OF BONE DISEASES 144

38

nervous system

N01 ANAESTHETICS 145

N02 ANALGESICS 146

N03 ANTI–EPILEPTICS 153

N04 ANTI–PARKINSON DRUGS 156

N05 PSYCHOLEPTICS 158

N06 PSYCHOANALEPTICS 164

N07 OTHER NERVOUS SYSTEM DRUGS 169

Anti–PArAsitic Products, insecticides And rePellents

P01 ANTI–PROTOZOALS 171

P02 ANTHELMINTICS 172

P03 ECTOPARASITICIDES, INCLUDING SCABICIDES, INSECTICIDES AND REPELLENTS 173

resPirAtory system

R01 NASAL PREPARATIONS 174

R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES 177

R05 COUGH AND COLD PREPARATIONS 180

R06 ANTI–HISTAMINES FOR SYSTEMIC USE 182

sensory orgAns

S01 OPHTHALMOLOGICALS 185

S02 OTOLOGICALS 190

S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS 191

vArious

V01 ALLERGENS 192

V03 ALL OTHER THERAPEUTIC PRODUCTS 193

P 2931G Lozenge 10mg 40.00

MG 148,100

1,369,716P 3306B Lozenge 10mg 40.0

0MG 4,48

040,395A01AB0

3CHLORHEXIDINEP 4161B Mouth wash 2mg per mL (0.2%) 250mL

30.00

MG 3,900

45,492A01AB0

9MICONAZOLEA 13832 Oral gel 20mg per mL (2%) 20g

0.20

GM 6,443

–A 14054 Oral gel 40mg per mL (2%) 40g

0.20

GM 4,048

–A01AB11

NYSTATINP 3033P Oral suspension 100,000 units per mL 24mL

1500.00

TE 130,704

1,265,924P 3343Y Oral suspension

100,000 units per mL 24mL1500.00

TE 776 7,366A01AB1

1POVIDINE IODINEA 10359 Gargle 1 – – 168 –

A01AB11

THYMOLA 11202 Mouth wash red 200m – – 134 –

39

A

2007atc ItEM tYPE codE forM and strEngth ddd unIts scrIPts

cost($)

ALIMENTARY TRACT AND METABOLISMSTOMATOLOGICAL PREPARATIONSSTOMATOLOGICAL PREPARATIONSANTIINFECTIVES FOR LOCAL ORAL TREATMENT

A01AB04 AMPHOTERICIN

CORTICOSTEROIDS FOR LOCAL ORAL TREATMENTA01AC01 TRIAMCINOLONE ACETONIDE with PECTIN

A 11075 Paste 1% 5gm – – 22,884 –OTHER AGENTS FOR LOCAL ORAL TREATMENT

A01AD02 BENZYDAMINE HYDROCHLORIDE

P 1121B Mouth and throat rinse 22.5mg per 15mL 500mL

– – 5,659 104,336P 5385K Mouth and throat rinse

22.5mg per 15mL 500mL– – 153 3,3

27A01AD02

BENZYDAMINE with CHLORHEXIDINEA 14359 Solution 200mL – – 153 –

A01AD11

CHOLINE SALICYLATE with CETALKONIUM CHLORIDEA 12855 Gel 10g 1

– – 2,135 –A01AD11

SALIVA SUBSTITUTEP 4568K Solution 25mL – – 510 4,5

12P 4569L Solution 100mL – – 558 7,180A01AD1

1VARIOUSP 5334R Spray 10mg per mL 100mL – – 253 3,1

68

40

P 1157X

Tablet 200mg 0.80

GM 3,615

82,359P 115

8YTablet 400mg 0.8

0GM 29,2

14674,231P 115 Tablet 800mg 0.8 GM 2,24 53,3

FAMOTIDINEP 2487X Tablet 20mg 40.0

0MG 74,7

591,444,532P 2488Y Tablet 40mg 40.0 MG 76,0 1,571,

NIZATIDINEP 1504E Capsules 300mg 30 0.3

0GM 40,7

89995,491P 1505F Capsules 150mg 30 0.3 GM 77,9 1,815,

RANITIDINE HYDROCHLORIDEP 193

7YEffervescent tablet 150mg (base)

0.30

GM 49,790

988,285P 197

7CTablet 300mg (base) 0.3

0GM 275,1

555,662,047P 197

8DTablet 150mg (base) 0.3

0GM 814,4

5316,149,339P 816

2NSyrup 150mg (base) per 10mL 300mL

0.30

GM 24,145

438,946P 890

3NEffervescent tablet 150mg (base)

0.30

GM 1,525

38,699P 890

5QSyrup 150mg (base) per 10mL 300mL

0.30

GM 379

8,934

A


cost($)

ALIMENTARY TRACT AND METABOLISMDRUGS FOR ACID RELATED DISORDERSANTACIDSALUMINIUM COMPOUNDS

A02AB01 ALUMINIUM HYDROXIDEA 10038 Tablet 600mg 100 – – 1,143 –

CALCIUM COMPOUNDSA02AC10 CALCIUM CARBONATE with GLYCINE

P 4055K Tablet 420mg–180mg – – 1,006 21,071COMBS.AND COMPLEXES OF ALUMINIUM,CALCIUM AND MAGNESIUM COMPOUNDS

A02AD ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDEP 215

7MOral suspension 200mg–200mg per 5mL 500mL

– – 83,869

1,076,013P 257

6NTablet 200mg–200mg – – 43,56

6556,731P 411

8ROral suspension 400mg–400mg–30mg per 5mL

– – 2,996

58,160A02AD ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE with

SIMETHICONEA 11196 Mixture 750mL 1 – – 152 –P 4453J Tablet 400mg–400mg–40mg 200

– – 2,465

106,777A02AD ALUMINIUM HYDROXIDE with MAGNESIUM

TRISILICATE and MAGNESIUM HYDROXIDEP 2159P Oral suspension 250mg–120mg–120mg per 5mL

– – 24,704

316,888DRUGS FOR PEPTIC ULCER AND GORD

H2–RECEPTOR ANTAGONISTSA02BA01 CIMETIDINE

A02BA03

A02BA04

A02BA02

41

P 8600P

Tablet 20mg (enteric coated) 30

30.00

MG

2,751,351

102,562,218P 860

1QTablet 40mg (enteric coated) 30

30.00

MG

1,995,868

119,132,811P 888 Tablet 20mg (enteric 30.0 M 114,9 4,277,

LANSOPRAZOLEP 224

0XCapsule 30mg 30.0

0MG

28,943

1,070,324P 224

1YCapsule 30mg 30.0

0MG

768,091

31,109,773P 819

8LCapsule 15mg 30.0

0MG

20,743

489,615P 852

8WSachet for oral suspension 30mg

30.00

MG

3,111

113,538P 852

9XSachet for oral suspension 30mg

30.00

MG

18,301

705,371P 973 Sachet for oral suspension 30.0 M 89 48,9

OMEPRAZOLEP 132

6TCapsule 20mg 20.0

0MG

21,250

654,063P 132

7WCapsule 20mg 20.0

0MG

220,332

8,701,389P 833

1LTablet 20mg (as magnesium salt) 30

20.00

MG

87,548

2,986,501P 833

2MTablet 10mg (as magnesium salt) 30

20.00

MG

70,637

1,904,341P 833

3NTablet 20mg (as magnesium salt) 30

20.00

MG

2,693,250

107,007,920P 910

9KTablet 20mg (as magnesium salt) 30

20.00

MG

25,893

896,158P 911 Tablet 20mg (as magnesium 20.0 M 735,2 26,466

PANTOPRAZOLEP 800

7KTablet (enteric coated) equivalent to 40mg

40.00

MG

302,653

11,440,813P 800

8LTablet (enteric coated) equivalent to 40mg

40.00

MG

2,526,686

102,221,950P 839 Tablet (enteric coated) 40.0 M 288,3 6,333,

RABEPRAZOLEP 850

7RTablet 10mg 30 20.0

0MG

49,981

1,875,752P 850

8TTablet 20mg 30 20.0

0MG

1,630,226

65,472,016P 850

9WTablet 20mg 30 20.0

0MG

223,977

8,314,984

A


cost($)

ALIMENTARY TRACT AND METABOLISMDRUGS FOR ACID RELATED DISORDERSDRUGS FOR PEPTIC ULCER AND GORDPROSTAGLANDINSA02BB01 MISOPROSTOL

P 1648R Tablet 200ug 0.80 MG 2,229 112,980PROTON PUMP INHIBITORS

A02BC05 ESOMEPRAZOLE

A02BC03

A02BC01

A02BC02

A02BC04

COMBINATIONS FOR ERADICATION OF HELICOBACTER PYLORIA02BD06 ESOMEPRAZOLE AMOXICILAN and CLARITHROMYCIN

P 8738X Pack 14 tabs(ent coated)equiv 20mg esomeprazole – –70,225 6,695,250

A02BD05 OMEPRAZOLE and CLARITHROMYCIN and AMOXYCILLINP 8272J Pack 14 caps 20mg,14 tabs 500mg,28 caps 500mg – – 13,592 1,295,825

OTHER DRUGS FOR PEPTIC ULCER AND GORDA02BX13 SODIUM ALGINATE with CALCIUM CARBONATE and SODIUM BICARBONATE

P 2014B Oral liquid 1gm–320mg in 20mL 500mL – –127,999 1,684,860

42

A02BX02 SUCRALFATEP 2055E Tablet 1g 4.00 GM 14,343 326,425

43

A


cost($)

ALIMENTARY TRACT AND METABOLISMDRUGS FOR ACID RELATED DISORDERSANTIFLATULENTSANTIFLATULENTS

A02DA PEPPERMINT OILA 13371 Capsule 0.2mL 21 – – 385 –

A 12730

Tablet 135mg 30 0.30 GM 24,493

–A 141

30Tablet 135mg 30 0.30 GM 7,26

6–

P 4328T

Tablet 135mg 0.30 GM 68,514

1,952,662

A 17465 Tablet 6mg 30 – – 647 –A 17466 Tablet 6mg 60 – – 984 –

A 12939

Tablet 10mg 100 60.00

MG 15,234

–A 152

87Tablet 10mg 60.0

0MG 21,42

8–

P 4279F

Injection 20mg in 1mL 60.00

MG 3,634 115,193P 531

7WInjection 20mg in 1mL 60.0

0MG 1,442 87,7

21P 5318X


MG 734 112,692

44

A


cost($)

ALIMENTARY TRACT AND METABOLISMDRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERSDRUGS FOR FUNCTIONAL BOWEL DISORDERSSYNT ANTICHOLIN,ESTERS WITH TERTIARY AMINO GROUP

A03AA04 MEBEVERINE HYDROCHLORIDE

SYNT ANTICHOLINERGICS,ESTERS,QUATER AMMONIUM COMPOUNDA03AB05 PROPANTHELINE

P 1953T Tablet 15mg 60.00MG 27,370 640,925DRUGS ACTING ON SEROTONIN RECEPTORS

A03AE02 TEGASEROD

OTHER DRUGS FOR FUNCTIONAL BOWEL DISORDERSA03AX13 SIMETHICONE

A 13445 Capsule 100mg 30 – – 266 –BELLADONNA AND DERIVATIVES PLAINBELLADONNA ALKALOIDS TERTIARY AMINES

A03BA01 ATROPINEP 1089H Injection 600ug in 1mL 1.50 MG 2,387 40,349P 3453R Injection 600ug in 1mL 1.50 MG 11,035 167,971

A03BA04 HYOSCYAMINE SULPHATE with ATROPINE SULPHATE with HYOSCINE HYDROBROMIDEA 10631 Mixture 100mL 1 1.00 MG 561 –A 10632 Drop 30mL 1 1.00 MG 319 –

A03BA KAOLIN with PECTIN with HYOSCYAMINE SULPHATE with ATROPINE SULPHATE with HYOSCINE HYDROBROMIDEA 10629 Suspension 200mL 1 – – 255 –

BELLADONNA ALKALOIDS SEMISYNT QUATER AMMONIUM COMPOUNDA03BB01 BUTYLSCOPOLAMINE

A03BB HYOSCINE HYDROBROMIDEA 10972 Ampoule 400ug 5 – – 1,662 –

DOMPERIDONEA 11309 Tablet 10mg 100 30.0

0MG 14,75

0–

P 1347X Tablet 10mg 30.0 MG 259,0 2,875,METOCLOPRAMIDE HYDROCHLORIDEA 111

38Tablet 10mg 100 30.0

0MG 5,76

3–

P 1205K

Syrup 5mg per 5mL 100mL

30.00

MG 223 1,824P 120

6LInjection 10mg in 2mL 30.0

0MG 37,78

5538,662P 120

7MTablet 10mg 30.0

0MG 768,6

725,526,064A 200

15Syrup 5mg per 5mL 100mL

30.00

MG 177 –P 347

6YInjection 10mg in 2mL 30.0

0MG 30,61

0353,645P 515

1DTablet 10mg 30.0

0MG 636 4,3

01

45

A


cost($)

ALIMENTARY TRACT AND METABOLISMDRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERSPROPULSIV

ES PROPULSIV

ES A03FA03

A03FA01

DOLASETRON MESYLATEP 592

3RTablet 200mg 0.2

0GM 387 16,3

26P 5924T

I.V. injection 100mg in 5mL 0.10

GM 938 17,390P 819

1DTablet 200mg 0.2

0GM 16,57

4927,569P 819 I.V. injection 100mg in 5mL 0.1 GM 7,40 255,

GRANISETRONP 589

8KTablet 2mg (base) 2 2.0

0MG 6,25

7320,746P 589

9LConcentrated injection 3mg (base) in 3mL

3.00

MG 8,554

227,662P 872

8JTablet 2mg (base) 2 2.0

0MG 22,17

21,476,435P 872

9KConcentrated injection 3mg (base) in 3mL

3.00

MG 25,685

1,072,617P 887 Tablet 2mg (base) 5 2.0 MG 163 36,6

ONDANSETRONP 159

4XTablet 4mg 16.0

0MG 2,59

4345,118P 159

5YTablet 8mg 16.0

0MG 3,23

6634,563P 159

6BI.V.injection 4mg/2mL 16.0

0MG 152 8,0

33P 1597C

I.V.injection 8mg in 4mL 16.00

MG 114 28,878A 160

47Suppository 16mg 5 – – 157 –

P 5967C

Tablet 4mg 16.00

MG 367 14,247P 596

8DTablet 8mg 16.0

0MG 10,27

4548,588P 596

9EWafer 4mg 4 16.0

0MG 117 6,2

15P 5970F

Wafer 8mg 4 16.00

MG 1,287

68,787P 597

2HI.V. injection 8mg in 4mL 16.0

0MG 9,02

7247,642P 822

4WTablet 4mg 16.0

0MG 10,38

9535,662P 822

5XTablet 8mg 16.0

0MG 47,04

63,329,273P 822

6YI.V. injection 4mg in 2mL 16.0

0MG 2,07

162,462P 822

7BI.V. injection 8mg in 4mL 16.0

0MG 33,07

21,591,925P 841

0PWafer 4mg 4 16.0

0MG 13,13

8595,549P 841

1QWafer 8mg 4 16.0

0MG 14,32

51,143,735P 841

2RWafer 4mg 10 16.0

0MG 4,07

9511,448P 841 Wafer 8mg 10 16.0 MG 3,66 739,

TROPISETRONP 274

5LCapsule 5mg (base) 5.0

0MG 30,07

71,851,914P 274

6MI.V. injection 5mg/5mL 5.0

0MG 17,80

9627,642P 598

6CCapsule 5mg (base) 5.0

0MG 7,48

9288,256P 598

7DI.V. injection 5mg/5mL 5.0

0MG 8,52

2170,589

46

A


cost($)

ALIMENTARY TRACT AND METABOLISMANTIEMETICS AND ANTINAUSEANTSANTIEMETICS AND ANTINAUSEANTSSEROTONIN (5HT3) ANTAGONISTS

A04AA04

A04AA02

A04AA01

A04AA03

VARIOUS ANTIEMETICSA04AD12 APREPITANT

P 5888X Pack 1 cap 125mg and 2 cap 80mg

95.00

MG 5,643

677,520P 8808N Pack 1 cap 125mg

and 2 cap 80mg95.00

MG 19,657

2,895,955

47

A


cost($)

ALIMENTARY TRACT AND METABOLISMBILE AND LIVER THERAPYBILE THERAPYBILE ACID PREPARATIONS

A05AA02 URSODEOXYCHOLIC ACID

P 8448P Capsule 250mg 100 0.75 GM 25,265 6,492,593

DOCUSATE SODIUMA 16099 Tablet 120mg 100 0.1

5GM 8,431 –

P 4200C Tablet 50mg 0.1 GM 8,329 94,2LIQUID PARAFFINA 10107 Oral suspension

vanilla 200mL15.00

GM 579 –A 10108 Oral suspension

vanilla 500mL15.00

GM 5,248 –

P 1258F

Suppositories 10mg 12

10.00

MG 1,483

25,563P 125

9GTablet 5mg 10.0

0MG 33,34

5440,173P 126

0HSuppositories 10mg 10

10.00

MG 42,574

840,474A 126

69Tablet 5mg 50 10.0

0MG 1,42

6–

P 3250C

Suppositories 10mg 10

10.00

MG 738 32,215P 530 Suppositories 10mg 10.0 MG 219 5,1

DOCUSATE SODIUM with SENNAA 12753 Tablet 30 – – 5,79

4–

P 4198Y Tablet 50mg–8mg – – 202,0 2,614,SENNA STANDARDISEDA 11880 Granules 150g 1 – – 3,17

6–

P 4455L Tablet 7.5mg – – 12,461

140,366

A 11156

Powder 500g 1 7.00

GM 793 –A 112

73Powder 500g 1 7.0

0GM 517 –

P 4285M

Sachets 3.5g 30 7.00

GM 3,524

56,867P 441

9NOral powder(orange–flavour sugar free)315g

7.00

GM 26,901

548,422P 442 Oral powder (non–flavoured) 7.0 GM 23,41 475,

STERCULIA with FRANGULA BARKP 110

4DGranules 620mg–80mg per g (62%–8) 500g

– – 84,647

1,958,743A 130

98Granules 200g 1 – – 288 –

P 3275J

Granules 620mg–80mg per g (62%–8) 500g

– – 783 25,712P 455 Granules 620mg–80mg per g – – 11,04 255,

STERCULIA, COMBINATIONSP 5322D Granules 620mg–80mg

per g (62%–8%) 500g– – 475 16,5

58P 5324F Granules 620mg–80mg per g (62%–8%) 500g

– – 120 4,571

48

A


cost($)

ALIMENTARY TRACT AND METABOLISMLAXATIVESLAXATIVESSOFTENERS EMOLLIENTS

A06AA02

A06AA01

CONTACT LAXATIVESA06AB02 BISACODYL

A06AB56

A06AB06

A06AB58 SODIUM PICOSULFATE with MAGNESIUM CARBONATEA 18511 Sachet 20g 2 – – 222 –

BULK PRODUCERSA06AC51 ISPAGHULA COMBINATIONS

P 4416K Oral Powder 440g – – 1,845 36,110A06AC01 PSYLLIUM HYDROPHILIC MUCILLOID

A06AC53

A06AC53

P 3064G

Mixture 3.34g per 5mL 500mL

6.70

GM 358,801

5,481,231P 538

7MMixture 3.34g per 5mL 500mL 1

6.70

GM 9,044

207,087P 538

8NMixture 3.34g per 5mL 500mL 1

6.70

GM 1,070

40,091

P 2091C

Enemas 3.125g–450mg–45mg in 5mL 12

– – 42,258

1,418,403P 327

4HEnemas 3.125g–450mg–45mg in 5mL 12

– – 3,812

201,697P 446

2WEnemas 3.125g–450mg–45mg in 5mL 4

– – 2,702

29,348P 533

1NEnemas 3.125g–450mg–45mg in 5mL 12

– – 976 48,698P 533

2PEnemas 3.125g–450mg–45mg in 5mL 12

– – 234 16,554

49

A


cost($)

ALIMENTARY TRACT AND METABOLISMLAXATIVESLAXATIVESOSMOTICALLY ACTING LAXATIVES

A06AD11 LACTULOSE

A06AD11 LACTULOSE with GALACTOSE with LACTOSE with EPILACTOSEA 10693 Syrup 200mL 1 6.70 GM 1,137 –

A06AD15 MACROGOLP 5389P Sachets powder 13.125g with electrolytes 30 10.00 GM 8,137

254,218P 5390Q Sachets powder 13.125g with electrolytes 30 10.00GM 1,595

56,500P 8612G Sachets powder 13.125g with electrolytes 30 10.00 GM

226,793 5,196,402A06AD SORBITOL

A 14787 Liquid 70% 500mL – – 10,258 –ENEMAS

A06AG02 BISACODYLP 1263L Enemas 10mg in 5mL 25 – – 9,731 368,774P 3263R Enemas 10mg in 5mL 25 – – 3,215 178,531P 5302C Enemas 10mg in 5mL 25 10.00MG 619 38,031

A06AG20 COMBINATION (SORBITOL/SODIUM CITRATE/SODIUM LAVRYL SULFOACETATE)

A06AG01 SODIUM PHOSPHATEA 15629 Laxative Mixt 3.3G/5mL – – 4,923 –

OTHER LAXATIVESA06AX01 GLYCEROL

P 2555L

Suppositories 700mg (for infants) 12

– – 483 6,658P 255

6MSuppositories 1.g (for children) 12

– – 628 9,404P 255

7NSuppositories 2.8g (for adults) 12

– – 8,082 123,113P 326

7YSuppositories 2.8g (for adults) 12

– – 223 6,110P 424

6LSuppositories 2.8g (for adults) 12

– – 407 6,062

NEOMYCIN SULPHATEP 232 Tablet 500mg 5.00 GM 740 16,4NYSTATINP 169

6GTablet 500,000 units 1500.

00TE 20,19

0379,826P 169

9KCapsule 500,000 units

1500.00

TE 33,467

691,590

A 11123

Tablet 2.5mg–25ug 15.00 MG 1,400

–A 162

60Tablet 2.5mg–25ug 15.00 MG 9,96

6–

P 250 Tablet 2.5mg–25ug 15.00 MG 287,3 2,407,LOPERAMIDE HYDROCHLORIDEP 1571Q Capsule 2mg 10.00 MG 285,8

523,635,516A 16133 Tablet 2mg 8 10.00 MG 160 –

50

A


cost($)

ALIMENTARY TRACT AND METABOLISMANTIDIARR. INTEST. ANTIINFL./ANTIINFECT. AGENTSINTESTINAL ANTIINFECTIVESANTIBIOTICSA07AA01

A07AA02

ELECTROLYTES WITH CARBOHYDRATESORAL REHYDRATION SALT FORMULATIONS

A07CA ELECTROLYTE REPLACEMENT (ORAL)P 3196F Sachets of powder for oral solution 4.87g 10 – – 26,445

361,059ANTIPROPULSIVESANTIPROPULSIVES

A07DA01 DIPHENOXYLATE HYDROCHLORIDE with ATROPINE SULPHATE

A07DA03

INTESTINAL ANTIINFLAMMATORY AGENTSCORTICOSTEROIDS FOR LOCAL USE

A07EA02 HYDROCORTISONE ACETATEP 1502C Rectal foam 125mg per applicator (10%) aerosol – –

14,516 522,260A07EA01 PREDNISOLONE SODIUM PHOSPHATE

P 1920C Retention enema equivalent to 20mg prednisolone

– – 6,423 831,888P 2554K Suppositories equivalent to

5mg prednisolone 10– – 6,894 299,

177

50

MESALAZINEP 161

1TTablet 250mg 1.5

0GM 73,2

6012,024,940P

P2214M2234N

Tablet 500mg (prolonged release)Oral granules(prolonged

1.50

1.5

GM

GM

581

25

113,037

71,5P 2287J

Oral granules(prolonged release)2g per sachet 60

1.50

GM 725

228,987P 859

8MOral granules 500mg per sachet 100

1.50

GM 3,126

540,855P 859

9NOral granules 1 mg per sachet 100

1.50

GM 19,723

5,822,132P 861

6LEnemas 2g in 60mL 7 1.5

0GM 2,02

1675,816P 861

7MEnemas 4g in 60mL 7 1.5

0GM 5,96

82,641,466P 873

1MTablet 500mg (enteric coated)

1.50

GM 39,636

9,596,317P 875

2PSuppositories 1gm 28 1.5

0GM 5,89

9745,938P 875

3QEnemas 1g in 100mL 7 1.5

0GM 52

5173,014P 876 Rectal foam 1g per app, 14 1.5 GM 1,19 390,

OLSALAZINE SODIUMP 1728Y Capsule 250mg 1.0

0GM 6,83

7599,476P 8086N Capsule 500mg 1.0 GM 15,7 2,153,

SULPHASALAZINEP 2093E Tablet 500mg 2.0

0GM 24,8

731,288,742P 2096H Tablet 500mg (enteric

coated)2.00

GM 198,769

11,312,226

A


cost($)

ALIMENTARY TRACT AND METABOLISMANTIDIARR. INTEST. ANTIINFL./ANTIINFECT. AGENTSINTESTINAL ANTIINFLAMMATORY AGENTSAMINOSALICYLIC ACID AND SIMILAR AGENTS

A07EC04 BALSALAZIDEP 8845M Capsule 750mg 6.75 GM 12,788 1,878,207

A07EC02

A07EC03

A07EC01

51

A 10636

Capsule 15mg 30 15.00 MG 15,756 –A 106

37Capsule 30mg 30 15.00 MG 78,275 –

A 106 Capsule 40mg 30 15.00 MG 94,875 –SIBUTRAMINEA 17447 Capsule 10mg

3010.00 MG 54,500 –

A 17448 Capsule 15mg 30

10.00 MG 74,340 –

A


cost($)

ALIMENTARY TRACT AND METABOLISMANTIOBESITY PREPARATIONS EXCL DIET PRODUCTSANTIOBESITY PREPARATIONS EXCL DIET PRODUCTSCENTRALLY ACTING ANTIOBESITY PRODUCTS

A08AA01 PHENTERMINE

A08AA10

PERIPHERALLY ACTING ANTIOBESITY PRODUCTSA08AB01 ORLISTAT


0.36 GM 3,677

–P 4570M Capsule 120mg

840.36 GM 15,01

81,913,294

52

A


cost($)

ALIMENTARY TRACT AND METABOLISMDIGESTIVES INCL ENZYMESDIGESTIVES INCL ENZYMESENZYME PREPARATIONS

A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)P 249

5HCapsule providing >10,000 BP units lipase activity

– – 8,580

1,484,176P 802

0DCapsule (containing enteric coated microspheres)

– – 13,387

2,228,326P 802

1ECapsule (containing enteric coated microspheres)

– – 27,362

4,454,383P 836

6HCapsule providing >25,000 BP units lipase activity

– – 2,003

288,100P 855

6HCapsule (containing enteric coated microspheres)

– – 11,421

1,302,437

A10AB02

INSULIN (BEEF)P 1713E Injection 100 units per mL 10mL

40.00

IE 611

83,343A10AB0

1INSULIN (HUMAN)P 1531N Injection 100 units per mL 10mL

40.00

IE 18,259

2,278,177P 1762R Injection 100 units per

mL 3mL 540.00

IE 29,822

6,391,129A10AB0

5INSULIN ASPARTP 8435Y Injection (human) 100 units per mL 3mL 5

40.00

IE 102,424

26,393,713P 8571D Injection (human) 100

units per mL 10mL 540.00

IE 10,647

1,660,047A10AB0

6INSULIN GLULISINEP 1921D Injection (human) 100 units per mL 3mL 5

40.00

IE 481

123,049A10AB0

4INSULIN LISPROP 8084L Injection 100 units per mL 10mL

40.00

IE 8,991

1,417,076P 8212F Injection 100 units per

mL 3mL 540.00

IE 31,060

8,125,953

P 1533Q Injection 100 units per mL 10mL

40.00

IE 31,223

4,124,096P 1761Q Injection 100 units

per mL 3mL 540.00

IE 76,025

16,592,407

P 1425B

Injection 100 units per mL (50 units–50 units)

40.00

IE 1,006

134,288P 142

6CInjection 100 units per ml (30 units–70 units)

40.00

IE 15,665

2,057,978P 176

3TInjection 100 units per mL (30 units–70 units)

40.00

IE 112,240

24,687,900A 201

58Injection 100 units per mL (20 units–80 units)

40.00

IE 292

–A 201

61Injection 100 units per ml 10ml 1

40.00

IE 1,074

–P 206

2MInjection 100 units per mL (50 units–50 units)

40.00

IE 6,047

1,328,811P 800

6JInjection 100 units per mL (20 units–80 units)

40.00

IE 3,518

778,031A10AD3

0INSULIN ASPART/PROTAMINE ASPARTP 8609D Injection (human analogue) 30/70 units per mL

IE 97,887

25,400,907A10AD0

4INSULIN LISPROP 8390N Injection (human analogue) 100 units per mL 3mL 5 40.00

IE

12,339

3,232,212P 8874C Inj (human analogue) 100

units(50/50)per mL 3mL 5 40.00IE

1,411

367,806

53

A


cost($)

ALIMENTARY TRACT AND METABOLISMANTIDIABETIC THERAPYINSULINS AND ANALOGUESINSULINS AND ANALOGUES FAST–ACTING

INSULINS AND ANALOGUES INTERMEDIATE–ACTINGA10AC02 INSULIN (BEEF)

P 1711C Injection 100 units per mL 10mL 40.00 IE 851 117,050A10AC01 INSULIN (HUMAN)

INSULINS AND ANALOGUES INTERMEDIATE ACTING COMBINED WITH FAST–ACTINGA10AD01 INSULIN (HUMAN)

INSULINS AND ANALOGUES LONG–ACTINGA10AE05 INSULIN DETEMIR

P 9040T Injection 100 units per mL 3mL 5 40.00 IE 21,4329,084,785

A10AE04 INSULIN GLARGINEA 18353 Injection 100 units

per mL 10mL40.00

IE 882

–P 9039R Injection 100 units

per mL 3mL 540.00

IE 103,721

43,355,035

P 1801T

Tablet 850mg 2.00

GM

447,230

6,385,443P 243

0XTablet 500mg 2.0

0GM

1,822,646

25,313,324P 860

7BTablet 1000mg 2.0

0GM

1,060,124

21,239,882P 888

4NTablet 500mg (extended release) 90

2.00

GM

507,471

6,620,060

A10BB01

GLIBENCLAMIDEP 2939Q Tablet 5mg 10.0

0MG

159,244

1,668,314A10BB0

9GLICLAZIDEP 2449X Tablet 80mg 0.1

6GM

588,647

8,481,041P 8535F Tablet 30mg

(modified release)0.16

GM

1,051,473

15,334,024A10BB1

2GLIMEPIRIDEP 8450R Tablet 1mg 30 2.0

0MG

81,611

711,160P 8451T Tablet 2mg 30 2.0

0MG

112,696

1,336,011P 8452W Tablet 4mg 30 2.0

0MG

279,657

4,455,183P 8533D Tablet 3mg 30 2.0

0MG

41,464

569,692A10BB0

7GLIPIZIDEP 2440K Tablet 5mg 100 10.0

0MG

90,855

995,663

P 9059T

Tablet Rosiglitazone/metformin

– – 10,221

674,812P 906

0WTablet Rosiglitazone/metformin2mg(base)/1000mg 56 – – 31,99

02,238,920P 906

1XTablet Rosiglitazone/metformin4mg(base)/500mg 56 – – 8,34

6796,725P 906

2YTablet Rosiglitazone/metformin4mg(base)/1000mg 56 – – 41,94 4,168,

METFORMIN and SULFONAMIDESP 881

0QTablet Metformin 500mg/glibenclamide 2.5mg, 90

– – 45,527

750,587P 881

1RTablet Metformin 500mg/glibenclamide 5mg, 90

– – 62,974

1,125,483P 883

8ETablet Metformin 250mg/glibenclamide 1.25, 90

– – 5,048

68,613

54

A


cost($)

ALIMENTARY TRACT AND METABOLISMANTIDIABETIC THERAPYORAL BLOOD GLUCOSE LOWERING DRUGSBIGUANIDES

A10BA02 METFORMIN HYDROCHLORIDE

SULFONAMIDES UREA DERIVATIVES

BIGUANIDES AND SULFONAMIDES IN COMBINATIONA10BD03 METFORMIN and ROSIGLITAZONE

A10BD02

ALPHA GLUCOSIDASE INHIBITORSA10BF01 ACARBOSE

P 8188Y Tablet 50mg 0.30 GM 29,137

849,772P 8189B Tablet 100mg 0.30 GM 27,60

71,106,952

P 8694N

Tablet 15mg (base) 28

30.00

MG 42,694

2,633,002P 869

5PTablet 30mg (base) 28

30.00

MG 105,401

9,582,649P 869 Tablet 30mg (base) 30.0 MG 57,9 6,708,

ROSIGLITAZONEP 8689H Tablet 4mg (base)

286.00 MG 255,7

7616,018,900P 8690JTablet 8mg (base) 28 6.00 MG 222,7

7820,221,238

55

A


cost($)

ALIMENTARY TRACT AND METABOLISMANTIDIABETIC THERAPYORAL BLOOD GLUCOSE LOWERING DRUGSTHIAZOLIDINEDIONES

A10BG03 PIOGLITAZONE HYDROCHLORIDE

A10BG02

OTHER BLOOD GLUCOSE LOWERING DRUGSA10BX02 REPAGLINIDE

A 16645

Tablet 0.5mg 90 6.00 MG 110

–A 166

46Tablet 1mg 90 6.00 MG 46

3–

A 16647

Tablet 2mg 90 6.00 MG 2,213 –

56

A


cost($)

ALIMENTARY TRACT AND METABOLISMVITAMINSMULTIVITAMINS COMBINATIONSMULTIVITAMINS WITH MINERALS

A11AA03 VITAMINSA 11955 Dispersible tablet

10– – 134 –

A 16530 Tablet 60 – – 391 –VITAMIN A AND D INCL COMBINATIONS OF THE T WOVITAMIN A PLAIN

A11CA01 VITAMIN AA 12182 Capsule 50 000 units 100 50.00 TE 556 –

VITAMIN D AND ANALOGUESA11CC04 CALCITRIOL

P 2502Q Capsule 0.25ug 1.00 UG 159,5408,671,042A11CC01 ERGOCALCIFEROL

A 16060 Capsule 25ug 60 – – 291,087 –VITAMIN B1,PLAIN AND IN COMB. WITH VITAMIN B6 AND B12THIAMINE (VITAMIN B1) PLAIN

A11DA01 THIAMINE HYDROCHLORIDEP 1070H Tablet 100mg 50.00 MG 14,10

5134,438P 4043T Tablet 100mg 50.00 MG 26,26

3249,596VITAMIN B–COMPLEX INCL COMBINATIONS

VITAMIN B–COMPLEX PLAINA11EA VITAMIN B GROUP COMPLEX

P 4493L Oral liquid 200mL – – 17,839 213,605VITAMIN B–COMPLEX WITH VITAMIN C

A11EB VITAMIN B with CA 14139 Tablet 90 – – 491 –

OTHER PLAIN VITAMIN PREPARATIONSOTHER PLAIN VITAMIN PREPARATIONS

A11HA02 PYRIDOXINE HYDROCHLORIDEA 116

48Tablet 25mg 100 160.

00MG 94

6–

A 11649

Tablet 100mg 50 160.00

MG 1,494 –A 185

83Tablet 25mg 100 160.

00MG 12

0–

OTHER VITAMIN PRODUCTS COMBINATIONSVITAMINS WITH MINERALS

A11JB VITAMINS with MINERALSA 100

99Capsule 30 – – 3,746 –

A 12946

Capsule 100 – – 410

–A 129

47Capsule 100 – – 75

6–

A 20271

Tablet 600mg (as carbonate) 120

3.00

GM 6,628

–P 311

6BTablet (chewable) 500mg (as carbonate)

3.00

GM 2,440

37,597P 311

7CTablet 600mg (as carbonate) 3.0

0GM 73,33

21,098,386P 433

3CTablet (chewable) 500mg (as carbonate) 120

3.00

GM 3,599

49,609P 433 Tablet 600mg (as carbonate) 3.0 GM 54,24 702,

CALCIUM CITRATEP 4332B Tablet 250mg (as citrate)

120– – 3,91

450,272P 8560M Tablet 250mg (as citrate) – – 1,91

725,198

57

A


cost($)

ALIMENTARY TRACT AND METABOLISMMINERAL SUPPLEMENTSCALCIUMCALCIUM

A12AA20 CALCIUM (DIFFERENT SALTS IN COMBINATION)A 15690 Compound effervescent tablet equivalent to 1g 0.50 GM

409 –A12AA04 CALCIUM CARBONATE

A12AA

CALCIUM, COMBINATIONS WITH OTHER DRUGSA12AX CALCIUM CARBONATE with CHOLECALCIFEROL

A 10600 Tablet 600mg 60 3.00 10,755 –POTASSIUMPOTASSIUM

A12BA01 POTASSIUM CHLORIDEP 2642C Tablet 600mg

(sustained release)3.00

GM 326,202

3,627,729P 3012M Effervescent tabs

14mmol K,8mmol Cl ions3.00

GM 30,228

355,793OTHER MINERAL SUPPLEMENTS

ZINCA12CB01 ZINC SULPHATE

A 12264 Capsule 50mg 100 0.60 GM 271 –MAGNESIUM

A12CC05 MAGNESIUM ASPARTATEA 11226 Tablet 100 – – 5,242 –P 4321K Tablet 500mg – – 26,56

7385,746

58

A


cost($)

ALIMENTARY TRACT AND METABOLISMANABOLIC AGENTS FOR SYSTEMIC USEANABOLIC STEROIDSESTREN DERIVATIVES

A14AB01 NANDROLONE DECANOATEP 1671Y Injection 50mg in 1mL

disposable syringe2.00

MG 19,112

383,468A 18759 Injection 50mg in 1mL

disposable syringe2.00

MG 506 –

P 2209G

Tablet 2mg 7.50 MG

915,391

8,479,409P 221

1JTablet 5mg 7.50 M

G638,858

6,891,799P 284

3PTablet 1mg 7.50 M

G1,037,902

9,890,872P 284

4QTablet 3mg 7.50 M

G304,468

3,078,696

P 2816F

Inj 5,000 units (anti–Xa) in 0.2mL syringe

2.50

TE 9,525

588,796P 826

9FInj 10,000 units (anti–Xa) in 1mL syringe

2.50

TE 245 54,765P 827

1HInj 7,500 units (anti–Xa) in 0.75mL syringe

2.50

TE 360 61,656P 860

3TInj 2,500 units (anti–Xa) in 0.2mL syringe

2.50

TE 6,483

348,178P 864

1TInj 2,500 units (anti–Xa) in 0.2mL syringe

2.50

TE 537 50,505P 864

2WInj 5,000 units (anti–Xa) in 0.2mL syringe

2.50

TE 1,069

104,415P 864 Inj 7,500 units (anti–Xa) in 2.5 TE 161 26,4

ENOXAPARINP 826

2WInj 60mg (6000u anti–Xa) in 0.6mL syringe

2.00

TE 28,109

3,026,056P 826

3XInj 80mg (8000u anti–Xa) in 0.8mL syringe

2.00

TE 40,215

5,007,231P 826

4YInj 100mg (10000u anti–Xa) in 1 mL syringe

2.00

TE 39,003

5,982,007P 851

0XInj 40mg (4000u anti–Xa) in 0.4 mL syringe

2.00

TE 101,497

6,261,748P 855

8KInj 20mg (2000u anti–Xa) in 0.2mL syringe

2.00

TE 37,835

2,087,006P 863

9QInj 40mg (4000u anti–Xa) in 0.4mL syringe

2.00

TE 13,951

1,327,526P 864

0RInj 60mg (6000u anti–Xa) in 0.6mL syringe

2.00

TE 7,093

1,012,377P 871 Inj 20mg (2000u anti–Xa) in 2.0 TE 4,43 404,

HEPARIN SODIUMP 107

6PInjection 35,000 units in 35mL 12

10.00

TE 1,544

234,178P 146

3BInjection 5,000 units in 5mL 10.0

0TE 3,87

2188,855P 146

6EInjection 5,000 units in 0.2mL

10.00

TE 34,138

411,626

59

B


cost($)

BLOOD AND BLOOD FORMING ORGANSANTITHROMBOTIC AGENTS

ANTITHROMBOTIC AGENTSVITAMIN K ANTAGONISTSB01AA02 PHENINDIONE

A 14975 Tablet 10mg 0.10 GM 1,150 –B01AA03 WARFARIN

HEPARIN GROUPB01AB04 DALTEPARIN

B01AB05

B01AB01

60

B01AC06 ASPIRINA 105

44Tablet 100mg 30 0.1

0GM

6,417

–A 105

99Tablet 100mg 28 0.1

0GM

20,985

–A 130

20Capsule 100mg 28 0.1

0GM

826

–P 407

6MTablet 100mg (enteric coated) 0.1

0GM

25,739

326,746P 407

7NTablet 100mg (enteric coated) 0.1

0GM

103,562

1,262,161P 407

8PCapsule 100mg (enteric coated pellets)

0.10

GM

16,007

210,005P 820 Tablet 100mg 0.1 G 1,206, 8,368,

B01AC04 CLOPIDOGRELP 4179Y Tablet 75mg (base) 28 75.0

0MG

35,457

2,911,936P 8358X Tablet 75mg 75.0 M 2,502, 205,31

B01AC07 DIPYRIDAMOLEA 13040 Tablet 100mg 100 0.4

0GM

803

–P 8335Q Capsule 200mg (sustained

release)0.40

GM

56,462

1,908,924B01AC3

0DIPYRIDAMOLE with ASPRINP 8382E Capsule 200mg (sustained release) 25mg

– – 463,749

15,550,752B01AC0

9EPOPROSTENOLP 6478Y Powder for I.V. infusion 1.5mg (base) with diluent

– – 130

542,743B01AC1

6EPTIFIBATIDEP 8683B Solution for I.V. injection 20mg (base) in 10mL

0.20

GM

344

88,780P 8684C Solution for I.V. infusion

75mg (base) in 100mL0.20

GM

338

257,308B01AC1

1ILOPROSTP 6456T Solution for inhalation 20ug (base) in 2mL, 30

0.15

MG

266

749,738B01AC0

5TICLOPIDINE HYDROCHLORIDEP 2095G Tablet 250mg 0.5

0GM

3,528

523,028B01AC1

7TIROFIBANP 8350L Solution concentrate I.V. infusion 12.5mg in 50mL

10.00

MG

1,869

769,975ENZYMES

B01AD11

TENECTEPLASEP 8527T Powder for injection 50mg with solvent

40.00

MG

234

481,878

B


cost($)

BLOOD AND BLOOD FORMING ORGANSANTITHROMBOTIC AGENTSANTITHROMBOTIC AGENTSPLATELET AGGREGATION INHIBITORS EXCL. HEPARINB01AC13 ABCIXIMAB

P 8048N I.V.injection 10mg in 5mL 25.00MG 1,941 2,891,879

DIRECT THROMBIN INHIBITORSB01AE06 BIVALIRUDIN

P 8844L Powder for I.V. injection 250mg (base) 0.25 GM 1,348997,838

61

B


cost($)

BLOOD AND BLOOD FORMING ORGANSANTIHAEMORRHAGICSANTIFIBRINOLYTICSAMINO ACIDS

B02AA02 TRANEXAMIC ACIDP 2180R Tablet 500mg 2.00 GM 33,087 1,652,964

VITAMIN K AND OTHER HAEMOSTATICSVITAMIN K

B02BA01 PHYTOMENADIONEA 110

80Tablet 10mg 100 20.0

0MG 696 –

A 16049

Ampoule 10mg/mL 5 20.00

MG 300 –A 166

48Ampoule 2mg/0.2mL 5 20.0

0MG 177 –

A 16996 Tablet 0.20

GM 50,901

–P 8815Y Oral liquid 30mg per

mL, 250mL0.20

GM 38,035

680,048

P 1508J


UG 130,568

1,578,455A 201

16Injection 1mg in 1mL 2

20.00

UG 399 –P 269

5WInjection 1mg in 1mL 5

20.00

UG 45,746

1,683,910P 904

8FInjection 1mg in 1mL 3

20.00

UG 182,856

2,863,874

62

B


cost($)

BLOOD AND BLOOD FORMING ORGANSANTIANAEMIC PREPARATIONSIRON PREPARATIONSIRON BIVALENT, ORAL PREPARATIONS

B03AA07 FERROUS SULPHATE DRIED

IRON TRIVALENT, PARENTERAL PREPARATIONSB03AC03 IRON POLYMALTOSE COMPLEX

P 2593L Injection 100mg (iron) in 2mL 0.10 GM 42,104 2,347,070B03AC02 SACCHARATED IRON OXIDE

P 8807M Concent for soln for infus 2.7g =100mg iron in 5mL 0.10 GM241 37,100

IRON IN COMBINATION WITH FOLIC ACIDB03AD02 FERROUS FUMARATE WITH FOLIC ACID

P 9011G Tablet 310mg–350ug – – 101,8271,104,225B03AD03 FERROUS SULPHATE DRIED with FOLIC ACID

A 14528 Capsule 270mg–300ug (delayed release)

– – 5,514 –A 18904 Tablet 270mg–300ug

(sustained release)– – 44,214 –

VITAMIN B12 AND FOLIC ACIDVITAMIN B12 (CYANOCOBALAMIN AND DERIVATIVES)

B03BA03 HYDROXOCOBALAMIN

FOLIC ACID AND DERIVATIVESB03BB01 FOLIC ACID

P 1437P Tablet 5mg – – 146,481

1,736,548P 2958Q Tablet 500ug 0.40 MG 60,09

2702,001

P 6320P

Injection 10ug in 0.4mL syringe 4

4.50

UG 215 42,655P 632

1QInjection 20ug in 0.5mL syringe 4

4.50

UG 2,977

1,161,307P 632

2RInjection 30ug in 0.3mL syringe 4

4.50

UG 3,186

1,720,954P 632

3TInjection 40ug in 0.4mL syringe 4

4.50

UG 9,318

6,390,910P 632

4WInjection 50ug in 0.5mL syringe 4

4.50

UG 1,239

1,003,536P 632

5XInjection 60ug in 0.3mL syringe 4

4.50

UG 4,061

4,240,931P 632

6YInjection 100ug in 0.5mL syringe

4.50

UG 2,461

4,416,100P 636

5BInjection 150ug in 0.3mL syringe

4.50

UG 821 1,880,425P 643

8WInjection 80ug in 0.4mL syringe 4

4.50

UG 1,644

2,113,132P 648

8LInjection 20ug in 0.5mL prefilled injection pen 1

4.50

UG 327 127,727P 648

9MInjection 40ug in 0.4mL prefilled injection pen 1

4.50

UG 604 369,989P 649

0NInjection 60ug in 0.3mL prefilled injection pen 1

4.50

UG 173 171,044P 649 Injection 80ug in 0.4mL 4.5 UG 112 140,

ERYTHROPOIETINP 620

5NInjection 3,000 units in 0.3mL syringe

1.00

TE 207 133,487P 620

6PInjection 4,000 units in 0.4mL syringe

1.00

TE 847 608,120P 620

7QInjection 10,000 units in 1mL syringe

1.00

TE 1,277

2,071,368P 630

2QInjection 5,000 units in 0.5mL syringe

1.00

TE 193 177,348P 630

3RInjection 6,000 units in 0.6mL syringe

1.00

TE 1,064

1,085,099P 630

5WInjection 8,000 units in 0.8mL syringe

1.00

TE 1,058

1,340,283P 633

9PInjection 40,000 units in 1mL syringe

1.00

TE 227 670,444P 643

4PInjection 20,000 units in 0.5mL syringe

1.00

TE 112 294,223P 648

2EInjection 4,000 units in 0.3mL syringe 6

1.00

TE 583 284,814P 648

4GInjection 6,000 units in 0.3mL syringe 6

1.00

TE 489 382,977P 648

5HInjection 10,000 units in 0.6mL pre–filled 6

1.00

TE 389 512,567

63

B


cost($)

BLOOD AND BLOOD FORMING ORGANSANTIANAEMIC PREPARATIONSOTHER ANTIANAEMIC PREPARATIONSOTHER ANTIANAEMIC PREPARATIONS

B03XA02 DARBEPOETIN ALPHA

B03XA01

64

B


cost($)

BLOOD AND BLOOD FORMING ORGANSBLOOD SUBSTITUTES AND PERFUSION SOLUTIONSBLOOD AND RELATED PRODUCTSBLOOD SUBSTITUTES AND PLASMA PROTEIN FRACTIONS

B05AA06 GELATIN SUCCINYLATEDP 8444K I.V. infusion 20g per 500mL,500mL – – 5,089

193,285I.V. SOLUTIONSSOLUTIONS FOR PARENTERAL NUTRITION

B05BA03 GLUCOSEP 2245E I.V. infusion 278mmol per l (5%) 1L – – 1,307 28,981

SOLUTIONS AFFECTING THE ELECTROLYTE BALANCEB05BB01 SODIUM CHLORIDE

A 18528

Ampoule 0.9% 10mL 50 – – 199 –P 226

0YI.V. infusion 513mmol per l (3%) 1L

– – 119 3,030P 226

4EI.V. infusion 154mmol per l (0.9% ) 1L

– – 25,152

908,220B05BB0

2SODIUM CHLORIDE with GLUCOSEP 2281C I.V. infusion 31mmol–222mmol per l (0.18%–4%) 1L

– – 4,899 116,878B05BB0

1SODIUM LACTATE COMPOUNDP 2286H I.V. infusion 1L – – 12,06

8281,019IRRIGATING SOLUTIONS

SALT SOLUTIONSB05CB01 SODIUM CHLORIDE

P 4460R Irrigation solution 9mg per mL (0 .9%) 500mL

– – 779

8,400P 4461T Irrigation solution 9mg per

mL (0 .9%) 1L– – 42

24,293I.V. SOLUTION ADDITIVES

ELECTROLYTE SOLUTIONSB05XA05 MAGNESIUM SULFATE

A 13927 Ampoule 5mL 5 – – 121 –

65

B


cost($)

BLOOD AND BLOOD FORMING ORGANSOTHER HAEMATOLOGICAL AGENTSOTHER HAEMATOLOGICAL AGENTSENZYMES

B06AA03 HYALURONIDASEA 10985 Ampoule 1500u 5 – – 498 –

P 2923W Capsule 100mg 0.40

GM 8,091 206,534P 2924X Capsule 150mg 0.4 GM 3,711 126,

QUINIDINEA 19846 Tablet 250mg

(sustained release) 1001.20

GM 384 –

P 2875H

Injection 100mg in 5mL

3.00 GM 762 34,509P 287

6JInfusion 500mg in 5mL 3.00 GM 245 10,1

01P 347 Injection 100mg in 3.00 GM 6,810 235,MEXILETINE HYDROCHLORIDEP 1682M Capsule 50mg 0.80 GM 4,692 158,

047P 1683N Capsule 200mg 0.80 GM 3,653 218,019

P 1088G Tablet 50mg 60 0.20 GM 58,462

2,256,182P 1090JTablet 100mg 0.20 GM 94,69

14,463,080

66

C


cost($)

CARDIOVASCULAR SYSTEMCARDIAC THERAPY

CARDIAC GLYCOSIDES

DIGITALIS GLYCOSIDES

C01AA05 DIGOXINP 132

2NTablet 250ug 0.2

5MG 175,8

461,627,775P 260

5DTablet 62.5ug 0.2

5MG 295,5

492,650,710P 316

4MOral solution for children 50ug per mL,

0.25

MG 1,151

28,197ANTIARRHYTHMICS CLASS I AND III

ANTIARRHYTHMICS CLASS IAC01BA03 DISOPYRAMIDE

C01BA01

ANTIARRHYTHMICS CLASS IBC01BB01 LIGNOCAINE HYDROCHLORIDE

C01BB02

ANTIARRHYTHMICS CLASS ICC01BC04 FLECAINIDE ACETATE

ANTIARRHYTHMICS CLASS IIIC01BD01 AMIODARONE HYDROCHLORIDE

P 2343H Tablet 200mg 0.20 GM 285,905

7,167,661P 2344JTablet 100mg 0.20 GM 117,1

011,920,699CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES

ADRENERGIC AGENTSC01CA24 ADRENALINE

P 1016L

Injection 1mg in 1mL (1 in 1,000)

0.50

MG 3,387

69,455A 134

37Syrng 1/10000 1 0.5

0MG 198 –

P 3451P

Injection 1mg in 1mL (1 in 1,000)

0.50

MG 22,653

420,533P 869

7RI.M. injection 150mg in 0.3mL syringe

0.50

MG 18,949

3,380,647P 869

8TI.M. injection 300mg in 0.3mL syringe

0.50

MG 33,779

4,420,170

GLYCERYL TRINITRATEP 145

9TTablets 600ug 100 2.5

0MG 89,6

22928,797P 151

5RTd pad releasing approx. 5mg per 24 hours

5.00

MG 232,935

6,264,104P 151

6TTd pad releasing approx. 10mg per 24 hours

5.00

MG 138,255

4,660,158P 347

5XBuccal/sublingual spray (pump pack) 400ug per dose

2.50

MG 20,544

377,953P 801

0NTd patch releasing approx. 5mg per 24 hours

5.00

MG 96,734

2,599,606P 801

1PTd patch releasing approx. 10mg per 24 hours

5.00

MG 55,953

1,884,064P 802

6KTd patch releasing approx. 1mg per 24 hours

5.00

MG 20,541

692,501P 802

7LTd patch releasing approx. 5mg per 24 hours

5.00

MG 10,403

280,665P 802

8MTd patch releasing approx. 10mg per 24 hours

5.00

MG 8,459

285,723P 811

9HTd patch releasing approx. 15mg per 24 hours

5.00

MG 5,090

173,007P 817 Buccal/sublingual spray (pump 2.5 MG 313,5 5,753,

ISOSORBIDE DINITRATEP 2587E Tablet 10mg 60.0

0MG 19,8

09247,874P 2588F Sublingual tablet 5mg 20.0 MG 9,30 123,

ISOSORBIDE MONONITRATEP 1558B Tablets sustained

release 60mg 3040.00

MG 783,818

10,712,471P 8273K Tablets sustained

release 120mg 3040.00

MG 301,167

7,528,099

67

C


cost($)

CARDIOVASCULAR SYSTEMCARDIAC THERAPYVASODILATORS USED IN CARDIC DISEASESORGANIC NITRATES

C01DA02

C01DA08

C01DA14

OTHER VASODILATORS USED IN CARDIAC DISEASESC01DX16 NICORANDIL

P 8228C Tablet 10mg 40.00 MG 150,076

3,168,105P 8229D Tablet 20mg 40.00 MG 68,58

51,894,876

CLONIDINEA 127

86Ampoule 150ug/mL 5 0.45 MG 748 –

P 3141H

Tablet 150ug 0.45 MG 31,771

1,131,245P 314 Tablet 100ug 0.45 MG 100,5 2,690,

MOXONIDINEP 9019Q Tablet 200mg 30 0.30 MG 15,21

4284,907P 9020R Tablet 400mg 30 0.30 MG 8,87

2240,929

P 1639G Tablet 50mg 0.10 GM 22,367

346,136P 1640H Tablet 25mg 0.10 GM 26,87

9366,903

68

C


cost($)

CARDIOVASCULAR SYSTEMANTIHYPERTENSIVESANTIADRENERGIC AGENTS CENTRALLY ACTINGMETHYLDOPA

C02AB01 METHYLDOPAP 1629R Tablet 250mg 1.00 GM 156,4202,103,710

IMIDAZOLINE RECEPTOR AGONISTSC02AC01

C02AC05

ANTIADRENERGIC AGENTS PERIPHERALLY ACTINGALPHA – ADRENOCEPTOR BLOCKING AGENTS

C02CA01 PRAZOSIN HYDROCHLORIDEP 147

8TTablet 5mg (base) 5.00 MG 138,2

163,328,324P 147

9WTablet 1mg (base) 5.00 MG 297,0

803,904,696P 148

0XTablet 2mg (base) 5.00 MG 168,5

302,723,936ARTERIOLAR SMOOTH MUSCLE AGENTS ACTING ON

HYDRAZINOPHTHALAZINE DERIVATIVESC02DB02 HYDRALAZINE HYDROCHLORIDE

PYRIMIDINE DERIVATIVESC02DC01 MINOXIDIL

P 2313R Tablet 10mg 20.00MG 4,576 258,250OTHER ANTIHYPERTENSIVESOTHER ANTHIYPERTENSIVESC02KX01 BOSENTAN

P 6429JTablet 62.5mg (base) 60

250.00

MG 378

1,139,144P 6430K Tablet 125mg

(base) 60250.00

MG 4,859

15,867,362

P 2411X

Oral solution 10mg per mL 30mL

40.00

MG

2,917

47,405P 241

2YTablet 40mg 40.0

0MG

1,253,177

10,438,694P 241

3BInjection 20mg in 2mL 40.0

0MG

5,708

69,931P 241

4CTablet 20mg 40.0

0MG

231,076

1,981,223P 241

5DTablet 500mg 40.0

0MG

15,987

333,725P 346

6KInjection 20mg in 2mL 40.0

0MG

8,953

93,637

P 8879H Tablet 25mg 30 50.00 MG 4,102

467,192P 8880JTablet 50mg 30 50.00 MG 694 81,6

SPIRONOLACTONEP 2339D Tablet 25mg 75.00 MG 287,9

073,728,964P 2340E Tablet 100mg 75.00 MG 64,61

92,299,934

69

C


cost($)

CARDIOVASCULAR SYSTEMDIURETICSLOW–CEILING DIURETICS THIAZIDESTHIAZIDES PLAIN

C03AA03 HYDROCHLOROTHIAZIDEP 1484D Tablet 25mg 25.00MG 92,372 1,788,760

LOW–CEILING DIURETICS EXCL. THIAZIDESSULFONAMIDES PLAIN

C03BA04 CHLORTHALIDONEP 1585K Tablet 25mg 25.00MG 38,638 469,312

C03BA11 INDAPAMIDEA 164

35Tablet 1.5mg 30 2.5

0MG 325 –

P 2436F

Tablet 2.5mg 90 2.50

MG 232,485

4,505,385P 853

2CTablet 1.5mg (sustained release) 90

2.50

MG 433,492

8,697,642HIGH–CEILING DIURETICS

SULFONAMIDES PLAINC03CA02 BUMETANIDE

A 17855 Tablet 1mg 1.00 MG 8,879 –C03CA01 FRUSEMIDE

ARYLOXYACETIC ACID DERIVATIVESC03CC01 ETHACRYNIC ACID

P 8748K Tablet 25mg 50.00MG 2,056 110,213POTASSIUM–SPARING AGENTSALDOSTERONE ANTAGONISTS

C03DA04 EPLERENONE

C03DA01

OTHER POTASSIUM–SPARING AGENTSC03DB01 AMILORIDE HYDROCHLORIDE

P 3109P Tablet 5mg 10.00MG 27,622 253,737

70

C


cost($)

CARDIOVASCULAR SYSTEMDIURETICSDIURETICS AND POTASSIUM–SPARING AGENTS IN COMBLOW–CEILING DIURETICS AND POTASSIUM–SPARING AGENTS

C03EA01 HYDROCHLOROTHIAZIDE with AMILORIDE HYDROCHLORIDEP 1486F Tablet 50mg–5mg – – 176,4222,017,123

C03EA01 HYDROCHLOROTHIAZIDE with TRIAMTERENEP 1280J Tablet 25mg–50mg 100 – –

45,575 522,634

71

C


cost($)

CARDIOVASCULAR SYSTEMPERIPHERAL VASODILATORSPERIPHERAL VASODILATORSPURINE DERIVATIVES

C04AD03 OXPENTIFYLLINEA 17632 Tablet 400mg 50 1.00 GM 2,258 –

OTHER PERIPHERAL VASODILATORSC04AX02 PHENOXYBENZAMINE HYDROCHLORIDE

P 1862B Capsule 10mg 30 30.00MG 2,648 150,504

C05AA01

HYDROCORTISONE with CINCHOCAINE HYDROCHLORIDEP 4036K Ointment 5mg–5mg per g

– 24,320

446,647C05AA0

1HYDROCORTISONE, CINCHOCAINE HYDROCHLORIDEA 14345 Ointment 5mg–5mg–10mg per g

– 16,013

–P 4038M Suppositories 5mg–5mg 12 – – 14,48

4259,811

and

CLEMIZOLE UNDECYLENATEA 14656 Ointment 1.9mg–5mg–

10mg per g(0.16–0.5%–1%) – – 11,203 –A 14657 Ointment 1.9mg–5mg–

10mg per g(0.195–0.5%–1%) – – 14,335 –A 14658 Suppositories 1.3mg–

1mg–5mg 12– – 6,863 –

A 12829 Cream 0.3%40g 1 – – 416

–A 13774 Cream 0.3% 20g – – 1,216 –HEPARINOID with HYALURONIDASEA 12830 Ointment 14g 1 – – 34

9–

A 12831 Ointment 40g 1 – – 255

–

72

C


cost($)

CARDIOVASCULAR SYSTEMVASOPROTECTIVESAGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USECORTICOSTEROIDS

C05AA01 HYDROCORTISONE, LIGNOCAINE BASE, ALUMINIUM SUBACETATE and ZINC OXIDEA 14653 Ointment 2.5mg–50mg–35mg–180mg per g – – 2,013

–C05AA04 PREDNISOLONE HEXANOATE, CINCHOCAINE HYDROCHLORIDE

LOCAL ANESTHETICSC05AD03 ADRENALINE EPHEDRINE BENZOCAINE ZINC OXIDE

A 13134 Ointment 50g 1 – – 2,435 –MUSCLE RELAXANTS

C05AE01 GLYCERYL TRINITRATEA 16349 Ointment 0.2% 30g 1 – – 4,827 –

OTHER AGENTS FOR TREATMENT HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USEC05AX04 ZINC OXIDE

P 4039N Compound ointment 50g

– – 2,128 27,631P 4040P Compound

suppositories, 12– – 2,193 26,8

55ANTIVARICOSE THERAPYHEPARINS OR HEPARINOIDS FOR TOPICAL USEC05BA01 HEPARINOID

C05BA01

CAPILLARY STABILIZING AGENTSBIOFLAVONOIDS

C05CA02 HYDROXYETHYLRUTOSIDESA 13500 Capsule 250mg 50 – – 193 –A 16101 Capsule 250mg

100– – 594 –

P 2942W Tablet 20mg 0.16 GM 2,258

19,610P 2961W Tablet 40mg 0.16 GM 11,15 119,

PINDOLOLP 3062E Tablet 5mg 15.00 MG 26,54

6312,798P 3065H Tablet 15mg 15.00 MG 25,61 380,

PROPRANOLOL HYDROCHLORIDEP 256

5BTablet 10mg 0.16 GM 132,6

161,128,214P 256

6CTablet 40mg 0.16 GM 319,0

652,800,643P 289 Tablet 160mg 0.16 GM 31,51 300,

SOTALOL HYDROCHLORIDEP 2043M Tablet 160mg 0.16 GM 128,8

754,021,781P 8398B Tablet 80mg 60 0.16 GM 318,9

505,535,846

C07AB03

ATENOLOLP 1081X Tablet 50mg 0.0

8GM

4,281,609

45,827,654C07AB0

7BISOPROLOLP 8604W Tablet 2.5mg 10.0

0MG

88,048

5,135,957P 8605X Tablet 5mg 10.0

0MG

77,795

5,642,129P 8606Y Tablet 10mg 10.0

0MG

69,014

5,713,084C07AB0

2METOPROLOL SUCCINATEP 8732N Tablet 23.75mg (controlled release) 15

150.00

MG

10,504

344,412P 8733P Tablet 47.5mg

(controlled release) 30150.00

MG

23,899

1,808,483P 8734Q Tablet 95mg

(controlled release) 30150.00

MG

23,937

2,221,425P 8735R Tablet 190mg

(controlled release) 30P 8818D Pack 15 tabs 23.75mg, 15 tabs 47.5mg, 15

150.00

M

MG

22

18,387

20,8

2,006,625

C07AB02

METOPROLOL TARTRATEP 1324Q Tablet 50mg 150.

00MG

1,101,150

11,923,549P 1325R Tablet 100mg 150.

00MG

482,274

6,059,688

A 16540

Tablet 6.25mg 30 37.50 MG 234

–P 825

5LTablet 3.125mg 30 37.50 MG 48,4

201,411,841P 825

6MTablet 6.25mg 37.50 MG 126,4

399,230,416P 825

7NTablet 12.5mg 37.50 MG 152,4

1413,623,878P 825 Tablet 25mg 37.50 MG 260,2 29,122

LABETALOL HYDROCHLORIDEP 1566K Tablet 100mg 0.60 GM 20,0

04283,206P 1567L Tablet 200mg 0.60 GM 21,3

32458,509

73

C


cost($)

CARDIOVASCULAR SYSTEMBETA BLOCKING AGENTSBETA BLOCKING AGENTS PLAINBETA BLOCKING AGENTS PLAIN NON–SELECTIVE

C07AA02 OXPRENOLOL HYDROCHLORIDE

C07AA03

C07AA05

C07AA07

BETA BLOCKING AGENTS PLAIN SELECTIVE

ALPHA– AND BETA– ADRENOCEPTOR BLOCKING AGENTSC07AG02 CARVEDILOL

C07AG01

P 1343Q

Tablet 5mg (base) maleate salt 30

5.00

MG

90,749

1,707,976P 134

5TTablet 10mg (base) maleate salt 30

5.00

MG

80,630

2,333,635A 201

26Tablet 10mg (base) besylate salt 30

5.00

MG

165

–P 275

1TTablet 5mg (base) besylate salt 3 0

5.00

MG

1,340,255

26,652,870P 275

2WTablet 10mg (base) besylate salt 30

5.00

MG

1,087,022

33,424,399P 498

5JTablet 5mg (base) besylate salt 3 0

5.00

MG

1,888

50,721P 498

6KTablet 10mg (base) besylate salt 30

5.00

MG

1,539

60,632P 892

3PTablet 5mg (base) besylate salt 30

5.00

MG

141,577

3,814,191P 892 Tablet 10mg (base) 5.0 M 164,3 6,538,

FELODIPINEP 236

1GTablet 2.5mg (extended release)

5.00

MG

210,279

3,171,306P 236

6MTablet 5mg (extended release)

5.00

MG

555,314

10,494,183P 236 Tablet 10mg (extended 5.0 M 664,0 20,683

LERCANIPIDINEP 495

9BTablet 20mg 30 10.0

0MG

395

16,890P 496

0CTablet 10mg 30 10.0

0MG

537

15,918P 853

4ETablet 10mg 30 10.0

0MG

894,465

20,797,311P 867


0MG

596,534

20,474,303P 893

9LTablet 10mg 30 10.0

0MG

73,421

2,086,658P 894 Tablet 20mg 30 10.0 M 70,0 2,794,

NIFEDIPINEP 169


0MG

38,690

712,167P 169

5FTablet 20mg 60 30.0

0MG

46,563

1,030,371P 190

6HTablet 30mg (controlled release) 30

30.00

MG

424,233

9,796,236P 190

7JTablet 60mg (controlled release) 30

30.00

MG

367,037

10,449,134P 861

0ETablet 20mg (controlled release) 30

30.00

MG

111,840

2,439,184P 893

8KTablet 20mg (controlled release) 30

30.00

MG

7,969

228,489

74

C


cost($)

CARDIOVASCULAR SYSTEMCALCIUM CHANNEL BLOCKERSSELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTSDIHYDROPYRIDINE DERIVATIVESC08CA01 AmLODIPINE

C08CA02

C08CA13

C08CA05

P 1241H

Tablet 240mg (sustained release)

0.24

GM 706,490

12,990,041P 124

8QTablet 40mg 0.2

4GM 37,9

39446,258P 125

0TTablet 80mg 0.2

4GM 38,2

16642,640P 125

3YTablet 160mg 0.2

4GM 18,2

76382,114P 125

4BTablet 120mg 0.2

4GM 6,83

4150,158P 220

6DCapsule 160mg (sustained release)

0.24

GM 55,161

745,775P 220

7ECapsule 240mg (sustained release)

0.24

GM 88,175

1,615,820P 220

8FCapsule 180mg (sustained release)

0.24

GM 223,110

3,375,696P 349

4XInjection 5mg in 2mL 0.2

4GM 3,26

635,840

75

C


cost($)

CARDIOVASCULAR SYSTEMCALCIUM CHANNEL BLOCKERSSELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTSPHENYLALKYLAMINE DERIVATIVES

C08DA01 VERAPAMIL HYDROCHLORIDE

BENZOTHIAZEPINE DERIVATIVESC08DB01 DILTIAZEM HYDROCHLORIDE

P 1312C

Capsule 180mg controlled delivery

0.24

GM 529,055

10,829,333P 131

3DCapsule 240mg controlled delivery

0.24

GM 532,797

13,665,016P 133

5GTablet 60mg 0.2

4GM 64,2

151,222,095P 848

0HCapsule 360mg controlled delivery 30

0.24

GM 300,183

9,542,134NON–SELECTIVE CALCIUM CHANNEL BLOCKERS

OTHER NON–SELECTIVE CALCIUM CHANNEL BLOCKERSC08EX02 PERHEXILINE MALEATE

P 1822X Tablet 100mg 0.20 GM 32,241 1,692,256

P 1147J

Tablet 12.5mg 50.00

MG

16,191

296,762P 114

8KTablet 25mg 50.0

0MG

36,858

893,296P 114

9LTablet 50mg 50.0

0MG

58,437

2,538,419P 876 Oral solution 5mg per 50.0 M 89 47,2

ENALAPRIL MALEATEP 136

8BTablet 10mg 10.0

0MG

238,293

4,857,739P 136

9CTablet 20mg 10.0

0MG

438,547

12,137,259P 137 Tablet 5mg 10.0 M 107,7 1,525,

FOSINOPRILP 1182F Tablet 10mg 30 15.0

0MG

166,078

2,919,184P 1183G Tablet 20mg 15.0 M 278,9 7,235,

LISINOPRILP 245

6GTablet 5mg 30 10.0

0MG

139,101

2,117,006P 245

7HTablet 10mg 30 10.0

0MG

262,673

5,358,141P 245 Tablet 20mg 30 10.0 M 451,2 11,753

PERINDOPRILA 198

89Tablet 2mg 30 4.0

0MG

1,206

–A 198

90Tablet 4mg 30 4.0

0MG

400

–A 198

91Tablet 8mg 30 4.0

0MG

460

–P 305

0MTablet 2mg 30 4.0

0MG

114,477

1,683,902P 305

1NTablet 4mg 30 4.0

0MG

181,538

4,048,799P 870

4DTablet 8mg 30 4.0

0MG

115,558

3,564,631P 900

6BTablet 2.5mg 30 4.0

0MG

1,070,651

15,673,383P 900

7CTablet 5mg 30 4.0

0MG

2,022,226

45,217,878P 900 Tablet 10mg 30 4.0 M 1,387, 42,876

QUINAPRILP 196

8NTablet 5mg 30 15.0

0MG

54,098

858,299P 196

9PTablet 10mg 30 15.0

0MG

147,339

3,011,906P 197

0QTablet 20mg 30 15.0

0MG

287,317

7,612,628A 198


0MG

135

–A 198

74Tablet 10mg 30 15.0

0MG

182

–

76

C


cost($)

CARDIOVASCULAR SYSTEMAGENTS ACTING ON RENIN–ANGIOTENSIN SYSTEMANGIOTENSIN–CONVERTING ENZYME (ACE) INHIBITORS, PLAINCONVERTING ENZYME BLOCKERSC09AA01 CAPTOPRIL

C09AA02

C09AA09

C09AA03

C09AA04

C09AA06

RAMIPRILP 131


0MG

3,299

95,480P 194

4HCapsule 1.25mg 28 2.5

0MG

164,883

2,025,381P 194

5JCapsule 2.5mg 28 2.5

0MG

569,897

8,850,622P 194

6KCapsule 5.0mg 28 2.5

0MG

1,201,198

22,571,918A 199

83Pack 7 Tabs 2.5mg 21 tabs 5mg and 10 caps 10mg

2.50

MG

164

–P 495

3QTablet 2.5mg 30 2.5

0MG

306

8,204P 496

2ECapsule 10mg 30 2.5

0MG

1,185

37,682P 847

0TCapsule 10mg 30 2.5

0MG

1,718,000

48,340,077P 866

8FPack 7 Tabs 2.5mg 21 tabs 5mg and 10 caps 10mg

2.50

MG

4,220

106,074P 893

7JCapsule 10mg 30 2.5

0MG

12,290

394,837P 894

5TTablet 1.25mg 30 2.5

0MG

149

2,126P 894

6WTablet 2.5mg 30 2.5

0MG

628

11,394P 894

7XTablet 5mg 30 2.5

0MG

2,010

51,520P 912

0BCapsule 1.25mg 30 2.5

0MG

222

2,736P 912

1CCapsule 2.5mg 30 2.5

0MG

878

13,709P 912 Capsule 5.0mg 30 2.5 M 1,90 34,6

TRANDOLAPRILP 279

1XCapsule 500ug 2.0

0MG

35,031

476,820P 279

2YCapsule 1mg 2.0

0MG

114,172

2,126,317P 279

3BCapsule 2mg 2.0

0MG

267,706

5,627,444P 875

8YCapsule 4mg 28 2.0

0MG

139,543

4,518,990

77

C


cost($)

CARDIOVASCULAR SYSTEMAGENTS ACTING ON RENIN–ANGIOTENSIN SYSTEMANGIOTENSIN–CONVERTING ENZYME (ACE) INHIBITORS, PLAINCONVERTING ENZYME BLOCKERS

C09AA05

C09AA10

ACE INHIBITORS, COMBINATIONSANGIOTENSIN–CONVERTING ENZYME BLOCKERS AND DIURETICS

C09BA02

ENALAPRIL and DIURETICSP 8477E Tablet 20mg–6mg – – 169,1

764,656,119C09BA0

9FOSINOPRIL and DIURETICSP 8400D Tablet 10mg–12.5mg – – 88,1

781,843,487P 8401E Tablet 20mg–12.5mg – – 475,4

7613,480,399C09BA0

4PERINDOPRIL and DIURETICSA 20124 Tablet 4mg (erbumine salt)–1.25mg 30

– – 1,879

–P 2190G Tablet 2.5mg (arginine salt)–0.625mg 30

– – 2,846

45,151P 2845R Tablet 5mg (arginine

salt)–1.25mg 30– – 941,1

9827,355,733P 8449Q Tablet 4mg (erbumine

salt)–1.25mg 30– – 893,0

0126,625,416C09BA0

6QUINAPRIL and DIURETICSP 8589C Tablet 10mg(base) / 12.5mg 30

– – 22,825

512,062P 8590D Tablet 20mg(base) /

12.5mg 30– – 101,1

212,616,613

P 2626F Tablet 2.5mg–2.5mg 30

– – 780 20,291P 2629JTablet 5mg–5mg 30 – – 5,279 174,

491

78

C


cost($)

CARDIOVASCULAR SYSTEMAGENTS ACTING ON RENIN–ANGIOTENSIN SYSTEMACE INHIBITORS, COMBINATIONSACE INHIBITORS AND CALCIUM CHANNEL BLOCKERS

C09BB05 RAMIPRIL and FELODIPINE

C09BB10 TRANDOLAPRIL and VERAPAMILP 2857J Tablet 4mg – 240mg (sustained release) 28 – – 10,369 449,935

ANGIOTENSIN II ANTAGONISTSANGIOTENSIN II ANTAGONISTS PLAIN

C09CA06 CANDESARTANP 829

5NTablet 4mg 30 8.00 M

G268,096

5,183,903P 829

6PTablet 8mg 30 8.00 M

G785,174

18,102,437P 829

7QTablet 16mg 30 8.00 M

G905,450

26,232,370P 888

9WTablet 32mg 30 8.00 M

G206,471

9,283,015C09CA02 EPROSARTAN

P 8397Y Tablet 400mg (base) 56

0.60 GM

31,930

861,351P 8447N Tablet 600mg

(base) 280.60 G

M107,978

3,013,616C09CA04 IRBESARTAN

P 8246B

Tablet 75mg 150.00

MG

511,247

9,921,904P 824

7CTablet 150mg 150.

00MG

1,846,859

43,080,357P 824

8DTablet 300mg 150.

00MG

1,888,616

53,566,919C09CA0

1LOSARTANA 16073 Tablet 50mg 30 0.05 G

M5,631

–C09CA08

OLMESARTAN MEDOXOMILP 2147B Tablet 20mg 30 20.0

0MG

12,544

292,943P 2148C Tablet 40mg 30 20.0

0MG

7,635

247,223C09CA0

7TELMISARTANP 8355R Tablet 40mg 40.0

0MG

829,879

16,445,576P 8356T Tablet 80mg 40.0

0MG

827,361

22,299,194

79

C


cost($)

CARDIOVASCULAR SYSTEMAGENTS ACTING ON RENIN–ANGIOTENSIN SYSTEMANGIOTENSIN II ANTAGONISTS COMBINATIONSANGIOTENSIN II ANTAGONISTS AND DIURETICS

C09DA06

CANDESARTAN and DIURETICSP 8504N Tablet 16mg–12.5mg 30 – – 982,1

3230,272,157C09DA0

2EPROSARTAN and DIURETICSP 8624X Tablet 600mg (base) –12.5mg 28

– – 101,418

2,987,315C09DA0

4IRBESARTAN and DIURETICSP 2136K Tablet 300mg–25mg 30 – – 7,48

9242,777P 8404H Tablet 150mg–12.5mg 30 – – 775,8

0319,649,742P 8405J Tablet 300mg–12.5mg

30– – 2,609,

22978,876,495C09DA0

8OLMESARTAN MEDOXOMIL AND DIURETICSP 2161R Tablet 20mg 12.5mg 30

– – 2,546

64,944P 2166B Tablet 40mg 12.5mg 30 – – 4,21

1127,817P 2170F Tablet 40mg 25mg 30 – – 5,01

5162,838C09DA0

7TELMISARTAN and DIURETICSP 8622T Tablet 40mg–12.5mg 28 – – 157,6

373,422,419P 8623W Tablet 80mg–12.5mg 28 – – 692,3

0119,821,349

80

P 8213G

Tablet 10mg 20.00

MG

1,941,812

78,534,977P 821

4HTablet 20mg 20.0

0MG

3,711,496

212,314,547P 821

5JTablet 40mg 20.0

0MG

3,454,803

270,977,008P 852 Tablet 80mg 20.0 M 1,219, 133,79

C10AA04 FLUVASTATINP 286

3QTablet 80mg (fluvastatin) (prolonged release) 28

60.00

MG

1,351

62,750P 802

3GCapsule 20mg (base) 60.0

0MG

34,508

870,971P 802 Capsule 40mg (base) 60.0 M 53,6 1,702,

C10AA03 PRAVASTATINP 283

3DTablet 10mg 30 30.0

0MG

122,251

3,335,372P 283


0MG

508,947

20,514,035P 819

7KTablet 40mg 30 30.0

0MG

1,017,978

60,925,866P 882 Tablet 80mg 30 30.0 M 135,1 11,925

C10AA07 ROSUVASTATINP 904

2XTablet 5mg 30 10.0

0MG

132,907

6,604,172P 904

3YTablet 10mg 30 10.0

0MG

626,811

43,258,295P 904


0MG

198,243

18,945,389P 904 Tablet 40mg 30 10.0 M 78,0 10,442

C10AA01 SIMVASTATINP 201

1WTablet 10mg 30.0

0MG

688,248

22,156,657P 201

2XTablet 20mg 30.0

0MG

2,097,197

92,213,498P 201

3YTablet 5mg 30.0

0MG

36,258

900,123A 201


0MG

760

–P 817

3ETablet 40mg 30.0

0MG

2,583,743

157,328,384P 831

3MTablet 80mg 30.0

0MG

679,700

57,917,214FIBRATE

C10AB05 FENOFIBRATEA 198


0GM

253

–P 902


0GM

19,021

529,356P 902


0GM

283,024

11,086,385

C


cost($)

CARDIOVASCULAR SYSTEMLIPID MODIFYING AGENTS PLAINLIPID MODIFYING AGENTS PLAINHMG REDUCTASE INHIBITORS

C10AA05 ATORVASTATIN

C10AB04 GEMFIBROZILP 1453L Tablet 600mg 1.20 GM 278,294 10,921,785

BILE ACID SEQUESTRANTSC10AC02 COLESTIPOL HYDROCHLORIDE

P 1224K Sachets 5g 120 20.00GM 1,304 87,300C10AC01 COLESTYRAMINE

P 2967E Sachets 4.7g(equiv to 4 g cholestyramine)

14.00

GM 29,254

1,616,512P 2978R Sachets 9.4g equiv to 8

g cholestyramine)14.00

GM 6,995

385,763

81

A 19529

Tablet 20mg –10mg 30 – – 312

–P 888

1KTablet 40mg –10mg 30 – – 171,9

5421,386,193P 888

2LTablet 80mg –10mg 30 – – 144,3

2021,386,762

C


cost($)

CARDIOVASCULAR SYSTEMLIPID MODIFYING AGENTS PLAINLIPID MODIFYING AGENTS PLAINNICOTINIC ACID AND DERIVATIVES

C10AD02 NICOTINIC ACIDA 19191 Tablet 250mg 2.00 GM 6,438 –

OTHER LIPID MODIFYING AGENTSC10AX09 EZETIMIBE

P 8757X Tablet 10mg 30 10.00MG 730,486 51,218,941LIPID MODIFYING AGENTS COMBINATIONSHMG COA REDUCTASE INHIBITORS IN COMBINATION WITH OTHER LIPID MOD AGENTS

C10BA02 SIMVASTATIN and EZETIMIBE

HMG COA REDUCTASE INHIBITORS, OTHER COMBINATIONSC10BX03 ATORVASTATIN AND AMLODIPINE

P 9049G

Tablet 10mg (base) 5mg (base) 30

– – 22,657

1,232,862P 905

0HTablet 20mg (base) 5mg (base) 30

– – 47,173

3,351,011P 905

1JTablet 40mg (base) 5mg (base) 30

– – 46,500

4,284,846P 905

2KTablet 80mg (base) 5mg (base) 30

– – 13,765

1,698,495P 905

3LTablet 10mg (base) 10mg (base) 30

– – 16,351

1,064,092P 905

4MTablet 20mg (base) 10mg (base) 30

– – 39,802

3,254,861P 905

5NTablet 40mg (base) 10mg (base) 30

– – 47,285

4,861,453P 905

6PTablet 80mg (base) 10mg (base) 30

– – 17,176

2,302,674

P 1698JCream 100,000 units per g 15g

– – 370 5,231P 4001N Cream 100,000 units

per g 15g– – 1,527 15,1

56

82

D


cost($)

DERMATOLOGICALSANTIFUNGALS FOR DERMATOLOGICAL USEANTIFUNGALS FOR TOPICAL USEANTIBIOTICS

D01AA01 NYSTATIN

IMIDAZOLE DERIVATIVESD01AC10 BIFONAZOLE

P 4003Q Cream 10mg per g (1%) 15g

– – 3,829 63,241P 8066M Cream 10mg per g (1%)

15g 2– – 1,438 39,6

20D01AC01 CLOTRIMAZOLEP 102

7CLotion 10mg per mL (1%) 20mL 2

– – 634 11,339A 155

76Cream 10mg per g (1%) 50g – – 1,870 –

A 15786

Cream 10mg per g (1%) 50g – – 13,959

–A 165

85Cream 10mg per g (1%) 20g – – 3,973 –

A 17061

Cream (vaginal) 100 mg per g (10%)

– – 3,219 –P 400

4RCream 10mg per g (1%) 20g – – 16,78

2130,977P 400

5TLotion 10mg per mL (1%) 20mL

– – 1,929 21,302D01AC CLOTRIMAZOLE AND FLUCONAZOLE

A 20245 Cream 1% 10g tube and capsule 150mg 1

– – 330 –D01AC03

ECONAZOLE NITRATEA 15470 Cream 10 mg per g (1%) 20g

– – 2,088 –D01AC08

KETOCONAZOLEP 1574W Shampoo 20mg per mL (2%) 60mL

– – 595 11,658P 4007X Shampoo 20mg per mL

(2%) 100mL– – 318 5,8

45P 4008Y Shampoo 20mg per mL (2%) 60mL

– – 3,398 57,649P 9024Y Shampoo 20mg per g

(2%) 30g 1– – 4,210 120,

701P 9025B Shampoo 10mg per g (1%) 100mL

– – 531 9,116D01AC0

2MICONAZOLEA 14846 Ointment 15g – – 224 –A 17964 Cream 10mg per g (1%) 40g

– – 3,379 –P 4341L Tincture 20mg per mL (2%), 20mL

– – 1,249 22,916P 9026C Tincture 20mg per mL

(2%), 15mL 2– – 904 14,0

42P 9027D Cream 20mg per g (2%) 30g 1

– – 967 14,121P 9028E Cream 20mg per g (2%)

70g 1– – 655 12,1

60P 9029F Powder 20mg per g (2%) 30g 1 1

– – 347 4,965P 9030G Lotion 20mg per mL

(2%) 30g 1 1– – 366 6,8

66P 9031H Tincture 20mg per mL (2%) 30mL 1

– – 549 10,056D01AC0

2MICONAZOLE NITRATEP 4454K Cream 20mg per g (2%) 30g

– – 2,023 27,139D01AC5

2MICONAZOLE and HYDROCORTISONEA 17966 Cream 1% 1g/100g 30g – – 19,78

1–

P 1460W Tablet 125mg 0.50 GM 1,894

40,846P 2982Y Tablet 500mg 0.50 GM 86,1 1,722,

TERBINAFINEP 2804N Tablet 250mg

(base)0.25 GM 89,0

0211,907,841P 4011D Tablet 250mg

(base)0.25 GM 4,18

7565,476

83

D


cost($)

DERMATOLOGICALSANTIFUNGALS FOR DERMATOLOGICAL USEANTIFUNGALS FOR TOPICAL USEOTHER ANTIFUNGALS FOR TOPICAL USE

D01AE16

AMOROLFINEP 4010C Nail treatment kit containing 50mg (base) per mL

– – 9,825 901,591D01AE1

4CICLOPIROXP 4106D Shampoo 15mg per g (1.5%), 60mL

– – 216 3,408D01AE1

5TERBINAFINEP 4463X Gel 10mg per g (1%) 15g – – 972 21,3

32P 4473K Cream 10mg per g (1%), 15g

– – 15,012

332,735D01AE1

8TOLNAFTATEP 4481W Spray aerosol 10mg per g (1%) 100g

– – 466 6,241ANTIFUNGALS FOR SYSTEMIC USE

ANTIFUNGALS FOR SYSTEMIC USED01BA01 GRISEOFULVIN

D01BA02

P 4551M

Cream 150mg–20mg per g (15%–2%) 600g

– – 179

3,767P 455

6TCream 150mg–20mg per g (15%–2%) 75g

– – 255

2,588

with MINERAL OIL with POLYETHYLENE GLYCOLA 10147 Ltn

250mL 1– – 237 –

84

D


cost($)

DERMATOLOGICALSEMOLLIENTS AND PROTECTIVESEMOLLIENTS AND PROTECTIVESSILICONE PRODUCTS

D02AA DIMETHICONE and GLYCEROL

D02AA SILICONEA 10740 Cream pump 1 – – 157 –

SOFT PARAFFIN AND FAT PRODUCTSD02AC DEWAXED OIL with SOLUBLE KERATIN with LANOLIN

D02AC PARAFFINP 4041Q Ointment 100g – – 1,282 14,722

CARBAMIDE PRODUCTSD02AE01 UREA

P 4042R Cream 100mg per g (10%) 100g – – 29,289329,901

OTHER EMOLLIENTS AND PROTECTIVESD02AX BATH EMOLLIENT

P 4122Y Bath oil 500mL – – 9,235 159,151D02AX CARMELLOSE SODIUM with PECTIN and

GELATINA 14151 Paste 167mg–167mg–

– – 213 –P 4518T Paste 167mg–167mg–167mg per g

– – 274 3,349D02AX CETOMACROGOL

A 15823 Sorbolene crm 100g – – 181 –D02AX CETOMACROGOL with GLYCERINE

A 11020 Cream 100g 1 – – 167 –D02AX DEWAXED OIL with LANOLIN

P 4107E Lotion 500mL – – 5,117 81,078PROTECTIVES AGAINST UV–RADIATION

PROTECTIVES AGAINST UV–RADIATION FOR TOPICAL USED02BA SUNSCREENS

P 4543D

Solid stick 4.5g – – 1,090 11,458P 454

4ECream 100g – – 12,99

8187,906P 454

6GLotion (non–alcoholic) 125mL

– – 3,449 51,564

85

D


cost($)

DERMATOLOGICALSPREPARATIONS FOR TREATMENT OF WOUNDS & ULCERSCICATRIZANTSOTHER CICATRIZANTS

D03AX VITAMIN AA 16106 Ointment 50g – – 1,639 –

A 12234 Gel 2% 15mL 1 – – 2,485 –A 12239 Ointment 5%15g

1– – 1,090 –

86

D


cost($)

DERMATOLOGICALSANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC.ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC.ANAESTHETICS FOR TOPICAL USE

D04AB01 LIGNOCAINE

D04AB01 LIGNOCAINE HYDROCHLORIDE and CARBOXYMETHYLCELLULOSEP 4308R Mucilage 20 mg–25 mg per mL (2%–2.5%), 200 mL – –

2,694 214,497OTHER ANTIPRURITICS

D04AX CROTAMITONA 12933 Cream 10%20g 1 – – 423 –

D04AX PINE TAR and TRIETHANOLAMINEP 4408B Solution 23mg–60mg per mL (2.3%–6%) 500mL

– – 2,375 44,427D04AX PINE TAR and TRIETHANOLAMINE LAURYL

SULPHATEA 12602 Ltn 100mL 1

– – 134 –

A 17059 Ointment 1.0% 50g 1

– – 587 –A 17060 Ointment 2.0%

50g 1– – 250 –

A 14883

Ointment 100gm – – 2,192

–A 158

67Cream 30g – – 2,00

9–

A 15868

Cream 100g – – 949 –A 169

79Scalp Solution 30mL 50ug/mL

– – 4,690

–P 208

0LCream 50ug per g (0.005%) 30g 1

– – 5,195

240,335P 829 Ointment 0.005%, 30gm – – 92,67 4,743,

TAZAROTENEA 19647 Cream 0.05% 30g 1 – – 1,28

7–

A 19648 Cream 0.1% 30g 1 – – 2,515

–

87

D


cost($)

DERMATOLOGICALSANTIPSORIATICSANTIPSORIATICS FOR TOPICAL USETARS

D05AA TARSP 8864M Gel 10mg per g (1%) 100mL – – 6,393 236,328

ANTRACEN DERIVATIVESD05AC01 DITHRANOL with SALICYLIC ACID

OTHER ANTIPSORIATICS FOR TOPICAL USED05AX02 CALCIPOTRIOL

D05AX05

ANTIPSORIATICS FOR SYTEMIC USEPSORALENS FOR SYSTEMIC USE

D05BA02 METHOXSALENA 11443 Capsule 10mg 100 10.00 128 –

RETINOIDS FOR TREATMENT OF PSORIASISD05BB02 ACITRETIN

P 2019G Capsule 10mg 35.00 MG 7,750

1,583,834P 2020H Capsule 25mg 35.00 MG 7,79

33,057,484

A 13705

Ointment nasal 3g 1 – – 49,053

–P 434

8WCream 20mg (as calcium) per g (2%), 15g

– – 173,971

2,600,650P 435

0YOintment 20mg per g(2%), 15g

– – 193,587

2,886,624

A 13610

Cream 1%500g 1 – – 230 –P 199

6CCream 10mg–2mg per g (1%–0.2%) 50g

– – 30,777

510,170P 199

7DCream 10mg–2mg per g (1%–0.2%) 100g

– – 46,335

985,490ANTIVIRAL

D06BB10 IMIQUIMODA 179

90Cream 5% sachets 6 – – 34,95

7–

A 20128

Cream sachets 50mg per g (5%), 250mg 12

– – 905 –P 254

6BCream 50mg per g (5%), 250mg Sachet 12

– – 21,411

3,440,832P 455 Cream sachets 50mg per g – – 8,27 1,381,

D06BB04 PODOPHYLLOTOXINA 174

02Paint 5mg per mL (0.5%) 3mL (with applicators)

– – 1,807

–A 179

33Cream 1.5mg per g (0.15%) 5g – – 2,72

9–

P 4566H

Paint 5mg per mL (0.5%), 3.5mL (with 30 swabs)

– – 7,660

157,765

88

D


cost($)

DERMATOLOGICALSANTIBIOTICS AND CHEMOTHER. FOR DERMATOLOGICAL USEANTIBIOTICS FOR TOPICAL USEOTHER ANTIBIOTICS FOR TOPICAL USE

D06AX01 FUSIDIC ACIDA 13926 Ointment 2% 15mg 1 – – 20,303 –

D06AX09 MUPIROCIN

D06AX POLYMIXIN B SULPHATE with NEOMYCIN with BACITRACINA 11330 Ointment 15g 1 – – 239 –

CHEMOTHERAPEUTICS FOR TOPICAL USESULFONAMIDES

D06BA51 SILVER SULPHADIAZINE with CHLORHEXIDINE GLUCONATE

OTHER CHEMOTHERAPEUTICS

D06BX01 METRONIDAZOLE

A 17694

Gel 0.75% 30g 1 – – 37,174

–P 403

0DGel 7.5mg per g (0.75%) 50g

– – 17,387

510,742P 434

0KCream 7.5mg per g (0.75%) 30g

– – 28,143

565,706

A 10542

Cream 0.5% 30g 1 – – 142 –A 107

19Cream 0.5% 30g 1 – – 2,63

8–

P 1495Q

Cream 10mg per g (1%) 50g – – 137,267

1,039,027A 161

65Cream 10mg per g (1%) 30g – – 254 –

A 16625

Cream 1%30g 1 – – 28,908

–A 166

26Cream 0.5%30g 1 – – 341 –

A 16627

Cream 1%30g 1 – – 10,120

–P 288

1PCream 10mg per g (1%) 50g – – 219,6

401,661,277P 288

2QTopical ointment 10mg per g (1%) 50g

– – 61,655

468,938P 288

7YCream 10mg per g (1%) 30g – – 101,9

10727,420P 288

8BTopical ointment 10mg per g (1%) 30g

– – 32,131

229,255

P 2117K Cream 200ug per g (0.02%) 100g

– – 289,010

3,942,595P 2118L Ointment 200ug per g

(0.02%) 100g– – 61,27

0835,702

A 10627

Ointment 30g 1 – – 40,211

–P 111

5QCream 500ug per g (0.05%) 15g

– – 364,613

3,750,010P 111

9XOintment 500ug per g (0.05%) 15g

– – 224,750

2,687,243A 128

81Cream 30g 1 – – 25,87

9–

A 15271

Cream 500ug per g (0.05%) 50g

– – 17,540

–A 152

72Ointment 500ug per g (0.05%) 50g

– – 10,590

–A 172

16Scalp lotion 500ug per mL (0.05%) 30mL

– – 538 –A 172

17Scalp lotion 500ug per mL (0.05%) 30mL

– – 25,590

–A 196

28Cream 500ug per g (0.05%) 30g

– – 801 –P 281

2BCream 200ug per g (0.02%) 100g

– – 443,067

6,597,307P 281

3CCream 500ug per g (0.05%) 15g

– – 99,139

767,356P 281

5EOintment 500ug per g (0.05%) 15g

– – 39,108

311,192P 282

0KOintment 200ug per g (0.02%) 100g

– – 83,051

1,245,003P 413

1KCream 1mg per g (0.1%) 30g – – 14,38

2343,942P 413 Ointment 1mg per g (0.1%) – – 8,73 221,

METHYLPREDNISOLONE ACEPONATEP 805

4XCream 1mg per g (0.1%) 15g – – 204,8

843,079,072P 805

5YOintment 1mg per g (0.1%) 15g

– – 111,465

1,918,360P 812

8TOintment 1mg per g (0.1%) 15g

– – 151,380

2,707,988P 861

8NLotion 1mg per g (0.1%) 20g – – 10,02

7164,468

89

D


cost($)

DERMATOLOGICALSCORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONSCORTICOSTEROIDS, PLAINCORTICOSTEROIDS, WEAK (GROUP I)

D07AA02 HYDROCORTISONE

CORTICOSTEROIDS, MODERATELY POTENT (GROUP II)D07AB09 TRIAMCINOLONE ACETONIDE

CORTICOSTEROIDS, POTENT (GROUP III)D07AC01 BETAMETHASONE

D07AC14

90

D


cost($)

DERMATOLOGICALSCORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONSCORTICOSTEROIDS, PLAINCORTICOSTEROIDS, POTENT (GROUP III)

D07AC13 MOMETASONEP 191

3QCream 1mg per g (0.1%) 15g

– – 519,138

7,818,487P 191

5TOintment 1mg per g (0.1%) 15g

– – 286,187

5,451,467P 434

2MCream 1mg per g (0.1%) 45g

– – 38,430

1,187,485P 434

3NOintment 1mg per g (0.1%) 45g

– – 23,555

794,183P 804

3HLotion 1mg per g (0.1% w/w) 30mL

– – 262,521

5,644,260CORTICOSTEROIDS, COMB WITH ANTISEPTICS

CORTICOSTEROIDS, WEAK, COMB WITH ANTISEPTICSD07BA04 HYDROCORTISONE and

CLIOQUINOLA 16100 Cream 1%–1%

30gm– – 9,271 –

A 17035 Cream 1%–1% 60gm

– – 5,243 –CORTICOSTEROIDS, COMB WITH ANTIBIOTICSCORTICOSTEROIDS, WEAK, COMB WITH ANTIBIOTICS

D07CA01 HYDROCORTISONE and CLOTRIMAZOLEA 13540 Cream 1%30g 1 – – 78,319 –

CORTICOSTEROIDS,MODERATELY POTENT,COMB. WITH ANTIBIOTICSD07CB01 TRIAMCINOLONE ACETONIDE with NEOMYCIN with GRAMICIDIN with NYSTATIN

A 11072 Ointment 30g 1 – – 20,690

–P 4482X Ointment 1 mg–2.5 mg

(base)–250 ug–– – 57,04

5882,012CORTICOSTEROIDS, OTHER COMBINATIONS

CORTICOSTEROIDS, WEAK, OTHER COMBINATIONSD07XA01 HYDROCORTISONE with CLOTRIMAZOLE

A 16834 Cream 1% 50g 1 – – 38,568 –CORTICOSTEROIDS, POTENT, OTHER COMBINATIONS

D07XC01 BETAMETHOSONE/CALCIPOTRIOLA 18741 Ointment 500ug per

g 15g– – 7,707 –

A 18742 Ointment 500ug per g 30g

– – 18,141 –

91

D


cost($)

DERMATOLOGICALSANTISEPTICS AND DISINFECTANTSANTISEPTICS AND DISINFECTANTSPHENOL AND DERIVATIVES

D08AE04 TRICLOSAN with ENTSUFONA 11587 Lotion 500mL 1 – – 122 –

IODINE PRODUCTSD08AG02 POVIDONE IODINE

A 10226

Ointment 25g 1 – – 608 –A 102

30Solution 15mL 1 – – 395 –

P 4411E

Solution 100mg per mL (10%) 100mL

– – 5,444 103,769

P 4932N Tube 10g 4 – – 624 56,552P 4933P Tube 20g 2 – – 198 17,565

92

D


cost($)

DERMATOLOGICALSMEDICATED DRESSINGSMEDICATED DRESSINGSOINTMENT DRESSINGS WITH ANTIINFECTIVES

D09AA CADEXOMER IODINE

D09AA09 POVIDONE–IODINEP 4779M Sterile sachets 22.5cm x 7.5cm 12 – – 125 3,888

ZINC BANDAGESD09AB01 BANDAGE ZINC PASTE

P 4750B Bandage 7.5cm x 6m – – 341 20,410SOFT PARAFFIN DRESSINGS

D09AX SOFT PARAFFIN DRESSINGP 4759L Sterile sachets 10cm

x 10cm 10– – 2,192 43,7

92P 4845B Sterile sachets 10cm x 10cm 10

– – 1,722 39,484

A 15680 Gel 0.1% 30G 1 – – 49,593 –A 16348 Cream 0.1% 30g

1– – 41,920 –

A 11780

Cream 0.05%20g 1 – – 17,839 –A 143

54Cream .025% 25g 1 – – 3,758 –

A 14355

Cream 0.05% 25g 1 – – 5,439 –A 143

56Cream 0.1% 25g 1 – – 3,075 –

A 14512

Cream 0.05% 50g 1 – – 20,299 –A 170

39Gel 0.01%30g 1 – – 6,580 –

A 13816

Topical solution 1% 100mL 1

– – 19,901 –A 164

22Topical solution 1% 50mL 1

– – 17,851 –A 165

20Lotion 10mg per mL 60mL

– – 2,590 –A 196

46Gel 1% 30g 1 – – 2,087 –

93

D


cost($)

DERMATOLOGICALSANTI–ACNE PREPARATIONSANTI–ACNE PREPARATIONS FOR TOPICAL USERETINOIDS FOR TOPICAL USE IN ACNE

D10AD03 ADAPALENE

D10AD04 ISOTRETINOINA 14786 Gel 0.05% 30g – – 8,351 –

D10AD01 TRETINOIN

PEROXIDESD10AE51 CLINDAMYCIN with Benzpylperoxide

A 19649 Gel 1%–5% 25g 1 – – 37,872 –ANTIINFECTIVES FOR TREATMENT OF ACNE

D10AF01 CLINDAMYCIN

D10AF02 ERYTHROMYCINA 15129 Gel 2% 30g 1 – – 87,079 –

OTHER ANTI–ACNE PREPARATIONS FOR TOPICAL USED10AX01 ALUMINIUM CHLORIDE

A 10734 Roll–on 20%50mL 1 – – 119 –ANTI–ACNE PREPARATIONS FOR SYSTEMIC USERETINOIDS FOR TREATMENT OF ACNE

D10BA01 ISOTRETINOINP 254

9ECapsule 40mg 30 30.00 MG 86

9118,253P 259

1JCapsule 10mg 30.00 MG 8,36

8797,449P 259

2KCapsule 20mg 30.00 MG 135,1

9619,691,641

D11AC30

P 4405W Scalp cleanser 3mg–3mg–1mg–3mg–10mg per mL –SALICYLIC ACID BENZALKONIUM CHLORIDE

– 794 15,295

and POLYOXYETHYLENE ETHERSP 4445Y Scalp cleanser 20mg–2mg–130mg–216mg per mL –

– 406 6,911D11AC3

0SALICYLIC ACID WITH COAL TAR SOLUTIONP 4560B Scalp cleanser 20mg–50mg per mL (2%–5%) 200mL –

– 3,667 63,919

94

D


cost($)

DERMATOLOGICALSOTHER DERMATOLOGICAL PREPARATIONSOTHER DERMATOLOGICAL PREPARATIONSANTIHIDROTICS

D11AA DIPHEMANIL METHYLSULPHATEP 4191N Dusting powder 20mg per g (2%) 50g – – 6,361

103,746MEDICATED SHAMPOOS

D11AC30 OTHERS

D11AC30 SALICYLIC ACID, COAL TAR SOLUTION, PINE TAR and UNDECYLENAMIDEP 4447C Scalp cleanser 20mg–10mg–10mg–10mg per mL – –

1,391 22,426D11AC03 SELENIUM SULFIDE

A 11876 Shampoo 2.5% 200m 1 – – 130 – P 4452H Shampoo 25mg per mL (2.5%) 125mL ––

1,320 17,212WART AND ANTI–CORN PREPARATIONS

D11AF PODOPHYLLUM RESIN with SALICYLIC ACIDA 11612 Ointment 10g 1 – – 1,748 –

OTHER DERMATOLOGICALSD11AX ALLANTOIN, GLYCEROL and ICHTHAMMOL

P 4280G Ointment 5mg–10mg per g(0.5%–1%–1 %), 50g

– – 386 5,623P 4281H Cream 5mg–10mg–10mg

per g(0.5%–1%–1%),50g– – 688 10,6

32D11AX CATIONIC CONDITIONER with PANTHENOLP 4519W Solution 250mL – – 405 4,9

18D11AX16

EFLORNITHINEA 19662 Cream 11.5%,30 g, 1 – – 851 –

D11AX HYDROLYZED COLLAGEN PROTEINSP 4271T Hair conditioner 250mL – – 1,02

512,225D11AX1

5PIMECROLIMUSA 18308 Cream 1% 30g,1 – – 8,92

0–

P 8802G Cream 10mg per g (1%) 15g – – 31,525

1,001,592D11AX SKIN CLEANSER

P 4549K Lotion 500mL – – 14,938

281,904D11AX ZINC OXIDE, STARCH and CHLORPHENESIN

P 4497Q Dusting powder 100g – – 728 7,981

A 15081

Vaginal cream 2% 40gm 0.10

GM 15,976

–NYSTATINP 401

2ECream pessaries 100,000 units, 15

100.00

TE 1,788 21,867P 401

3FVaginal cream 100,000 units per dose, 15 doses,

100.00

TE 8,943 110,076

95

G


cost($)

GENITO URINARY SYSTEM AND SEX HORMONESGYNAECOLOGICAL ANTIINFECTIVES AND ANTISEPTICSANTIINFECTIVES/ANTISEPT.,EXCL. COMB. WITH CORTICOSTEROIDSANTIBIOTICS

G01AA10 CLINDAMYCIN

G01AA01

ORGANIC ACIDSG01AD02 RICINOLEIC ACID, ACETIC ACID and HYDROXYQUINOLINE SULPHATE

P 4434J Vaginal jelly 7mg–9.4mg–250ug per g– – 48910,052

IMIDAZOLE DERIVATIVESG01AF15 BUTOCONAZOLE

A 19783 Vaginal Cream 100mg in 5g (2%) 0.10 GM 2,607–

G01AF02 CLOTRIMAZOLEA 159

13Pessary 500mg 0.1

0GM 7,051 –

A 19063

Vaginal cream 50mg per 5g (1%) 35g

0.10

GM 1,568 –A 190

67Vaginal cream 50mg per 5g (1%) 35g

0.10

GM 166 –P 401

4GPessaries 100mg 6 0.1

0GM 7,690 117,

210P 4015H

Pessary 500mg 0.10

GM 6,506 106,366P 401

6JVaginal cream 50mg per 5g (1%) 35g

0.10

GM 32,513

483,362P 401

7KVaginal cream 100mg per 5g (2%)20g

0.10

GM 26,797

420,916G01AF2

0CLOTRIMAZOLE AND FLUCONAZOLEA 20144 Vaginal Cream 1% 10g and capsule 150mg 1

– – 354 –G01AF05

ECONAZOLE NITRATEA 12661 Foam–sol 1%10g 3 0.1

0GM 849 –

A 15473 Pessaries 150 mg, 3 0.10

GM 1,081 –G01AF04

MICONAZOLE NITRATEA 18370 Vaginal ovule 1.2g/cream(2%) 9 g, 100mg per 5g

0.10

GM 629 –P 4021P Vaginal cream 100mg per 5g (2%) 40g

0.10

GM 256 2,421

96

G


cost($)

GENITO URINARY SYSTEM AND SEX HORMONESOTHER GYNAECOLOGICALSCONTRACEPTIVES FOR TOPICAL USEINTRAUTERINE CONTRACEPTIVES

G02BA03 PLASTIC IUD with PROGASTERONEP 8633J Intrauterine drug 52mg releasing 20ug per 24 hours – – 55,161 12,552,145

G02BA02 POLYETHYLENE COPPERA 13296 Intrauterine device 1 – – 833 –

OTHER GYNAECOLOGICALSPROLACTIN INHIBITORS

G02CB01

BROMOCRIPTINE MESYLATEP 1444B Tablet 2.5mg 5.00 MG 3,39

466,541G02CB0

3CABERGOLINEP 8114C Tablet 0.5mg 0.50 MG 28,15

22,552,608P 8115D Tablet 0.5mg 0.50 MG 2,15

483,907G02CB0

4QUINAGOLIDEP 8822H Tablet 75ug (base)

75.00

UG 614 41,012

97

G


cost($)

GENITO URINARY SYSTEM AND SEX HORMONESSEX HORMONES AND MODULATORS OF THE GENITAL SYSTEMHORMONAL CONTRACEPTIVES FOR SYSTEMIC USEPROGESTOGENS AND ESTROGENS, FIXED COMBINATIONS

G03AA09

DESOGESTREL with ETHINYLOESTRADIOLA 14249 Tablet 28 1 150 ug/30ug – – 72,9

61–

G03AA DIENOGEST with ETHINYLOESTRADIOLA 19955 Ethinyloest30mg&Dienogest

2mg Tab2mg–– – 2,06

9–

A 19956 Tablet 2mg – 30ug + 7 inert 28x3

– – 9,325

–G03AA ETHINYLOESTRADIOL and ETONOGESTREL

A 19917 Ethinyloest 11.7mg & Etonog 2.7mg vaginal ring 1

– – 10,440

–A 19918 Ethinyloest 11.7mg & Etonog 2.7mg vaginal ring 3

– – 17,993

–G03AA12

ETHINYLOESTRADIOL with DROSPIRENONEA 17645 Tablet 3mg – 30ug 21 + 7 inert

– – 121,155

–A 17646 Tablet 3mg – 30ug 21 + 7 inert,28*3

– – 439,027

–G03AA10

ETHINYLOESTRADIOL with GESTODENEA 15082 Tablets 75ug/30ug, 21 + 7 – – 20,5

56–

G03AA07

LEVONORGESTREL with ETHINYLOESTRADIOLP 1393H Tablets 150ug – 30ug 21

– – 16,166

256,415P 1394J Tablets 150ug – 30ug 21 +

7 iner t, 28– – 1,472,

99623,483,961P 1456P Tablets 125ug – 50ug 21 +

7 iner t– – 93,6

781,494,230A 16212 Tablets 100ug – 50ug 28 – – 122,5

19–

A 16217 Tablets 100ug – 20ug + 7 inert 28

– – 29,968

–A 16970 Tablets 100ug – 20ug 21 + 7 iner t

– – 140,793

–A 17707 Tablets 100ug 20ug + 7 inert 28

– – 236

–A 17708 Tablets 100ug 20ug + 7 inert 28X3

– – 5,499

–G03AA05

NORETHISTERONE with ETHINYLOESTRADIOLP 2772X Tablets 500ug–35ug 21

– – 1,885

29,610P 2773Y Tablets 1mg–35ug, 21 – – 1,12

617,728P 2774B Tablets 500ug–35ug 21 + 7

inert 28– – 141,2

832,219,527P 2775C Pack containing 21 tablets

1mg–35ug– – 93,3

801,466,925G03AA0

5NORETHISTERONE with MESTRANOLP 3176E Tablets 1mg–50ug 21 – – 2,32

936,618P 3179H Tablets 1mg–50ug 21 + 7

inert 28– – 15,5

05244,012G03AA1

2OESTRADID with DROSPIRENONEA 19550 Tablet 1mg – 2mg 28 – – 20,2

23–

G03AB06

ETHINYLOESTRADIOL WITH GESTODENEA 18555 Tablet 30ug/75ug 28x3 – – 14,16

0–

G03AB03

LEVONORGESTREL with ETHINYLOESTRADIOLP 1392G Pack containing 6 tablets

– – 598,542

9,547,473G03AB0

4NORETHISTERONE with ETHINYLOESTRADIOLP 2776D Tablets 500/35ug

– – 8,277

129,889

A 17548

Tablet 0.75mg 2 – – 19,963

–A 191

55Tablet 0.75mg 2 – – 43,76

2–

A 19549

Tablet 0.75mg 2 – – 39,845

–A 201

37Tablet 30ug 28x4 – – 4,83

2–

P 2913H

Tablets 30ug 28 0.03 MG 122,556

1,915,325G03AC06 MEDROXYPROGESTERONE

P 3118D Injection 150mg in 1mL

1.67 MG 247,492

3,310,006G03AC01 NORETHISTERONE

P 1967M Tablets 350ug 28 – – 27,917

438,407ANDROGENS

A 16153

Cream 2%, 50g – – 1,186

–A 163

26Cream 1%, 50g – – 1,34

7–

A 17178

Cream 5%, 50g – – 1,724

–P 210

1NInjection 250mg 18.0

0MG 41,49

41,303,439P 211

4GInjection 250mg in 1mL 18.0

0MG 10,17

5318,754P 211

5HCapsule 40mg 120.

00MG 29,47

81,455,827P 267

0MInjection 100mg 18.0

0MG 6,88

8131,334P 809

8FSubcutaneous implant 100mg 18.0

0MG 2,70

2501,786P 809

9GSubcutaneous implant 200mg 18.0

0MG 3,27

4834,120P 846

0GTransdermal patch 12.2mg (2.5mg per 24 hr) 60

3.00

MG 3,767

380,004P 861

9PTransdermal patch 24.3mg (5mg per 24 hr) 30

3.00

MG 8,367

847,580P 883

0RTransdermal gel 50mg in 5mg sachet 30

50.00

MG 40,740

4,339,589P 900

4XInjection 1000 mg in 4mL 18.0

0MG 18,27

22,683,425

98

G


cost($)

GENITO URINARY SYSTEM AND SEX HORMONESSEX HORMONES AND MODULATORS OF THE GENITAL SYSTEMHORMONAL CONTRACEPTIVES FOR SYSTEMIC USEPROGESTOGENS AND ESTROGENS,SEQUENTIAL PREPARATIONS

PROGESTOGENSG03AC08 ETONOGESTREL

P 8487Q Subcutaneous implant 68mg 0.07 MG 60,954 13,075,123G03AC03 LEVONORGESTREL

3–OXOANDROSTEN (4) DERIVATIVESG03BA03 TESTOSTERONE

5–ANDROSTANON (3) DERIVATIVESG03BB01 MESTEROLONE

A 11642 Tablet 25mg 50 50.00MG 793 –

A 16209

Tablet 1mg 28 2.00

MG 6,529

–A 162

10Tablet 2mg 28 2.0

0MG 13,18

3–

P 1742Q

Vaginal tablets 25ug 0.03

MG 429,013

8,871,450P 174

3RTransdermal patches 2mg 8 0.0

5MG 66,71

31,091,017P 174

4TTransdermal patches 4mg 8 0.0

5MG 85,61

01,399,413P 174

5WTransdermal patches 8mg 8 0.0

5MG 25,40

0474,580A 189

85Transdermal patches 5.7mg(rel 75ug/24hrs)

0.05

MG 134 –A 202

78Transdermal patches 3.28mg (rel 37.5ug/24hrs)

0.05

MG 902 –A 202

79Transdermal patches 4.33mg (rel 50ug/24hrs)8

0.05

MG 833 –A 202


0.05

MG 375 –A 202


0.05

MG 125 –P 801

2QTransdermal patches 3.28mg 0.0

5MG 18,59

9302,284P 801

3RTransdermal patches 4.33mg(rel 50ug/24hrs)

0.05

MG 16,034

260,846P 801

4TTransdermal patches 6.57mg(rel 50ug/24hrs)

0.05

MG 7,809

144,677P 804

1FTransdermal patches 8.66mg(rel 100ug/24hrs)

0.05

MG 6,854

130,242P 812

5PTransdermal patches 3.9mg(rel 50ug/24hrs)

0.05

MG 54,192

885,398P 812

6QTransdermal patches 7.8mg(rel 100ug/24hrs)

0.05

MG 20,269

385,994P 814

0KTransdermal patches 1.5mg(rel 50ug/24hrs)

0.05

MG 22,323

365,150P 828

6DTransdermal gel 1mg in 1g sachet 28

1.00

MG 84,880

1,475,736P 831

1KTransdermal pat 750ug (rel 25ug/24 hrs)

0.05

MG 11,906

194,519P 831

2LTransdermal patch 3mg (rel 100ug/24 hrs)

0.05

MG 8,964

169,020P 848

5NTransdermal patches 2mg(rel 25ug/24hrs)

0.05

MG 25,965

423,595P 848

6PTransdermal patches 5.7mg(rel 75ug/24hrs)

0.05

MG 8,466

158,172P 864

5BNasal spray 150 ug per actuation, 60 actuat, 4.2mL

0.30

MG 20,290

450,100P 876

1DTransdermal patches 3.9mg(rel 25ug/24hrs)

0.05

MG 9,255

150,873P 876

2ETransdermal patches 5.85mg(rel 37.5ug/24hrs)

0.05

MG 17,043

279,800P 876

3FTransdermal patches 7.8mg(rel 500ug/24hrs)

0.05

MG 31,616

516,167P 876

4GTransdermal patches 1.17mg(rel 75ug/24hrs)

0.05

MG 14,267

265,294P 876 Transdermal patches 0.0 MG 12,76 240,

OESTRADIOL VALERATEP 166

3MTablets 1mg 28 2.0

0MG 46,16

2494,793P 166

4NTablets 2mg 28 2.0

0MG 72,82

2976,100A 196

26Injection 10mg in 1mL 1.0

0MG 179 –

P 4365R

Implant 50mg 1 – – 1,398

48,896P 436

6TImplant 100mg 1 – – 5,24

7592,509P 827 Tablets 2mg 56 2.0 MG 4,47 58,1

OESTRIOLP 177

1FPessaries 500ug 15 0.2

0MG 59,75

61,163,008P 178

1RVaginal cream 1mg per g (0.1%), 15g

0.20

MG 293,309

4,945,089A 197

32Tablets 1mg 30 2.0

0MG 3,78

6–

99

G


cost($)

GENITO URINARY SYSTEM AND SEX HORMONESSEX HORMONES AND MODULATORS OF THE GENITAL SYSTEMESTROGENSNATURAL AND SEMISYNTHETIC ESTROGENS, PLAIN

G03CA03 OESTRADIOL

G03CA03

G03CA04

100

P 1733F Tablets 300ug 28

0.63 MG 199,826

2,573,122P 1734G Tablets 625ug 0.63 MG 339,5 4,549,

OESTRONEA 114

13Tablet 625ug 100 1.00 MG 176 –

P 1777M

Tablet 730ug 1.00 MG 68,183

731,633P 177

8NTablet 1.46mg 1.00 MG 69,00

8902,461

A 14247

Tablet 2.5mg 5.00

MG 1,949

–P 231

9CInjection 50 mg in 1 mL 7.0

0MG 495 5,6

99P 2321E

Tablet 10mg 5.00

MG 43,494

659,958P 232

3GTablet 5mg 56 5.0

0MG 124,7

201,729,681P 272 Tablet 10mg 5.0 MG 16,96 521,

PROGESTERONEA 153

28Cream 3.2% 50g – – 1,25

3–

A 16638

Cream 10% 50g – – 406 –A 187

49Pessaries 100mg 15 90.0

0MG 215 –

A 18750

Pessaries 200mg 15 90.00

MG 323 –P 636

6CGel Vaginal (prolonged release) 90mg single dose

90.00

MG 390 –

G


cost($)

GENITO URINARY SYSTEM AND SEX HORMONESSEX HORMONES AND MODULATORS OF THE GENITAL SYSTEMESTROGENSNATURAL AND SEMISYNTHETIC ESTROGENS, PLAIN

G03CA57 OESTROGENS CONJUGATED

G03CA07

OTHER ESTROGENSG03CX01 TIBOLONE

A 16835 Tablet 2.5mg 28 2.50 MG 277,577 –A 20242 Tablet 2.5mg 28 2.50 MG 17

0–

PROGESTOGENSPREGNEN (4) DERIVATIVES

G03DA02 MEDROXYPROGESTERONE

G03DA04

PREGNADIEN DERIVATIVESG03DB01 DYDROGESTERONE

P 1350C Tablet 10mg 10.00MG 12,207 182,550ESTREN DERIVATIVES

G03DC02 NORETHISTERONEP 2993M Tablet 5mg 5.00 MG 144,9674,985,523

101

P 8168X Tablet 625ug 2.5mg 28

0.63

MG 143,881

2,339,362P 8169Y Tablet 625ug 5mg 28 0.6 MG 213,4 3,474,

NORETHISTERONE AND ESTROGENP 8081H Pack containing 28

tablets 2mg–1mg2.00

MG 136,106

2,218,593P 8353P Tablets 1mg–500ug, 28 – – 201,2

553,270,577

G03GA08

CHORIOGONADOTROPIN ALFAP 9606N Powder for injection 250ug withsolvent 1

0.25

MG 139 –G03GA05

FOLLITROPIN ALFAP 8713N Injection 300i.u. in 0.5mL multi–dose cartridge

75.00

IE 580 306,768P 8714P Injection 450i.u. in

0.75mL multi–dose cartridge75.00

IE 349 261,740P 8715Q Injection 900i.u. in 1.5mL

multi–dose cartridge75.00

IE 923 1,062,310G03GA0

6FOLLITROPIN BETAP 8565T Soln for injection 300iu in 0.36mL mulit–dose cart

75.00

IE 1,148

581,993P 8566W Soln for injection 600iu in

0.75mL mulit–dose cart75.00

IE 1,639

1,175,861P 8871X Soln for injection 900iu in

1.08mL mulit–dose cart75.00

IE 564 603,024G03GA0

1HUMAN CHORIONIC GONADOTROPHINP 1579D Ampoules pdr for inj. 500units 1ml solvent 3/3

250.00

IE 645 44,496P 1581F Ampoules pdr for inj.

1500units 1ml solvent 3/3250.00

IE 5,856

329,286P 6181H Ampoules pdr for inj.

5000units 1ml solvent 3/3250.00

IE 453 –

G


cost($)

GENITO URINARY SYSTEM AND SEX HORMONESSEX HORMONES AND MODULATORS OF THE GENITAL SYSTEMPROGESTOGENS AND ESTROGENS IN COMBINATIONPROGESTOGENS AND ESTROGENS,FIXED COMBINATIONS

G03FA12 MEDROXYPROGESTERONE AND ESTROGEN

G03FA01

PROGESTOGENS AND ESTROGENS,SEQUENTIAL PREPARATIONSG03FB08

DYDROGESTERONE AND ESTROGENP 8244X tabs estradiol 2mg+est/dydro 2mg/10mg,28mg(14/14)2.00

MG 8,285

134,362G03FB0

6MEDROXYPROGESTERONE AND ESTROGENA 19194 Pack 14 tablets oestrogens 625ug 0.63

MG 564 –G03FB05

OESTRADIOL with NORETHISTERONE ACETATEP 176

4WTablets sequential pack 2mg–1mg

2.00

MG 100,479

1,636,592P 802

9NPack containing 4 transdermal patches oestradiol

0.05

MG 12,553

232,538P 842

5KTransdermal patch 4 4.33mg, 4 620ug/2.7mg

0.05

MG 13,694

254,414P 842

6LTransdermal patch 4 4.33mg, 4 510ug/4.8mg

0.05

MG 10,236

188,200P 842

7MTransdermal patch 620ug/2.7mg, 8

0.05

MG 63,682

1,177,186P 842

8NTransdermal patch 510ug/4.8mg, 8

0.05

MG 27,101

499,996GONADOTROPHINS AND OTHER OVULATION STIMULANTS

GONADOTROPHINS

OVULATION STIMULANTS, SYNTHETIC

G03GB02 CLOMIPHENE CITRATEP 1211R Tablet 50mg 9.00 MG 38,729 1,523,269

P 1269T

Tablet 50mg 0.10 GM 22,125

1,783,189P 127

0WTablet 50mg 0.10 GM 13,6

333,638,009P 801


8511,150,222

P 1285P Capsule 100mg 0.60 GM 656 37,749P 1287R Capsule 200mg 0.60 GM 1,863 163,

772

102

G


cost($)

GENITO URINARY SYSTEM AND SEX HORMONESSEX HORMONES AND MODULATORS OF THE GENITAL SYSTEMANTIANDROGENSANTIANDROGENS, PLAIN PREPARATIONS

G03HA01 CYPROTERONE ACETATE

ANTIANDROGENS AND ESTROGENSG03HB01 CYPROTERONE and OESTROGEN

A 14126

Tablet 35ug/2mg 28 1 – – 23,071 –A 141

27Tablet 35ug/2mg 28 3 – – 133,794 –

A 15418

Tablet 28 1 – – 11,116 –A 154

19Tablet 28 3 – – 74,822 –

A 17090

Tablet 28 1 – – 17,229 –A 170

91Tablet 28 3 – – 130,274 –

A 18070

Tablet 35ug/2mg 28 1 – – 25,634 –A 180

71Tablet 35ug/2mg 28 3 – – 241,066 –

A 19849

Tablet 2mg 11 / 2mg + 1mg 1

– – 581

–OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEMANTIGONADOTROPINS AND SIMILAR AGENTS

G03XA01 DANAZOL

G03XA02 GESTRINONEP 8015W Capsule 2.5mg 0.70 MG 368 28,553

ANTIGONADOTROPINS AND SIMILAR AGENTSG03XC01 RALOXIFENE

P 8363E Tablet 60mg 28 60.00MG 327,606 18,924,321

A 19785 Tablet modified release 7.5 mg (H B r salt) 28

7.50

MG 1,498

–A 19786 Tablet modified release 7.5 MG 432 –OXYBUTYNINA 20073 Transdermal patch

3.9mg per 24hrs 83.90

MG 266 –P 8039D Tablet 5mg 15.0 MG 233,3 3,568,SOLIFENACINA 19781 Tablet 5mg 30 5.0

0MG 46,54

7–

A 19782 Tablet 10mg 30 5.0 MG 14,34 –TOLTERODINEA 18891 Tablet 1mg 56 4.0

0MG 4,49

7–

A 18892 Tablet 2mg 56 4.00

MG 14,856

–

P 4579B Intracavernosal injection 10ug in single syringe

0.02

MG 8,905

723,052P 4580C Intracavernosal injection 0.0 MG 16,5 1,697,

SILDENAFILP 458


0MG 3,00

31,032,264P 458


0MG 60,5

595,422,103P 458

6JTablet 100mg 4 50.0

0MG 353,1

6227,083,612P 960 Tablet 20mg 90 50.0 MG 54 506,

TADALAFILA 188


0MG 45,2

67–

P 4596X

Tablet 10mg 4 10.00

MG 18,053

1,272,569P 459 Tablet 20mg 4 10.0 MG 267,6 20,322

VARDENAFILA 179


0MG 26

4–

A 17961

Tablet 10mg 4 10.00

MG 9,405

–A 179


0MG 76

5–

A 17963

Tablet 20mg 2 10.00

MG 57,243

–

103

G


cost($)

GENITO URINARY SYSTEM AND SEX HORMONESUROLOGICALSOTHER UROLOGICALS, INCL. ANTISPASMODICSURINARY ANTISPASMODICSG04BD10 DARIFENACIN

G04BD04

G04BD08

G04BD07

DRUGS USED IN ERECTILE DYSFUNCTIONG04BE01 ALPROSTADIL

G04BE03

G04BE08

G04BE09

OTHER UROLOGICALSG04BX SODIUM BICARBONATE

P 4458P Capsule 840 mg – – 15,734

204,008G04BX SODIUM CITRO–TARTRATE

A 19768 Sachets cont. oral effervescent powder 4g 28

– – 239 –P 4049D Sachets cont. oral effervescent powder 4g 28

– – 29,757

366,997

P 4396J

Starter pack 7 tablets 1mg and 7 tablets 2mg

5.00

MG 157 2,863P 439

7KTablet 2mg 5.0

0MG 1,882 80,1

78P 4398L

Tablet 5mg 5.00

MG 2,962 174,681P 439

9MTablet 10mg 5.0

0MG 927 78,6

91

104

G


cost($)

GENITO URINARY SYSTEM AND SEX HORMONESUROLOGICALSDRUGS USED IN BENIGN PROSTATIC HYPERTROPHYALPHA–ADRENORECEPTOR ANTAGONISTS

G04CA02 TAMSULOSINA 19574 Capsule 400ug (modified release) 0.40 MG

184,938 –G04CA03 TERAZOSIN

TESTOSTERONE–5–ALPHA REDUCTASE INHIBITORSG04CB01 FINASTERIDE

A 16113 Tablet 1mg 28 – – 73,836

–P 4233T Tablet 5mg 5.00 MG 55,04

15,943,097

P 6423C

Injection 60mg (base) single dose syringe

3.00

MG 324 464,313P 642

4DInjection 90mg (base) single dose syringe

3.00

MG 173 333,978P 642 Injection 120mg (base) single 3.0 MG 321 733,

OCTREOTIDEP 622

8TInjection 100ug in 1mL ampoule 5

0.70

MG 234 185,844P 642

6FInj(mod release) 10mg(base) vial + diluent syringe

0.70

MG 142 226,665P 642

7GInj(mod release) 20mg(base) vial + diluent syringe

0.70

MG 751 1,627,489P 642

8HInj(mod release) 30mg(base) vial + diluent syringe

0.70

MG 1,010

2,984,364

105

H


cost($)

SYSTEMIC HORMONAL PREP EXCL.SEX HORMONESPITUITARY, HYPOTHALAMIC HORMONES AND ANALOGUESANTERIOR PITUITARY LOBE HORMONES AND ANALOGUESACTH

H01AA02 TETRACOSACTRINP 2832C Injection 1mg in 1mL 0.25 MG 372 25,463

THYROTROPHINH01AB01 THYROTROPIN

P 2700D Powder for injection 0.9mg 2 – – 163 310,286SOMATROPIN AND ANALOGUES

H01AC01 SOMATROPINP 6266T Injection 4mg vial with 3.5mL diluent 2.00 IE 209 –

POSTERIOR PITUITARY LOBE HORMONESVASOPRESSIN AND ANALOGUESH01BA02 DESMOPRESSIN

P 2129C

Intranasal solution 100ug per mL 2.5mL

25.00

UG 3,446

574,055P 866

2XTablet 200mg 90 400.

00UG 4,30

3685,982P 866

3YTablet 200mg 30 400.

00UG 13,03

5945,827P 871

1LNasal spray (pump pack) 10ug per mL 5, 60 act

6mL 25.00

UG 13,378

2,243,222P 871

2MNasal spray (pump pack) 10ug per mL 5, 60 act

6mL 25.00

UG 34,827

3,178,983HYPOTHALAMIC HORMONES

GONADOTROPHIN–RELEASING HORMONESH01CA02 NAFARELIN

P 2962X Nasal spray (pump pack) 200 ug base per dose 60 0.40 MG3,319 314,855

ANTIGROWTH HORMONEH01CB03 LANREOTIDE

H01CB02

106

H


cost($)

SYSTEMIC HORMONAL PREP EXCL.SEX HORMONESCORTICOSTEROIDS FOR SYSTEMIC USECORTICOSTEROIDS FOR SYSTEMIC USE, PLAINMINERALOCORTICOIDS

H02AA02 FLUDROCORTISONE ACETATEP 1433K Tablet 100ug 0.10 MG 25,720 420,633

GLUCOCORTICOIDSH02AB01

BETAMETHASONEP 2694T Injection 3mg–3.9mg (equiv.to 5.7 mg) in 1ml

1.50

MG 62,168

1,523,122H02AB1

6BUDESONIDEA 16037 Capsule 3mg 50 9.0

0MG 135 –

A 16038 Capsule 3mg 90 9.00

MG 3,203

–H02AB10

CORTISONEP 1246N Tablet 5mg 37.5

0MG 10,16

8204,201P 1247P Tablet 25mg 37.5

0MG 32,29

8493,074H02AB0

2DEXAMETHASONEP 1291Y Injection 8mg in 2mL 1.5

0MG 10,82

3283,664P 1292B Tablet 500ug 1.5

0MG 27,37

5208,595P 2507Y Tablet 4mg 1.5

0MG 90,26

5935,206P 2509C Injection 4mg in 1mL 1.5

0MG 7,89

6134,880P 3472R Injection 4mg in 1mL 1.5

0MG 8,33

5131,156H02AB0

9HYDROCORTISONEP 1499X Tablet 4mg 30.0

0MG 21,73

7278,640P 1500Y Tablet 20mg 30.0

0MG 16,20

3219,373P 1501B Injection equivalent to

100mg with 2ml solvent30.00

MG 3,343

53,156P 1510L Injection equivalent to


MG 10,335

373,408P 1511M Injection equivalent to


MG 388 23,685P 3096Y Injection equivalent to


MG 576 8,588P 3470P Injection equivalent to


MG 10,689

161,313P 3471Q Injection equivalent to


MG 8,611

126,826H02AB0

4METHYLPREDNISOLONEP 1928L Injection 40mg in 1mL 20.0

0MG 48,53

31,124,991P 2981X Injection equiv to 40mg

methylprednisolone20.00

MG 4,454

290,930P 8834Y Injection equiv to 1g

methylprednisolone = diluent20.00

MG 1,803

347,892H02AB0

6PREDNISOLONEP 1916W Tablet 25mg 10.0

0MG 508,5

635,153,408P 1917X Tablet 5mg 10.0

0MG 677,5

335,435,961P 3152X Tablet 1mg 10.0

0MG 209,5

821,616,254P 8285C Oral solution equiv to 5mg

prednisolone per mL10.00

MG 337,304

4,552,420H02AB0

7PREDNISONEP 1934T Tablet 1mg 10.0

0MG 104,1

15803,726P 1935W Tablet 5mg 10.0

0MG 325,5

072,618,264P 1936X Tablet 25mg 10.0

0MG 229,7

702,339,078H02AB0

8TRIAMCINOLONE ACETONIDEA 11073 Ampoule 40mg per ml 5 7.5

0MG 1,05

0–

107

P 2990J Injection 10mg in 1mL 7.50

MG 25,632

628,695

P 2173J

Tablet equivalent to 200ug anhydrous

0.15

MG 66,885

1,760,872P 217

4KTablet equivalent to 50ug anhydrous

0.15

MG 573,112

11,499,339P 217

5LTablet equivalent to 100ug anhydrous

0.15

MG 557,938

11,782,561

108

H


cost($)

SYSTEMIC HORMONAL PREP EXCL.SEX HORMONESTHYROID THERAPYTHYROID PREPARATIONSTHYROID HORMONES

H03AA01 LEVOTHYROXINE SODIUM

H03AA02 LIOTHYRONINEP 2318B Tablet 20ug 60.00UG 10,931 913,396

ANTITHYROID PREPARATIONSTHIOURACILS

H03BA02 PROPYLTHIOURACILP 1955X Tablet 50mg 0.10 GM 16,306 742,752

SULPHUR–CONTAINING IMIDAZOLE DERIVATIVESH03BB01 CARBIMAZOLE

P 1153Q Tablet 5mg 15.00MG 72,598 2,041,505

109

H


cost($)

SYSTEMIC HORMONAL PREP EXCL.SEX HORMONESPANCREATIC HORMONESGLYCOGENOLYTIC HORMONESGLYCOGENOLYTIC HORMONES

H04AA01 GLUCAGON HYDROCHLORIDEP 1449G Injection set

containing 1mg (1 i.u.)1.00

MG 28,829

1,188,153P 3467L Injection set

containing 1mg (1 i.u.)1.00

MG 16,346

663,202

110

H


cost($)

SYSTEMIC HORMONAL PREP EXCL.SEX HORMONESCALCIUM HOMEOSTASISANTI–PARATHYROID AGENTSCALCITONIN PREPARATIONS

H05BA01 CALCITONIN (SALMON SYNTHETIC)

P 2997R Injection (salmon) 100iu in 1mL ampoule 100.00 IE253 58,371

110

A 18808

Capsule 100mg 21 0.10

GM 489 –A 188


0GM 436 –

P 2702F

Tablet 100mg (HCl salt after 1 Oct 2007) 28

0.10

GM 80,802

1,253,634P 270

3GCapsule 100mg (as HCl salt after 1 Oct 2007)

0.10

GM 58,515

920,204P 270

7LCapsule 50mg (as HCl salt after 1 Oct 2007)

0.10

GM 275,334

2,769,343P 270

8MCapsule 100mg (as HCl salt after 1 Oct 2007)

0.10

GM 288,826

2,333,396P 270

9NTablet 100mg (as HCl salt after 1 Oct 2007)

0.10

GM 378,781

3,098,252P 271

1QTablet 50mg (as HCl salt after 1 Oct 2007) 25

0.10

GM 403,129

4,042,687P 271

4WTablet 100mg (as HCl salt after 1 Oct 2007) 21

0.10

GM 61,244

786,963P 271

5XCapsule 100mg (as HCl salt after 1 Oct 2007)

0.10

GM 46,135

599,749P 332

1TTablet 100mg 0.1

0GM 4,36

034,349P 332

2WCapsule 100mg 0.1

0GM 1,61

912,816P 508

2LTablet 100mg (monohydrate) 7

0.10

GM 205 1,653P 910

5FTablet 100mg (monohydrate) 7

0.10

GM 30,014

240,455P 910

6GTablet 50mg (as monohydrate) 25

0.10

GM 52,897

531,200P 910

7HTablet 100mg (monohydrate) 28

0.10

GM 5,764

90,632P 910 Tablet 100mg (as 0.1 GM 3,10 40,0

MINOCYCLINEP 1616C Tablet 50mg 0.2

0GM 426,5

137,178,352P 3037W Capsule 100mg 0.2

0GM 3,29

831,871

J


cost($)

GENERAL ANTIINFECTIVES FOR SYSTEMIC USEANTIBACTERIALS FOR SYSTEMIC USETETRACYCLINESTETRACYCLINES

J01AA02 DOXYCYCLINE

J01AA08

111

P 1878W

Sachet containing oral powder 3g

1.00

GM

16,853

162,565P 188

3DChewable tablet 250mg 1.0

0GM

91,396

813,980P 188

4ECapsule 250mg 1.0

0GM

378,891

3,061,729P 188

6GPowder for syrup 125mg per 5mL 100mL

1.00

GM

557,918

5,729,532P 188

7HPowder for syrup 250mg per 5mL 100mL

1.00

GM

903,836

10,276,464P 188

8JPowder paediatric oral drops 100mg per mL 20mL

1.00

GM

156,248

1,856,170P 188

9KCapsule 500mg 1.0

0GM

2,806,862

30,517,241A 197

39Powder for syrup 250mg per 5mL 100mL

1.00

GM

560

–A 199

85Capsule 250mg 1.0

0GM

422

–A 199


1.00

GM

394

–P 330

0QCapsule 500mg 1.0

0GM

485,213

5,138,028P 330

1RCapsule 250mg 1.0

0GM

74,944

599,847P 330

2TPowder for syrup 125mg per 5mL 100 mL

1.00

GM

11,972

122,787P 330

3WChewable tablet 250mg 1.0

0GM

1,682

14,920P 330

9ESachet containing oral powder 3g

1.00

GM

33,686

294,067P 339

3NPowder for syrup 250mg per 5mL 100mL

1.00

GM

7,788

87,938P 522

5BPowder for oral suspension 500mg per 5mL 100mL

1.00

GM

183

2,555P 858

1PTablet 1g 14 1.0

0GM

330,392

3,606,149P 870

5EPowder for oral suspension 500mg per 5mL 100mL

1.00

GM

43,292

609,155P 971 Powder paediatric oral drops 1.0 G 39 2,8

AMPICILLINP 239

0TInjection 500mg (solvent required)

2.00

GM

280

3,256P 267

1NCapsule 500mg 2.0

0GM

2,130

28,880P 297

7QInjection 1g (solvent required) 2.0

0GM

8,472

160,458

J


cost($)

GENERAL ANTIINFECTIVES FOR SYSTEMIC USEANTIBACTERIALS FOR SYSTEMIC USEBETA–LACTAM ANTIBACTERIALS,PENICILLINSPENICILLINS WITH EXTENDED SPECTRUM

J01CA04 AMOXYCILLIN

J01CA01

P 8167W

Injection 900mg in 2mL cartridge–needle unit

3.60

GM 235 11,594P 874

3EInjection 900mg in 2mL cartridge–needle unit

3.60

GM 196 10,374P 900

2TPowder for injection 900mg(1.2MU)1–needle unit

3.60

GM 1,047

57,033P 900 Powder for injection 3.6 GM 1,19 84,9

BENZATHINE PHENOXYMETHYLPENICILLINP 235

4XOral suspension 250mg per 5mL 100mL

2.00

GM 113,638

1,668,431P 235

6BPaediatric oral suspension 125mg per 5mL 100mL

2.00

GM 39,174

472,769P 336

5DPaediatric oral suspension 125mg per 5mL 100mL

2.00

GM 223 2,171P 336 Oral suspension 250mg per 2.0 GM 187 2,2

BENZYLPENICILLINP 177

5KInjection 600mg (solvent required )

3.60

GM 7,022

439,554P 264

7HInjection 3g (solvent required) 3.6

0GM 1,33

0116,512P 339

8WInjection 600 mg (solvent required)

3.60

GM 130 2,344P 348

6LInjection 600mg (with sterilised water)

3.60

GM 4,881

153,081P 348 Injection 3g (solvent supplied) 3.6 GM 3,59 39,5

PHENOXYMETHYLPENICILLINP 170

3PTablet 250mg 2.0

0GM 10,65

7126,072P 170

5RCapsule 250mg 2.0

0GM 27,46

7321,178P 178

7CTablet 250mg 2.0

0GM 21,70

9248,764P 178

9ECapsule 250mg 2.0

0GM 30,82

4351,337P 296

5CCapsule 500mg 2.0

0GM 236,9

373,529,216P 302

8JTablet 500mg 2.0

0GM 111,7

351,629,524P 336

0WTablet 250mg 2.0

0GM 3,08

827,642P 336

1XTablet 500mg 2.0

0GM 4,31

245,312P 336

3BCapsule 250mg 2.0

0GM 4,13

341,264P 336 Capsule 500mg 2.0 GM 13,01 154,

PROCAINE PENICILLINP 1794K Injection 1.5g 0.6

0GM 9,19

0501,986P 3485K Injection 1.5g 3.6

0GM 21,82

81,190,434

112

J


cost($)

GENERAL ANTIINFECTIVES FOR SYSTEMIC USEANTIBACTERIALS FOR SYSTEMIC USEBETA–LACTAM ANTIBACTERIALS,PENICILLINSBETA–LACTAMASE SENSITIVE PENICILLINS

J01CE08 BENZATHINE PENICILLIN

J01CE10

J01CE01

J01CE02

J01CE09

DICLOXACILLINP 812

1KCapsule 250mg 2.0

0GM 44,33

5530,556P 812

2LCapsule 500mg 2.0

0GM 329,7

057,120,497P 812

3MInjection 500mg (solvent required)

2.00

GM 188 3,780P 812 Injection 1g (solvent 2.0 GM 1,81 72,9

FLUCLOXACILLINP 152

4FInjection 500mg (solvent required )

2.00

GM 236 6,628P 152

5GInjection 1g (solvent required)

2.00

GM 16,266

974,215P 152

6HCapsule 250mg 2.0

0GM 58,34

8710,585P 152

7JCapsule 500mg 2.0

0GM 346,1

987,497,996P 152

8KPowder for syrup 125mg per 5mL 100mL

2.00

GM 16,528

223,967P 152

9LPowder for syrup 250mg per 5mL 100mL

2.00

GM 60,476

1,143,955A 197


2.00

GM 860 –P 509

1YCapsule 500mg 2.0

0GM 223 4,0

64

P 1891M

Tablet 500mg–125mg 1.00

GM

451,911

5,823,230P 189

2NPowder for syrup 125mg–31.25mg per 5mL 75mL

1.00

GM

64,687

803,400P 500

6LTablet 875mg–125mg 1.0

0GM

47,627

748,681P 500

8NTablet 500mg–125mg 1.0

0GM

11,369

142,793P 500

9PPowder for syrup 125mg–31.25mg per 5mL 75mL

1.00

GM

132

1,609P 501

1RPowder for syrup 400mg–57mg per 5mL 50mL

1.00

GM

307

4,346P 825

4KTablet 875mg–125mg 1.0

0GM

2,615,949

42,330,455P 831 Powder for syrup 400mg– 1.0 G 428,4 6,249,

TICARCILLIN with CLAVULANIC ACIDP 2179Q Injection 3g–100mg

(solvent required)15.00

GM

23,728

3,687,904P 6884H Injection 3 g–100 mg

10mL and NS15.00

GM

3,190

603,050

113

J


cost($)

GENERAL ANTIINFECTIVES FOR SYSTEMIC USEANTIBACTERIALS FOR SYSTEMIC USEBETA–LACTAM ANTIBACTERIALS,PENICILLINSBETA–LACTAMASE RESISTANT PENICILLINS

J01CF01

J01CF05

COMBINATIONS OF PENICILLINS, INCL.BETA–LACTAMASE INHIBITORSJ01CR02 AMOXYCILLIN with CLAVULANIC ACID

J01CR03

P 3058Y

Capsule 250mg 2.00

GM

351,414

3,018,442P 309

4WGranules for syrup 125mg per 5mL 100mL

2.00

GM

143,105

1,649,175P 309

5XGranules for syrup 250mg per 5mL 100mL

2.00

GM

366,250

4,970,765P 311

9ECapsule 500mg 2.0

0GM

3,375,522

37,337,308P 331

7NCapsule 250mg 2.0

0GM

4,464

37,294P 331

8PCapsule 500mg 2.0

0GM

25,041

270,315P 331

9QGranules for syrup 125mg per 5mL 100mL

2.00

GM

292

3,316P 332

0RGranules for syrup 250mg per 5mL 100mL

2.00

GM

342

4,488J01DB0

3CEPHALOTHINP 2964B Injection 1g (solvent required)

4.00

GM

53,569

2,201,067J01DB0

4CEPHAZOLINP 1257E Injection 1g (solvent required)

3.00

GM

18,992

1,219,249

P 1169M

Tablet 375mg (sustained release)

1.00

GM 711,290

9,827,196A 198

62Tablet 375mg (sustained release)10

1.00

GM 520 –P 246

0LPowder for oral susp 125mg per 5mL 100mL

1.00

GM 146,695

2,003,208P 246

1MPowder for oral susp 250mg per 5mL 75mL

1.00

GM 318,293

4,490,337P 504

5MTablet 375mg (sustained release)

1.00

GM 645 8,752

P 1085D Injection 1g (solvent required)

4.00

GM 1,775 44,954P 1086E Injection 2g (solvent

required)4.00

GM 408 17,372

A 17175

Injection 1g (solvent required)

2.00

GM 223 –P 178

4XInjection 1g (solvent required)

2.00

GM 47,187

1,706,617P 178

5YInjection 2g (solvent required)

2.00

GM 6,011

393,619A 198

28Injection 250mg (solvent required )

2.00

GM 274 –A 198

55Injection 500mg (solvent required )

2.00

GM 176 –P 905

8RInjection 500mg (solvent required )

2.00

GM 277 2,561

114

J


cost($)

GENERAL ANTIINFECTIVES FOR SYSTEMIC USEANTIBACTERIALS FOR SYSTEMIC USEOTHER BETA–LACTAM ANTIBACTERIALSFIRST–GENERATION CEPHALOSPORINS

J01DB01 CEFALEXIN

SECOND–GENERATION CEPHALOSPORINSJ01DC04 CEFACLOR

J01DC02 CEFUROXIMEP 8292K Tablet 250mg 14 0.50 GM 104,7361,643,820

THIRD–GENERATION CEPHALOSPORINSJ01DD01 CEFOTAXIME

J01DD02 CEFTAZIDIMEA 12747 Vial 1g 1 6.00 GM 410 –

J01DD04 CEFTRIAXONE

FOUTH–GENERATION CEPHALOSPORINSJ01DE01 CEFEPIME

P 8315P Injection 1g (solvent required)

2.00

GM 191

48,256P 8316Q Injection 2g (solvent

required)2.00

GM 201

83,337

A 19032

Tablet 500mg 3 0.30

GM

2,696

–P 411

5NTablet 500mg 0.3

0GM

5,024

248,208P 622

1KTablet 600mg 0.3

0GM

139

10,808P 820

0NTablet 500mg 0.3

0GM

57,834

1,273,502P 820

1PPowder for oral suspension 200mg per 5mL 15mL

0.30

GM

2,705

58,378P 833 Tablet 500mg 2 0.3 G 32,7 718,

CLARITHROMYCINA 164

32Liquid 250mg per 5mL 1 0.5

0Gm

443

–P 615


0GM

207

21,136P 831 Tablet 250mg 14 0.5 G 602,9 8,380,

ERYTHROMYCINP 139

7MI.V. infusion 1g (base) 1.0

0GM

734

36,799P 140

4XCapsule 250mg 1.0

0GM

135,523

1,307,730P 242

4NGranules for paediatric oral susp 200mg

1.00

GM

116,956

1,286,480P 242

8TGranules for oral susp 400mg (base) per 5mL 10

1.00

GM

173,662

2,206,418P 275

0RTablet 400mg (base) 1.0

0GM

385,520

3,576,299P 332

5BCapsule 250mg 1.0

0GM

19,314

175,694P 333

4LGranules for paediatric oral suspension 200mg

1.00

GM

263

2,892P 333

6NTablet 400mg (base) 1.0

0GM

7,812

69,956P 333 Granules for oral suspension 1.0 G 11 1,4

ROXITHROMYCINP 176

0PTablet 150mg 0.3

0GM

897,554

11,035,764P 801

6XTablet 300mg 0.3

0GM

1,327,041

16,538,159P 812

9WTablet for oral suspension 50 mg

0.30

GM

74,342

862,224

115

J


cost($)

GENERAL ANTIINFECTIVES FOR SYSTEMIC USEANTIBACTERIALS FOR SYSTEMIC USESULFONAMIDES AND TRIMETHOPRIMTRIMETHOPRIM AND DERIVATIVES

J01EA01 TRIMETHOPRIMP 2922T Tablet 300mg 0.40 GM 748,8486,102,309

COMBINATIONS OF SULFONAMIDES AND TRIMETHOPRIM, INCL. DERIVATIVESJ01EE01 TRIMETHOPRIM with SULPHAMETHOXAZOLE

A 20264

Oral suspension 40 mg–200 mg per 5 mL, 100 mL

– – 699 –P 294

9FTablet 80mg–400mg – – 7,01

273,544P 295

1HTablet 160mg–800mg – – 338,2

293,524,117P 310

3HOral suspension 40mg–200mg per 5mL 100mL

– – 117,048

1,041,113P 339

0KTablet 160mg–800mg – – 1,12

710,248MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS

MACROLIDESJ01FA10 AZITHROMYCIN

J01FA09

J01FA01

J01FA06

A 14783

Ampoule 300mg 2mL 1.80 GM 129 –A 166

44Capsule 150mg 100 1.20 GM 228 –

P 3138E

Capsule 150mg 1.20 GM 99,376

3,376,419P 505

7ECapsule 150mg 1.20 GM 32,86

2580,212

P 1208N

Tablet 250mg 1.00 GM 17,657

787,588P 120

9PTablet 500mg 1.00 GM 123,4

4310,041,412P 121

0QTablet 750mg 1.00 GM 37,4

135,209,115P 131 Tablet 250mg 1.00 GM 4,03 50,7

MOXIFLOXACINA 19908 Tablet 400mg

(base) 50.40 GM 35

9–

P 4329W Tablet 400mg 5 0.40 GM 6,22 318,NORFLOXACINA 13660 Tablet 400mg 6 0.80 GM 45,6

59–

P 3010K Tablet 400mg 0.80 GM 203,030

4,841,840

116

J


cost($)

GENERAL ANTIINFECTIVES FOR SYSTEMIC USEANTIBACTERIALS FOR SYSTEMIC USEMACROLIDES, LINCOSAMIDES AND STREPTOGRAMINSLINCOSAMIDES

J01FF01 CLINDAMYCIN

J01FF02 LINCOMYCINP 2530E Injection 600mg in 2mL 1.80 GM 2,325 86,697

AMINOGLYCOSIDE ANTIBACTERIALSOTHER AMINOGLYCOSIDES

J01GB03 GENTAMICIN SULPHATEP 2824P Injection 80mg (base) in 2mL 0.24 GM 21,197

426,979J01GB01 TOBRAMYCIN

P 1356J Injection 80mg (base) 0.24

GM 2,354 275,751P 8872Y Injection 80mg (base) in

2mL (without preserv)0.24

GM 824 111,687QUINOLONE ANTIBACTERIALS

FLUOROQUINOLONESJ01MA02 CIPROFLOXACIN

J01MA14

J01MA06

P 2270L

Powder for injection 1 gm(1000000iu) 3

2.00

GM 486 95,077P 313

0RInjection 500mg(500000iu) (solvent required)

2.00

GM 948 78,247P 313

1TInjection 500mg(500000iu) (solvent required)

2.00

GM 29,541

5,082,038

P 1692C Capsule 50mg 0.20 GM 73,506

1,094,989P 1693D Capsule 100mg 0.20 GM 84,67

41,902,255

117

J


cost($)

GENERAL ANTIINFECTIVES FOR SYSTEMIC USEANTIBACTERIALS FOR SYSTEMIC USEOTHER ANTIBACTERIALSGLYCOPEPTIDE ANTIBACTERIALS

J01XA01 VANCOMYCIN

STEROID ANTIBACTERIALSJ01XC01 FUSIDIC ACID

P 2312Q Tablet (sodium salt) 250mg (enteric coated) 1.50 GM 20,3783,432,717

IMIDAZOLE DERIVATIVESJ01XD01 METRONIDAZOLE

P 1638F I.V. infusion 500mg in 100mL 1.50 GM 31,928 1,350,459NITROFURAN DERIVATIVES

J01XE01 NITROFURANTOIN

OTHER ANTIBACTERIALSJ01XX05 METHENAMINE

P 3124K Tablet 1g 2.00 GM 72,431 2,612,617

P 1572R Tablet 200mg 0.20 GM 20,965

829,289P 1573T Tablet 200mg 0.20 GM 29,92

6571,956

A 14171


GM 26,157

–P 147

1KCapsule 50mg 28 0.2

0GM 3,67

2566,668P 147

2LCapsule 100mg 28 0.2

0GM 9,39

72,832,676P 147

3MSolution for IV infusion 100mg in 50mL 7

0.20

GM 150 31,835P 147

4NSolution for IV infusion 200mg in 100mL 7

0.20

GM 729 405,813P 147

5PCapsule 200mg 0.2

0GM 8,15

65,114,752A 159

80Susp 50mg/5mL 35mL 0.2

0GM 133 –

A 19776


GM 21,962

–A 199


0GM 7,30

4–

A 19902


GM 3,853

–A 201


0GM 296 –

A 202 Capsule 150mg 1 0.2 GM 162 –ITRACONAZOLEA 148

10Capsule 100mg 0.2

0GM 1,86

0–

A 16227


GM 1,765

–P 819

6JCapsule 100mg 0.2

0GM 5,67

61,707,380

118

J


cost($)

GENERAL ANTIINFECTIVES FOR SYSTEMIC USEANTIMYCOTICS FOR SYSTEMIC USEANTIMYCOTICS FOR SYSTEMIC USEANTIBIOTICS

J02AA01 AMPHOTERICINP 1047D Injection 50mg (solvent required) 35.00 MG 135 15,014

IMIDAZOLE DERIVATIVESJ02AB02 KETOCONAZOLE

TRIAZOLE DERIVATIVESJ02AC01 FLUCONAZOLE

J02AC02

P 1981G

Capsule 150mg 0.60

GM 1,246 12,453P 198

2HCapsule 150mg 0.6

0GM 568 19,4

66P 1983J

Capsule 300mg 0.60

GM 2,254 139,307P 198

4KCapsule 300mg 0.6

0GM 8,114 117,

119PHYDRAZID

ES

8025J

Syrup 100mg per 5mL 60mL

0.60

GM 460 14,914

119

J


cost($)

GENERAL ANTIINFECTIVES FOR SYSTEMIC USEANTIMYCOBACTERIALSDRUGS FOR TREATMENT OF TUBERCULOSISANTIBIOTICS

J04AB02 RIFAMPICIN

J04AC01 ISONIAZIDP 1554T Tablet 100mg 0.30 GM 1,217 11,761

DRUGS FOR TREATMENT OF LEPRADRUGS FOR TREATMENT OF LEPRA

J04BA02 DAPSONEP 1272Y Tablet 100mg 50.00 MG 2,638 286,

429P 8801F Tablet 25mg 50.00 MG 1,146 114,577

120

ACICLOVIRP 100

3TTablet 200mg 4.00 GM 5,37

2477,538P 100

7BTablets 200mg 90 4.00 GM 33,2

405,373,444P 105

2JTablets 800mg 35 4.00 GM 8,31

31,602,143P 823 Tablets 800mg 120 4.00 GM 21 123,

FAMCICLOVIRA 196

96Tablet 250mg 14 0.75 GM 39

0–

A 19996

Tablet 500mg 3 0.75 GM 1,806

–P 800

2ETablet 250mg 0.75 GM 45,0

926,440,727P 809

2XTablet 125mg 0.75 GM 10,2

301,397,901P 821

7LTablet 250mg 0.75 GM 60,6

7421,796,412P 889

6FTablet 500mg 56 0.75 GM 3,29

61,186,028P 889 Tablet 500mg 30 0.75 GM 2,05 417,

VALACICLOVIRP 806

4KTablet 500mg 3.00 GM 32,8

947,000,810P 813


091,621,972P 813

4DTablet 500mg 3.00 GM 283,9

5247,523,669

J


cost($)

GENERAL ANTIINFECTIVES FOR SYSTEMIC USEANTIVIRALS FOR SYSTEMIC USEDIRECT ACTING ANTIVIRALSNUCLEOSIDES AND NUCLEOTIDES EXCL. REVERSE TRANSCRIPTASE INHIBITORS

J05AB01

J05AB09

J05AB11

PROTEINASE INHIBITORSJ05AE08 ATAZANAVIR

P 6451M Capsule 150mg (base) 60 0.30 GM 1,649 755,867NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS

J05AF08

ADEFOVIR DIPIVOXILP 6450L Tablet 30mg 30 10.0

0MG 3,52

52,379,053J05AF0

2DIDANOSINEP 6300N Capsule 250mg (enteric coated beads)

0.40

GM 122 –P 6301P Capsule 400mg (enteric coated beads)

0.40

GM 111 26,608J05AF1

0ENTECAVIRP 9602J Tablet 0.5mg 30 0.5

0MG 4,09

81,691,517P 9603K Tablet 1mg 30 0.5

0MG 1,59

81,068,214J05AF0

5LAMIVUDINEP 6193Y Tablet 150 mg 0.3

0GM 236 14,1

04P 6257H Tablet 100mg 0.30

GM 8,692

1,397,246P 6435Q Tablet 300mg 30 0.3

0GM 347 –

J05AF04

STAVUDINEP 6190T Capsule 40mg 80.0

0MG 191 21,6

25

121

A 17034 Capsule 75mg 10 – – 32,118 –A 18057 Suspension 12mg

per ml 1– – 3,102 –

J


cost($)

GENERAL ANTIINFECTIVES FOR SYSTEMIC USEANTIVIRALS FOR SYSTEMIC USEDIRECT ACTING ANTIVIRALSNON–NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS

J05AG03 EFAVIRENZP 6356M Tablet 600mg 30 0.60 GM 188 53,964

J05AG01 NEVIRAPINEP 6215D Tablet 200mg 0.40 GM 1,613 463,702

NEURAMINIDASE INHIBITORSJ05AH02 OSELTAMIVIR

J05AH01 ZANAMIVIRA 16327 Rotadisk 5mg 20 20.00MG 2,034 –

ANTIVIRALS FOR TREATMENT OF HIV INFECTIONJ05AR LOPINAVIR WITH RITONAVIR

P 6495W Tablet 200mg – 50mg 120 – – 1,304 927,288J05AR0

3TENOFOVIR DISOPROXIL and EMTRICITABINEP 6468K Tablet 300mg (base)–

– – 259 207,927J05AR0

4ZIDOVUDINE LAMIVUDINE and ABACAVIRP 6327B Tablet 300mg (base) 150mg–300mg 6 0

– – 243 891J05AR0

1ZIDOVUDINE and LAMIVUDINEP 6234D Tablet 150mg – 300mg – – 850 516,

350

A 17391

Vial 0.5mL 1 – – 1,113 –A 176

37Syringe 10ug per 0.5mL conjugated 1

– – 430

–A 201

45Injection 10mg per 0.5mL prefilled syringe 1

– – 111

–

P 3463G Injection 0.5mL in pre–filled syringe

– – 31,906

5,962,919P 8783G Injection 0.5mL in pre–

filled syringe– – 11,94

1641,331

J07AP01

SALMONELLA–TYPHIA 19176 Oral live attenuated capsule Typhoid

– – 5,912 –J07AP01

TYPHOID ORAL LIVE ATTENUATEDA 13158 Cap–ec 3 1 – – 37

7–

J07AP03

TYPHOID PURIFIED POLYSACCHARIDE ANTIGENA 14718 Syringe 0.5mL

– – 69,900 –A 16719 Injection 25ug – – 23,080 –

122

J


cost($)

GENERAL ANTIINFECTIVES FOR SYSTEMIC USEVACCINESBACTERIAL VACCINESCHOLERA VACCINES

J07AE02 CHOLERA, LIVE ATTENUATEDA 18382 Oral granules Cholera, inactivated 14 – – 38,161–

HEMOPHILUS INFLUENZA B VACCINESJ07AG01 HAEMOPHILUS INFLUENZA B CONJUGATE VACCINE

A 16731 Injection 0.5mL 1 – – 149 –J07AG01 HAEMOPHILUS INFLUENZA B CONJUGATE and HEPATITIS B VACCINES

A 19684 Injection 0.5mL, 1 – – 171 –J07AG01 HAEMOPHILUS INFLUENZA B VACCINE

A 14180 Injection 0.5mL 1 – – 371 –MENINGOCOCCAL VACCINES

J07AH04 MENINGOCOCCALA 14507 Vial 0.5mL 1 – – 7,569 –

J07AH07 MENINGOCOCCAL C

PERTUSSIS VACCINESJ07AJ52 DIPHTERIA WITH TETANUS WITH PERTUSSIS PURIFIED ANTIGEN

A 17092 Injection 0.5mL 1 – – 19,183 –PNEUMOCOCCAL VACCINES

J07AL01 PNEUMOCOCCALP 1903E Injection 0.5mL (23 valent) – – 39,871 1,586,900

TETANUS VACCINESJ07AM51 TETANUS TOXOID, COMBINATIONS with DIPTHERIA

TYPHOID,VACCINES

OTHER BACTERIAL VACCINESJ07AX Q FEVER

A 15417 Vaccine 0.5mL – – 167 –

A 19065 Injection 0.25mL – – 163

–P 2852D Injection (trivalent)

0.5mL– – 848,2

1915,124,221

A 15677

Syringe 720u/0.5mL – – 13,750 –A 156

87Syringe 144u 1 – – 60,827 –

A 15770

Syringe 25u 1 – – 276

–A 157 Syringe 50u 1 – – 87 –HEPATITIS A\HEPATITIS BA 157

60Syringe 1mL – – 128,521 –

A 15917

Syringe 0.5mL – – 1,745 –A 170 Syringe 0.5mL – – 1,749 –HEPATITIS BA 129

13Vial 1mL 1 – – 5,578 –

A 12914

Vial 0.5mL 1 – – 825

–A 130

26Ampoule 20ug per mL 1 – – 61,644 –

A 13473

Ampoule 10ug per 0.5ml 1

– – 3,151 –A 157

83Vial 40ug per mL 1 – – 1,243 –

A 17628

Vial 5ug/0.5mL (paediatric) 10

– – 230

–A 176

29Vial 10ug/0.5mL (adult) 10

– – 228

–

A 14107 Injection 1mL 1 – – 2,242 –A 19166 Injection 2.5ug 1 – – 1,174 –

123

J


cost($)

GENERAL ANTIINFECTIVES FOR SYSTEMIC USEVACCINESVIRAL VACCINESENCEPHALITIS VACCINES

J07BA02 JAPANESE ENCEPHALITIS VACCINEA 16423 Vaccine 1mL vial 3 – – 1,259 –

J07BB02 INFLUENZA VACCINE

HEPATITIS VACCINESJ07BC02 HEPATITIS A

J07BC20

J07BC01

J07BC20 SALMONELLA and HEPATITIS AA 17818 Prefilled syringe 25ug and 160 Elisa units – – 73,764

–MEASLES VACCINES

J07BD52 MEASLES with MUMPS with RUBELLA UBELLA)A 18509 Injection 0.5mL 1 – – 4,008 –

POLIOMYELITIS VACCINESJ07BF03 POLIOMYELITIS

A 16235 Injection 0.5mL – – 11,281 –RABIES VACCINES

J07BG01 RABIES INACTIVATED

ROTA VIRUS DIARRHEA VACCINESJ07BH01 ROTAVIRUS VACCINE,LIVE

A 19674 Oral liquid 2mL 1 – – 5,465 –A 19688 Oral liquid 2mL 1 – – 14,748 –

A 16723 Vaccine 0.5mL – – 15,856 –A 17821 Vaccine 0.5mL – – 82

0–

124

J


cost($)

GENERAL ANTIINFECTIVES FOR SYSTEMIC USEVACCINESVIRAL VACCINESRUBELLA VACCINES

J07BJ01 RUBELLAA 11227 Injection 0.5mL – – 1,896 –

VARICELLA VACCINESJ07BK01 VARICELLA LIVE ATTENUATED

YELLOW FEVER VACCINESJ07BM02 VACCINE PAPILLOMAVIRUS (HUMAN TYPES 16 AND 18)

A 20142 Injection 0.5mL prefilled syringe 1 – – 885 –BACTERIAL AND VIRAL VACCINES, COMBINEDBACTERIAL AND VIRAL VACCINES, COMBINED

J07CA02 DIPHTHERIA–PERTUSSIS–POLIOMYELITIS–TETANUSA 19175 Injection 0.5mL, 1 – – 15,782 –

P 1031G

Injection 2g (solvent required)

– – 10,881

458,642P 107

9TInjection 500mg (solvent required)

– – 2,099 56,036P 108

0WInjection 1g (solvent required)

– – 6,350 176,675P 126

6PTablet 50mg – – 8,678 254,

964P 5914G

Injection 500mg (solvent required)

– – 2,380 25,847P 591

5HInjection 1g (solvent required)

– – 4,352 73,071P 591 Injection 2g (solvent – – 1,129 33,5

IFOSFAMIDEP 594

3TPowder for I.V. injection 1g – – 146 14,8

21P 5944W

Powder for I.V. injection 2g – – 230 54,898P 807

6CPowder for I.V. injection 1g – – 355 99,0

88P 8077D

Powder for I.V. injection 2g – – 723 339,278

P 5900M Powder for injection 208mg with solvent

– – 268 254,210P 8786K Powder for injection

208mg with solvent– – 631 947,

384

125

L


cost($)

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSANTINEOPLASTIC AGENTSALKYLATING AGENTSNITROGEN MUSTARD ANALOGUES

L01AA02 CHLORAMBUCILP 1163F Tablet 2mg – – 4,585 505,396

L01AA01 CYCLOPHOSPHAMIDE

L01AA06

L01AA03 MELPHALANP 2547C Tablet 2mg – – 3,239 85,469

ALKYL SULPHONATESL01AB01 BUSULPHAN

P 1128J Tablet 2mg – – 39417,254

NITROSOUREASL01AD05 FOTEMUSTINE

OTHER ALKYLATING AGENTSL01AX03

TEMOZOLOMIDEP 588

3PCapsule 100mg 15 – – 112 234,

737P 5982W

Capsule 100mg 5 – – 185 357,313P 598

3XCapsule 250mg 5 – – 131 236,

759P 8378Y

Capsule 5mg – – 172 48,481P 837

9BCapsule 20mg 5 – – 1,09

5785,041P 838

0CCapsule 100mg 5 – – 3,35

38,364,052P 838

1DCapsule 250mg 5 – – 1,38

22,756,543P 881

9ECapsule 5mg 15 – – 207 79,7

49P 8820F

Capsule 20mg 15 – – 825 834,157P 882

1GCapsule 100mg 15 – – 1,01

62,827,995

P 1622J

Tablet 2.5mg – – 83,958

1,023,476P 162

3KTablet 10mg – – 90,07

74,149,839P 239

5CInjection 50mg in 2mL – – 15,65

8552,361P 239

6DInjection 5mg in 2mL – – 1,16

985,350P 596

2TInjection 5mg in 2mL – – 351 5,4

59P 5963W

Injection 50mg in 2mL – – 557 5,960P 885

1WSolution concentrate I.V. infusion 1000mg in 10mL

– – 344 133,368P 885 Solution concentrate I.V. – – 114 115,

PEMETREXEDP 580

1HPowder for I.V. infusion 500mg (base) 2

– – 315 988,869P 588

7WPowder for I.V. infusion 500mg (base) 2

– – 168 466,924P 880

9PPowder for I.V. infusion 500mg (base) 2

– – 352 1,152,196P 971

3FPowder for I.V. infusion 500mg (base) 2

– – 1,610

5,705,758

P 8361C Tablet 150mg – – 2,028

274,428P 8362D Tablet 500mg 120 – – 20,4 15,958

CYTARABINEP 2884T Injection set containing

100mg and 5mL solvent– – 1,16

3417,558P 5918L Injection set containing – – 53 16,2

FLUOROURACILP 252

8CInjection 500mg in 10mL – – 39,1

042,256,554P 422

2FCream 50mg per g (5%) 20g – – 86,9

713,986,055P 587

2CInjection 1000mg in 20mL 5 – – 2,08

971,387P 593

5JInjection 500mg in 10mL – – 12,0

13369,525P 900 Injection 100mg in 20mL 5 – – 2,21 119,

GEMCITABINEP 593

6KPowder for I.V. infusion 200mg (base)

– – 3,001

479,357P 593

7LPowder for I.V. infusion 1gm (base)

– – 5,938

2,560,473P 804

9PPowder for I.V. infusion 200mg (base)

– – 5,354

2,173,310P 805

0QPowder for I.V. infusion 1gm (base)

– – 15,317

13,872,910

126

L


cost($)

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSANTINEOPLASTIC AGENTSANTIMETABOLITESFOLIC ACID ANALOGUES

L01BA01 METHOTREXATE

L01BA04

L01BA03 RALTITREXEDP 8284B Powder for I.V. infusion 2mg – – 201 184,354

PURINE ANALOGUESL01BB02 MERCAPTOPURINE

P 1598D Tablet 50mg – – 12,817 2,503,265L01BB03 THIOGUANINE

P 1233X Tablet 40mg – – 714 85,580PYRIMIDINE ANALOGUES

L01BC06 CAPECITABINE

L01BC01

L01BC02

L01BC05

P 2199R Injection set containing 10mg and 10mL solvent

– – 1,126

90,885P 5989F Injection set containing – – 1,05 29,0

VINCRISTINE SULPHATEP 2374Y Injection set containing

1mg and 1mL solvent– – 5,30

0656,172P 5991H Injection set containing – – 2,79 89,8

VINORELBINEP 599

2JSolution for I.V. infusion 10mg (base) in 1mL

– – 258 68,837P 599

3KSolution for I.V. infusion 50mg (base) in 5mL

– – 792 333,737P 828

0TSolution for I.V. infusion 10mg (base) in 1mL

– – 793 715,803P 828

1WSolution for I.V. infusion 50mg (base) in 5mL

– – 1,797

1,907,947P 900

9ECapsule 20 mg (base),20 – – 158 270,

699

127

L


cost($)

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSANTINEOPLASTIC AGENTSPLANT ALKALOIDS AND OTHER NATURAL PRODUCTSVINCA ALKALOIDS AND ANALOGUES

L01CA01 VINBLASTINE SULPHATE

L01CA02

L01CA04

PODOPHYLLOTOXIN DERIVATIVESL01CB01 ETOPOSIDE

P 1389D

Capsule 100 mg – – 398

164,360P 139

0ESolution for I.V. infusion 100mg in 5mL

– – 1,957

351,286P 139

6LCapsule 50mg – – 72

6340,323P 593

1ESolution for I.V. infusion 100mg in 5mL

– – 790

77,128P 593

2FPowder for I.V. infusion 113.6mg

– – 3,201

288,073P 593

3GPowder for I.V. infusion 1136mg

– – 123

36,851P 812

0JPowder for I.V. infusion 113.6mg

– – 3,564

643,644P 851

5EPowder for I.V. infusion 1136mg

– – 653

231,105P 901

0FCapsule 30 mg,16 – – 25

8521,237TAXANES

L01CD02 DOCETAXELP 592

1PInjection set containing I.V. infusion 20mg

– – 2,255

1,427,059P 592

2QInjection set containing I.V. infusion 80mg

– – 2,939

4,705,059P 807

1TInjection set containing I.V. infusion 20mg

– – 5,954

8,887,147P 807

4YInjection set containing I.V. infusion 80mg

– – 8,433

20,273,507L01CD01 PACLITAXEL

P 3017T

Solution for I.V. infusion 150mg in 25mL

– – 3,321

7,726,727P 302

6GSolution for I.V. infusion 30mg in 5mL

– – 2,679

2,918,217P 597

3JSolution for I.V. infusion 30mg in 5mL

– – 1,516

530,600P 597

4KSolution for I.V. infusion 100mg in 16.7mL

– – 1,565

1,410,195P 597

5LSolution for I.V. infusion 150mg in 25mL

– – 1,415

1,625,881P 597

6MSolution for I.V. infusion 300mg in 50mL

– – 1,189

2,131,692P 801

8BSolution for I.V. infusion 100mg in 16.7mL

– – 4,170

8,019,247P 836

0BSolution for I.V. infusion 300mg in 50mL

– – 6,675

14,433,522

P 1336H

Solution for I.V. or intravesical 10mg

– – 724 71,084P 134

0MSolution for I.V. or intravesical 20mg

– – 1,020

169,090P 134

2PSolution for I.V. or intravesical 50mg

– – 13,323

5,162,915P 587

9KSolution for I.V. or intravesical 100mg in 50mL

– – 1,181

294,638P 589

1CSolution for I.V. infusion 20mg in 10mL

– – 472 482,194P 589

2DSuspn for IV infusion 50mg in 25mL

– – 406 652,652P 592

5WSolution for I.V. or intravesical 10mg

– – 776 54,063P 592

6XSolution for I.V. or intravesical 20mg

– – 1,076

118,470P 592

7YSolution for I.V. or intravesical 50mg

– – 5,048

1,051,434P 856

9BSuspn for IV infusion 20mg in 10mL

– – 1,334

2,643,367P 857

0CSuspn for IV infusion 50mg in 25mL

– – 1,490

3,614,389P 882

7NSolution for I.V. or intravesical 100mg in 50mL

– – 1,492

505,063P 882 Solution for I.V. or intravesical – – 138 93,6

EPIRUBICIN HYDROCHLORIDEP 137

5JSolution for I.V. injection 10mg in 5mL 4

– – 489 70,519P 137

6KSolution for I.V. injection 20mg in 10mL 4

– – 517 135,892P 137

7LSolution for I.V. injection 50mg in 25mL 3

– – 5,824

4,943,590P 587

1BPowder for injection 50mg 3 – – 127 79,6

39P 5884Q

Solution for injection 200mg in 100mL

– – 219 188,320P 588

5RSolution for injection 100mg in 50mL 2

– – 589 391,977P 592

8BSolution for I.V. injection 10mg in 5mL 4

– – 429 36,802P 592

9CSolution for I.V. injection 20mg in 10mL 4

– – 581 98,585P 593

0DSolution for I.V. injection 50mg in 25mL 3

– – 2,051

1,208,525P 881

7CSolution for injection 100mg in 50mL 2

– – 1,815

1,673,772P 885

8FSolution for injection 200mg in 100mL

– – 1,787

1,823,435P 901

8PPowder for injection 50mg 3 – – 325 232,

681

P 1929M

Injection 20mg in 10mL – – 1,624 504,210P 193

0NInjection 25mg in 12.5mL

– – 1,232 472,414P 193

2QInjection 10mg in 5mL – – 357 66,7

79P 5965Y


6BInjection 25mg in 12.5mL

– – 256 83,827

P 2315W Injection 15,000 units (solvent required)

– – 1,013 301,122P 5903Q Injection 15,000 units

(solvent required)– – 1,580 147,

213

128

L


cost($)

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSANTINEOPLASTIC AGENTSCYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCESANTHRACYCLINES AND RELATED SUBSTANCES

L01DB01 DOXORUBICIN HYDROCHLORIDE

L01DB03

L01DB06 IDARUBICIN HYDROCHLORIDEP 8531B Solution for I.V. injection 10mg in 10mL – – 165

339,489L01DB07 MITOZANTRONE

OTHER CYTOTOXIC ANTIBIOTICSL01DC01 BLEOMYCIN

L01DC03 MITOMYCINA 13990 Vial 2mg 10 – – 836 –

P 1160C

Solution for I.V. injection 50mg in 5mL

– – 1,408

86,035P 116

1DSolution for I.V. injection 150mg in 15mL

– – 9,777

3,738,748P 116

2ESolution for I.V. injection 450mg in 45mL

– – 7,782

1,990,540P 590

6WSolution for I.V. injection 50mg in 5mL

– – 1,384

55,168P 590

7XSolution for I.V. injection 150mg in 15mL

– – 4,454

609,211P 590 Solution for I.V. injection – – 4,97 727,

CISPLATINP 257

8QI.V. injection 10mg in 10mL – – 24

89,072P 257

9RI.V. injection 50mg in 50mL – – 3,29

6142,304P 258

0TI.V. injection 100mg in 100mL

– – 8,805

599,193P 590

9BI.V. injection 10mg in 10mL – – 11

3786

P 5910C

I.V. injection 50mg in 50mL – – 1,368

26,702P 591 I.V. injection 100mg in – – 3,64 171,

OXALIPLATINP 587

7HSolution for I.V. infusion 50mg in 10mL

– – 2,113

874,414P 587

8JSolution for I.V. infusion 100mg in 20mL

– – 4,371

4,078,758P 599

4LPowder for I.V. infusion 50mg

– – 228

124,547P 599

5MPowder for I.V. infusion 100mg

– – 438

531,937P 853

9KPowder for I.V. infusion 50mg

– – 2,648

2,426,059P 854

0LPowder for I.V. infusion 100mg

– – 5,784

10,049,759P 884

7PSolution for I.V. infusion 50mg in 10mL

– – 3,795

4,236,403P 884

8QSolution for I.V. infusion 100mg in 20mL

– – 8,079

15,477,120

P 5896H

Solution for IV infusion 100mg\10mL

– – 2,657

2,182,543P 589

7JSolution for IV infusion 500mg\50mL

– – 2,351

5,344,289P 597

8PSolution for IV infusion 100mg\10mL

– – 3,612

3,092,954P 597

9QSolution for IV infusion 500mg\50mL

– – 3,354

7,664,448P 829

3LSolution for IV infusion 100mg\10mL

– – 9,475

11,582,372P 829

4MSolution for IV infusion 500mg\50mL

– – 9,796

24,532,701P 866

5CSolution for IV infusion 100mg\10mL

– – 9,645

11,500,093P 866

6DSolution for IV infusion 500mg\50mL

– – 9,724

24,267,035P 961

1WSolution for IV infusion 500mg\50mL

– – 255

1,144,128

129

L


cost($)

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSANTINEOPLASTIC AGENTSOTHER ANTINEOPLASTIC AGENTSPLATINUM COMPOUNDSL01XA02 CARBOPLATIN

L01XA01

L01XA03

MONOCLONAL ANTIBODIES

L01XC07 BEVACIZUMABA 19029 Soln for IV infusion 100mg/4mL – – 341 –

L01XC02 RITUXIMAB

L01XC03 TRASTUZUMABP 6497Y Powder for IV infusion 150mg – – 18,117 64,143,435

130

P 2482P

Tablet 50mg 60 – – 139

737,270P 248 Tablet 70mg 60 – – 21 1,382,

GEFITINIBP 876 Tablet 250mg 30 – – 49 1,927,IMATINIBP 644

0YTablet 100mg (base) 60 – – 67

42,381,810P 644

1BTablet 400mg (base) 30 – – 1,97

47,563,698P 644

4ETablet 100mg (base) 60 – – 3,77

314,478,215P 644

5FTablet 400mg (base) 30 – – 7,72

131,542,221P 644

6GTablet 100mg (base) 60 – – 60

12,763,247P 644

7HTablet 400mg (base) 30 – – 65

23,178,144P 911

2NTablet 400mg (base) 30 – – 16

4644,636P 911

3PTablet 100mg (base) 60 – – 15

0585,560P 911

4QTablet 400mg (base) 30 – – 25

31,039,955

P 5958N

I V injection 40mg in 2mL

– – 1,158

202,357P 595

9PI V injection 100mg in 5mL

– – 2,477

1,857,205P 841

4WI V injection 40mg in 2mL

– – 2,098

1,088,661P 841

5XI V injection 100mg in 5mL

– – 7,238

10,304,709

L


cost($)

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSANTINEOPLASTIC AGENTSOTHER ANTINEOPLASTIC AGENTSPROTEIN KINASE INHIBITORSL01XE06 DASATINIB

L01XE02

L01XE01

OTHER ANTINEOPLASTIC AGENTSL01XX05 HYDROXYUREA

P 3093T Capsule 500mg – – 32,469 2,464,019L01XX19 IRINOTECAN

L01XX17 TOPOTECANP 8199M Powder for I.V. infusion 4mg (base) – – 180

383,659

131

P 2316X

Tablet 200mg 1000.00

MG 1,691 183,557P 272

5KTablet 100mg 1000.

00MG 2,203 210,

891P 2727M

Tablet 250mg 1000.00

MG 202 26,971P 272

8NTablet 500mg 1000.

00MG 850 114,

202

P 1454M

Subcutaneous implant 3.6mg 0.13

MG 21,590

7,170,382P 809

3YSubcutaneous implant 10.8mg (base) in prefilled

0.13

MG 46,604

51,510,480P 906

4CSubcutaneous implant 3.6mg(base) in prefilled

0.13

MG 171

90,718P 906

5DSubcutaneous implant 10.8mg (base) in prefilled

0.13

MG 183

235,712P 906 Subcutaneous implant 10.8mg 0.1 MG 65 1,083,

LEUPRORELIN ACETATEA 147

27Injection 5mg 0.1

3MG 64

3–

P 8707G

Suspn subcutaneous inj(mod rel) 7.5mg inj set

0.13

MG 650

272,151P 870

8HSuspn subcutaneous inj(mod rel) 22.5mg inj set

0.13

MG 1,901

2,100,548P 870

9JSuspn subcutaneous inj(mod rel) 30mg inj set

0.13

MG 1,239

1,778,968P 885

9GSuspn subcutaneous inj(mod rel) 45mg inj set

0.13

MG 1,958

4,113,465P 887

5DI.M. injection (modified release) 7.5mg diluent

0.13

MG 5,025

2,106,832P 887

6EI.M. injection (modified release) 22.5mg diluent

0.13

MG 13,302

14,702,667P 887

7FI.M. injection (modified release) 30mg diluent

0.13

MG 9,470

13,590,294

L


cost($)

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSENDOCRINE THERAPYHORMONES AND RELATED AGENTSPROGESTOGENS

L02AB02 MEDROXYPROGESTERONE

L02AB01 MEGESTROLP 2734X Tablet 160mg 160.00 MG 1,486 107,714

GONADOTROPHIN RELEASING HORMONE ANALOGUESL02AE03 GOSERELIN

L02AE02

P 2109B

Tablet 10mg (base) 60

20.00

MG 5,082

236,006P 211

0CTablet 20mg (base) 60

20.00

MG 135,671

10,404,706L02BA0

2TOREMIFENE

P Tablet 60mg (base) 60.00

MG 3,377

229,333

L02BB03

BICALUTAMIDEP 8094B Tablet 50mg 50.00 MG 34,85

47,750,574L02BB0

1FLUTAMIDEP 1417N Tablet 250mg 750.00 MG 3,37

3728,439L02BB0

2NILUTAMIDEP 8131Y Tablet 150mg 30.00 MG 4,92

01,128,243

132

L


cost($)

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSENDOCRINE THERAPYHORMONE ANTAGONISTS AND RELATED AGENTSANTI–ESTROGENS

L02BA01 TAMOXIFEN

ANTI–ANDROGENS

ENZYME INHIBITORSL02BG01

AMINOGLUTETHIMIDEP 1036M Tablet 250mg 1000.

00MG 49

378,337L02BG0

3ANASTROZOLEP 8179L Tablet 1mg 1.00 MG 167,4

2531,277,431L02BG0

6EXEMESTANEP 8506Q Tablet 25mg 30

25.00 MG 14,002

2,613,220L02BG0

4LETROZOLEP 8245Y Tablet 2.5mg 2.50 MG 66,8

9312,490,623

P 6291D Injection 300ug in 0.5mL syringe

0.35

MG 1,745

3,433,036P 6292E Injection 480ug in

0.5mL syringe0.35

MG 788 3,611,767

P 8289G

Inj. set 1 vial powder dose 30ug(6000000 i.u.)

4.30

UG 3,634

3,833,505P 840

3GInj. 44ug (12000000iu)in 0.5 mL single syringe

4.30

UG 17,539

18,498,378P 880

5KInj. 30ug (6000000iu) in 0.5mL single syringe

4.30

UG 15,857

16,735,123L03AB0

8INTERFERON BETA–1bP 8101J

Injection set 1 vial powder dose ME 34,5

5040,558,217L03AB0

4INTERFERON–ALFA–2aP 8180M Solution for injection 3000000iu in 0.5mL

ME 1,723

952,780P 8181N Solution for injection

3000000iu in 0.5mLME 16

587,253P 8551C Injection 45000000iu in 0.5mL

syringeME 12

788,710L03AB0

5INTERFERON–ALFA–2bP 6255F Solution for injection 60000000iu in 1.2mL mult

ME 116

306,711P 8348J

Soln for inj.18000000iu in 1.2mL multi–ME 45

9279,034L03AB1

1PEGINTERFERON ALFA–2aP 6449K Prefilled syringe 180ug/0.5mL, 4 26.00

UG 931

1,305,476L03AB6

0PEGINTERFERON ALFA–2b COMBINATIONSP 6394M 112 ribavirin tabs 200mg +4 syrngs PEG–IFN alfa–2b –

– 645

1,181,375P 6395N 140 ribavirin tabs 200mg +4

syrngs PEG–IFN alfa–2b –– 75

81,458,260P 6396P 168 ribavirin tabs 200mg +4

syrngs PEG–IFN alfa–2b –– 82

31,690,464P 6405D 112 ribavirin 200mg/4 single

use injection pens –– 49

9880,922P 6407F 140 ribavirin 200mg/4 single

use injection pens –– 38

6780,025P 6410J168 ribavirin 200mg/4 single use

injection pens –– 29

6687,660

P 1131M

Vial powder for intravesical admin. 5x108 CFU

– – 1,223 657,879P 114

0BInjection set 1 vial Powder – – 1,117 463,

987P 5901N

Injection set 1 vial Powder – – 437 102,870P 590

2PAmpoule containing powder 5x10<^> 8<D>CFU

– – 169 37,731

133

L


cost($)

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSIMMUNOSTIMULANTSCYTOKINES AND IMMUNOMODULATORSCOLONY STIMULATING FACTORS

L03AA02 FILGRASTIM

L03AA13 PEGFILGRASTIMP 6363X Injection 6mg in 0.6mL single use syringe 0.30 MG 11,961

25,629,526INTERFERONS

L03AB07 INTERFERON BETA–1a

OTHER IMMUNOSTIMULANTS

L03AX03 BCG VACCINE

L03AX13 GLATIRAMER ACETATEP 8726G Inj 20mg in 1mL single dose prefilled syringe 20.00 MG 17,664

19,249,091

134

L


cost($)

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSIMMUNOSUPPRESSANTSIMMUNOSUPPRESSANTSSELECTIVE IMMUNOSUPPRESSANTSL04AA21 EFALIZUMAB

P 9000Q Inj set 4 vials pdr 125 mg and 4 pre filled syring

10.00

MG 1,253

1,313,200P 9001R Inj set 4 vials pdr 125 mg

and 4 pre filled syring10.00

MG 3,635

3,899,394L04AA1

8EVEROLIMUSP 8841H Tablet 0.5 mg 60 1.5

0MG 13

292,560L04AA1

3LEFLUNOMIDEP 8374R Tablet 10mg 30 20.0

0MG 34,9

403,445,309P 8375T Tablet 20mg 30 20.0

0MG 110,3

7015,930,303L04AA0

6MYCOPHENOLIC ACIDP 6208R Capsule 250mg 2.0

0GM 21

098,631P 6209T Tablet 500mg 2.0

0GM 1,17

2852,065P 8649F Capsule 250mg 300 2.0

0GM 93

3570,392P 8650G Capsule 500mg 150 2.0

0GM 4,79

93,080,072P 8652J Tablet (enteric coated)

180mg 1202.00

GM 165

46,285P 8653K Tablet (enteric coated)

360mg 1202.00

GM 678

340,346L04AA1

0SIROLIMUSP 8724E Tablet 1mg 100 3.0

0MG 42

3399,193P 8833X Tablet 2mg 100 3.0

0MG 17

9280,272

P 8737W

Injection 40mg in 0.8mL prefilled syringe

2.90

MG 5,153

8,989,574P 874

1CInjection 40mg in 0.8mL prefilled syringe

2.90

MG 19,664

34,313,610P 903

3KInjection 40mg in 0.8mL prefilled syringe

2.90

MG 1,160

2,022,542P 903

4LInjection 40mg in 0.8mL prefilled syringe

2.90

MG 1,767

3,082,736P 907

7RInjection 40mg in 0.8mL prefilled syringe 2

2.90

MG 974

1,703,388P 907

8TInjection 40mg in 0.8mL prefilled syringe 2

2.90

MG 576

1,006,417P 909

9XInjection 40mg in 0.8mL prefilled syringe

2.90

MG 623

1,086,778P 910

0YInjection 40mg in 0.8mL prefilled syringe 2

2.90

MG 964

1,682,522P 910

1BInjection 40mg in 0.8mL prefilled syringe 2

2.90

MG 163

284,497P 910

2CInjection 40mg in 0.8mL prefilled syringe 2

2.90

MG 121

211,191P 910 Injection 40mg in 0.8mL 2.9 MG 23 405,

ETANERCEPTP 636

7DInjection set vial pdr 25mg and syringe solvent 4

7.00

MG 1,472

2,461,233P 863

7NInjection set vial pdr 25mg and syringe solvent 4

7.00

MG 584

1,050,070P 863

8PInjection set vial pdr 25mg and syringe solvent 4

7.00

MG 5,978

10,734,990P 877

8BInjection set vial pdr 25mg and syringe solvent 4

7.00

MG 351

715,316P 877

9CInjection set vial pdr 25mg and syringe solvent 4

7.00

MG 4,112

7,402,287P 886

1JInjection set vial pdr 50mg and syringe solvent 4

7.00

MG 2,743

4,785,970P 886

2KInjct set 4 vials pdr 50mg and 4 pre–filled syr

7.00

MG 13,075

22,821,898P 903

5MInjct set 4 vials pdr 25mg & 4 prefilled syr solv

7.00

MG 558

1,003,304P 903

6NInjection set 4 vials pdr 25mg and 4 syringe solv

7.00

MG 1,236

2,222,153P 903

7PInjection set 4 vials pdr 25mg and 4 syringe solv

7.00

MG 165

290,906P 903

8QInjct set 4 vials pdr 50mg & 4 prefilled syr solv

7.00

MG 538

945,488P 908

1YInjct set 4 vials pdr 50mg and 4 pre–filled syr

7.00

MG 143

260,220P 908

2BInjct set 4 vials pdr 50mg & 4 prefilled syr solv

7.00

MG 460

806,804P 908

3CInjct set 4 vials pdr 50mg & 4 prefilled syr solv

7.00

MG 115

200,708P 908

4DInjct set 4 vials pdr 50mg & 4 prefilled syr solv

7.00

MG 469

819,238P 908

5EInjection 50mg in 1mL single use refilled syr 4 1

7.00

MG 522

911,353P 908

6FInjection 50mg in 1mL single use refilled syr 4 1

7.00

MG 1,529

2,668,605P 908

7GInjection 50mg in 1mL single use refilled syr 4 1

7.00

MG 260

453,800P 908

8HInjection 50mg in 1mL single use refilled syr 4 1

7.00

MG 512

893,832P 908

9JInjection 50mg in 1mL single use refilled syr 4 1

7.00

MG 1,558

2,719,284P 909

0KInjection 50mg in 1mL single use refilled syr 4 1

7.00

MG 4,837

8,443,038P 909 Injection 50mg in 1mL single 7.0 MG 13 236,

INFLIXIMABP 639

7QPowder for I.V. infusion 100mg 1

3.75

MG 1,794

4,402,517P 644

8JPowder for I.V. infusion 100mg 1

3.75

MG 3,414

13,044,090P 649

6XPowder for I.V. infusion 100mg 1

3.75

MG 369

1,436,920P 961

3YPowder for I.V. infusion 100mg 1

3.75

MG 314

960,293

135

L


cost($)

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSIMMUNOSUPPRESSANTSIMMUNOSUPPRESSANTSTUMOR NECROSIS FACTOR ALPHA INHIBITORS

L04AB04 ADALIMUMAB

L04AB01

L04AB02

P 6232B

Capsule 10mg (with microemulsion pre–

0.25

GM 201 16,058P 635

2HCapsule 25mg 30 0.2

5GM 1,92

1406,918P 635


5GM 1,44

8366,739P 635


5GM 2,13

81,055,126P 865

7PCapsule 10mg 120 0.2

5GM 770 77,8

35P 8658Q


GM 6,779

948,034P 865

9RCapsule 50mg 60 0.2

5GM 8,98

22,057,746P 866

0TCapsule 100mg 60 0.2

5GM 9,29

74,258,253P 866 Oral liquid 100mg per mL 0.2 GM 221 138,

TACROLIMUSP 621

6ECapsule 1mg 5.0

0MG 658 537,

511P 6328C

Capsule 500ug 100 5.00

MG 170 43,800P 864

6CCapsule 500ug 100 5.0

0MG 1,50

2346,173P 864

7DCapsule 1mg 100 5.0

0MG 5,92

73,724,883P 864

8ECapsule 5mg 100 5.0

0MG 313 499,

264

P 2687K Tablet 50mg 0.15 GM 113,268

8,221,765P 2688L Tablet 25mg 0.15 GM 13,40

2592,685

136

L


cost($)

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSIMMUNOSUPPRESSANTS

IMMUNOSUPPRESSANTS INTERLEUKIN

INHIBITORS L04AC03 ANAKINRA

P 8774T Injection 100mg in 0.67mL pre–filled syringe 280.10 GM 279377,040

CALCINEURIN INHIBITORS

L04AD01 CYCLOSPORIN

L04AD02

OTHER IMMUNOSUPPRESSANTSL04AX01 AZATHIOPRINE

L04AX02 THALIDOMIDEP 6469L Capsules 50mg 28 0.10 GM 1,944 2,291,084

P 1299J

Tablet 25mg (enteric coated)

0.10

GM

84,071

1,127,359P 130

0KTablet 50mg (enteric coated) 50

0.10

GM

1,068,974

11,948,847P 130

2MSuppository 100mg 40 0.1

0GM

17,768

392,744A 169


0GM

21,968

–A 169


0GM

6,315

–A 174


0GM

25,805

–A 185


0GM

118,288

–A 187

26Suppository 50mg 10 0.1

0GM

524

–P 507

6ETablet 25mg (enteric coated)

0.10

GM

187

1,840P 507

7FTablet 50mg (enteric coated)

0.10

GM

2,087

21,050P 536

2FTablet 50mg (enteric coated) 50

0.10

GM

2,842

50,735P 536

4HTablet 25mg (enteric coated) 100

0.10

GM

179

42P 536

5JTablet 50mg (enteric coated) 50

0.10

GM

1,982

35,969

P 2454E

Capsule 25mg 0.10 GM 322,233

3,373,096P 275

7DSuppository 100mg 0.10 GM 64,04

81,285,451P 537

7BCapsule 25mg 100 0.10 GM 1,25

918,048P 537

8CSuppository 100mg 40 0.10 GM 449 14,2

17P 5379D

Capsule 25mg 100 0.10 GM 1,517

22,447P 538 Suppository 100mg 40 0.10 GM 297 2,9

KETOROLACA 13986 Ampoule 30mg per

1mL 530.00

MG 4,481

–A 14188 Tablet 10mg 30 30.0 MG 2,11 –SULINDACP 2047R Tablet 100mg 0.40 GM 4,56

866,631P 2048T Tablet 200mg 0.40 GM 13,74

5189,896

137

M


cost($)

MUSCULO–SKELETAL SYSTEMANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTSANTIINFLAMMATORY/ANTIRHEUMATIC PRODDUCTS,NON–STEROIDSACETIC ACID DERIVATIVES AND RELATED SUBSTANCESM01AB05 DICLOFENAC

M01AB55 DICLOFENAC WITH MISOPROSTOLP 4190M Tablet 50mg 200ug 60 – – 2,872 105,545

M01AB01 INDOMETHACIN

M01AB15

M01AB02

MELOXICAMP 856

1NTablet 7.5mg 15.0

0MG

455,995

9,968,544P 856

2PTablet 15mg 15.0

0MG

1,161,710

34,154,470P 888

7RCapsule 7.5mg 30 15.0

0MG

214,148

4,616,947P 888 Capsule 15mg 30 15.0 M 343,5 9,914,

PIROXICAMP 189

5RDispersible tablet 10mg 50

20.00

MG

14,834

192,909P 189

6TDispersible tablet 20mg 25

20.00

MG

96,561

1,221,775P 189

7WCapsule 10mg 20.0

0MG

33,059

430,262P 189

8XCapsule 20mg 20.0

0MG

163,247

2,065,470P 520

1RDispersible tablet 10mg 20.0

0MG

342

4,296P 520

2TDispersible tablet 20mg 20.0

0MG

336

2,398P 520

3WCapsule 10mg 20.0

0MG

934

11,343

A 13267

Tablet 200mg 12 1.20

GM 411 –A 132

68Tablet 200mg 24 1.2

0GM 4,52

0–

A 13372


GM 1,913

–A 154

01Susp 0.1/5mL 100mL 1.2

0GM 1,31

9–

A 16004


GM 150 –P 319

0XTablet 400mg 1.2

0GM 230,7

542,998,304P 319


0GM 195,0

491,553,372P 319

8HTablet 200mg 1.2

0GM 18,79

8191,312P 512

1MTablet 200mg 1.2

0GM 607 5,0

95P 5123P

Tablet 400mg 1.20

GM 778 7,572P 512


0GM 6,95

955,227P 536

8MTablet 400mg 100 1.2

0GM 564 8,7

92P 537 Tablet 400mg 100 1.2 GM 307 4,9IBUPROFEN with CODEINEA 177

16Tablet 200mg 12.8mg 48 – – 40,20

6–

A 18882

Tablet 200mg 12.8mg 48 – – 27,281

–A 188

87Tablet 200mg 12.8mg 48 – – 110 –

A 197 Tablet 200mg 12.8mg 75 – – 9,30 –KETOPROFENP 158

8NSuppository 100mg 0.1

5GM 2,85

860,878P 159

0QCapsules 200mg (sustained release) 28

0.15

GM 195,867

3,046,073P 513

6HCapsule 200mg (sustained release)

0.15

GM 127 1,591

138

M


cost($)

MUSCULO–SKELETAL SYSTEMANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTSANTIINFLAMMATORY/ANTIRHEUMATIC PRODDUCTS,NON–STEROIDSOXICAMS

M01AC06

M01AC01

PROPIONIC ACID DERIVATIVESM01AE01 IBUPROFEN

M01AE51

M01AE03

A 11401


GM 354 –P 161

4YTablet 750mg (sustained release) 28

0.50

GM 99,674

1,282,285P 161

5BTablet 1g (sustained release) 28

0.50

GM 253,652

3,907,725P 165

8GOral suspension 125mg per 5mL 474mL

0.50

GM 565 45,948P 165

9HTablet 500mg 0.5

0GM 209,3

222,832,946P 167

4DTablet 250mg 0.5

0GM 51,84

3713,051P 179

5LTablet 550mg 50 0.5

0GM 46,00

8634,794P 517

6KTablet 250mg 0.5

0GM 203 2,0

09P 5177L

Tablet 500mg 0.50

GM 136 1,563P 517

9NTablet 1g (sustained release)

0.50

GM 118 1,449P 534


0GM 134 59

P 5346J


GM 767 9,920P 534

7KTablet 750mg (sustained release) 28

0.50

GM 282 4,403P 534

8LTablet 1g (sustained release) 28

0.50

GM 1,096

17,995P 534


0GM 205 1,1

04P 5350N


GM 773 20,887P 535

1PTablet 750mg (sustained release) 28

0.50

GM 156 2,698P 535

2QTablet 1g (sustained release) 28

0.50

GM 247 4,379P 535


0GM 149 3,2

44P 5354T


GM 135 –


1.00 GM 606 –P 1824B Capsule 250mg 1.00 GM 43,94

8723,791

A 17093

Capsule 200mg 10 0.20 GM

3,343

–P 843

9ECapsule 100mg 60 0.20 G

M226,948

6,802,110P 844 Capsule 200mg 60 0.20 G 1,436, 44,405

LUMIRACOXIBA 187

36Tablet 400mg 5 0.10 G

M7,975

–A 201

35Tablet 200mg 30 0.10 G

M9,963

–P 226

1BTablet 100mg 30 0.10 G

M425

30P 903

2JTablet 200mg 30 0.10 G

M433,611

12,965,476

139

M


cost($)

MUSCULO–SKELETAL SYSTEMANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTSANTIINFLAMMATORY/ANTIRHEUMATIC PRODDUCTS,NON–STEROIDSPROPIONIC ACID DERIVATIVES

M01AE02 NAPROXEN

M01AE11 TIAPROFENIC ACIDP 2103Q Tablet 300mg 600.00 MG 15,690

250,061FENAMATES

M01AG01 MEFENAMIC ACID

COXIBSM01AH01 CELECOXIB

M01AH06

OTHER ANTIINFL./ANTIRHEUMATIC AGENTS, NON–STEROIDSM01AX12 PENTOSAN–POLY SULFATE SODIUM

A 14955 Capsule 100mg 100 – – 1,103 –

140

P 2016D

Injection 10mg 2.40 MG 184 9,550P 201

7EInjection 20mg 2.40 MG 336 26,6

41P 2018F

Injection 50mg 2.40 MG 2,104 259,911

M


cost($)

MUSCULO–SKELETAL SYSTEMANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTSSPECIFIC ANTIRHEUMATIC AGENTSGOLD PREPARATIONS

M01CB03 AURANOFINP 1095P Tablet 3mg 6.00 MG 3,627 231,167

M01CB01 SODIUM AUROTHIOMALATE

PENICILLAMINEM01CC01 PENICILLAMINE

P 2721F Tablet 125mg 0.50 GM 469 16,954P 2838JTablet 250mg 0.50 GM 4,608 213,

076

141

DICLOFENACA 148

60Gel 50g 1 – – 4,069 –

A 14861

Gel 100g 1 – – 13,455 –A 149

79Gel 20g 1 – – 2,881 –

A 201 Gel 3% 25g 1 – – 98 –KETOPROFENA 14948 Gel 2.5% 30g 1 – – 12

4–

A 14949 Gel 2.5% 60g 1 – – 88 –PIROXICAMA 15090 Gel 0.5% 25g 1 – – 73

1–

A 15091 Gel 0.5% 50g 1 – – 574

–

A 10653

Cream 50g 1 – – 175 –A 129

31Cream 100g 1 – – 6,001 –

P 4022Q

Compound Cream APF 100gm

– – 2,982 37,523P 402

3ROintment BP 100gm – – 1,971 21,1

47P 4025W

Compound ointment APF 1934 100gm

– – 484 4,573P 402

6XLiniment APF 100gm – – 2,306 19,6

99P 402 Compound liniment APF – – 323 3,3METHYL SALICYLATE with MENTHOL with EUCALYPTUS OILA 11224 Cream 125g 1 – – 2,740 –A 12943 Cream 50g 1 – – 468 –

M


cost($)

MUSCULO–SKELETAL SYSTEMTOPICAL PRODUCTS FOR JOINT and MUSCULAR PAINTOPICAL PRODUCTS FOR JOINT and MUSCULAR PAINANTIINFL. PREP., NON–STEROIDS FOR TOPICAL USE

M02AA15

M02AA10

M02AA07

CAPSAICIN and SIMILAR AGENTSM02AB CAPSAICIN

A 15579 Cream 0.025% 45g – – 191 –PREPARATIONS with SALICYLIC ACID DERIVATIVES

M02AC METHYL SALICYLATE

M02AC

142

M


cost($)

MUSCULO–SKELETAL SYSTEMMUSCLE RELAXANTSMUSCLE RELAXANTS, CENTRALLY ACTING AGENTSETHERS, CHEMICALLY CLOSE TO ANTIHISTAMINES

M03BC01 ORPHENADRINE CITRATEA 11353 Tablet 100mg 100 0.12 GM 6,043 –

M03BC51 ORPHENADRINE CITRATE with PARACETAMOLA 11354 Tablet 100 0.12 GM 2,955 –

OTHER CENTRALLY ACTING AGENTSM03BX01 BACLOFEN

P 2729P

Tablet 10mg 50.00

MG 88,823

3,624,808P 273

0QTablet 25mg 50.0

0MG 47,62

13,895,815P 628

4RIntrathecal injection 10mg in 5mL

0.55

MG 588 319,148MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS

DANTROLENE AND DERIVATIVESM03CA01 DANTROLENE SODIUM

P 1779P Capsule 25mg 0.10 GM 4,517 267,230P 1780Q Capsule 50mg 0.10 GM 2,639 178,723

P 2600W Tablet 100mg 0.40 GM 261,609

3,598,765P 2604C Tablet 300mg 0.40 GM 930,2

359,642,543

143

M


cost($)

MUSCULO–SKELETAL SYSTEMANTIGOUT PREPARATIONSANTIGOUT PREPARATIONSPREPARATIONS INHIBITING URIC ACID PRODUCTIONM04AA01 ALLOPURINOL

PREPARATIONS INCREASING URIC ACID EXCRETIONM04AB01 PROBENECID

P 1940D Tablet 500mg 1.00 GM 18,603 1,272,907PREPARATIONS WITH NO EFFECT ON URIC ACID METABOLISM

M04AC01 COLCHICINEP 1227N Tablet 500ug 1.00 MG 261,9122,537,863

P 8090T Tablet 40mg 10.00

MG

18,217

2,874,820P 8511Y Tablet 70mg alendronic 10.0 M 1,727, 89,109

CLODRONIC ACIDP 8132B Capsule equivalent to

400mg sodium clodronate1.60

GM

876

296,446P 8265B Capsule equivalent to

800mg sodium clodronate1.60

GM

16,986

6,633,071

P 6223M

Vial pdr for IV infuse 90mg amp solvent 10mL

MG 2,366

1,073,952P 627

9L2 vials pdr for IV infuse 30mg 2 amp solvent 10mL 60.00

MG 153

43,876P 628

9BConcentrated injection 90mg in 10mL

MG 498

208,896P 820

9C2 vials pdr for IV infuse 30mg 2 amp solvent 10mL 60.00

MG 782

240,837P 846 Concentrated injection 60mg in MG 16 44,0

RISEDRONIC ACIDP 444

3WTablet 5mg 28 5.00 MG 89

546,731P 444

4XTablet 35mg 4 5.00 MG 29,5

741,545,411P 848

1JTablet 5mg 28 5.00 MG 15,8

32826,102P 848

2KTablet 30mg 28 5.00 MG 4,00

71,214,732P 862

1RTablet 35mg 5.00 MG 526,4

7527,461,047

144

M


cost($)

MUSCULO–SKELETAL SYSTEMDRUGS FOR TREATMENT OF BONE DISEASESDRUGS AFFECTING BONE STRUCTURE AND MINERALIZATIONBISPHOSPHONATES

M05BA04 ALENDRONIC ACID

M05BA02

M05BA01 DISODIUM ETIDRONATEP 2920Q Tablet 200mg 0.40 GM 409 61,184

M05BA03 DISODIUM PAMIDRONATE

M05BA07

M05BA05 TILUDRONIC ACIDP 8267D Tablet 200mg 0.40 MG 796 241,578

M05BA08 ZOLEDRONIC ACIDP 6371H Injection concentrate I.V. infusion 4mg (

as monohydrate) in 5mL 4.00 MG 21,271 10,223,633BISPHOSPHONATES AND CALCIUMM05BB03 ALENDRONIC ACID and COLECALCIFEROL

P 9012H Tablet equiv to 70mg alendronic with 70ug Colecal – –645,318 33,132,593

M05BB01 ETIDRONIC ACID AND CALCIUMP 8056B 28 tabs 200mg and 76 tabs calcium (equiv 500mg) – –

14,589 1,014,573M05BB02 RISEDRONIC SODIUM with CALCIUM CARBONATE

P 8899J Pack containing 4 tablets 35mg and 24 tabs 1.25g – – 625,245 32,637,998

BISPHOSPHONATES AND CALCIUMM05BX03 STRONTIUM RANELATE

P 3036T Granules for oral suspension 2g, 28 Sachets 2.00 GM 50,4242,583,943

145

N


cost($)

NERVOUS SYSTEMANAESTHETICSANAESTHETICS, GENERALOPIOID ANAESTHETICSN01AH01 FENTANYL

A 14186 Ampoule 100ug/2 5 – – 209 –ANAESTHETICS, LOCALAMIDES

N01BB01

BUPIVACAINEA 11219 Vial 0.5% 20mL 5 – – 167 –

N01BB02

LIGNOCAINE HYDROCHLORIDEA 15896 Ampoule 1%2mL 50 – – 172 –A 15901 Ampoule 2% 5mL 50 – – 159 –A 17544 Ampoule 1% 5mL 50 – – 514 –

N01BB52

LIGNOCAINE with ADRENALINEA 15905 Vial 2% 20mL 5 – – 537 –A 16268 Ampoule 1% 5mL 50 – – 340 –

N01BB52

PRILOCAINE with LIGNOCAINEA 14984 Patch 1 g – – 386 –

N01BB09

ROPIVACAINEA 15645 Injection 10mL 10mg/mL 5

– – 751 –

CODEINE with ASPIRINA 100

90Tablet soluble 8mg – 300mg 20

– – 439

–A 100

91Tablet soluble 8mg – 300mg 100

– – 14,444

–A 104

65Tablet soluble 8mg– 500mg 50

– – 566

–A 121

69Tablet 8mg – 325mg 100 – – 93

1–

P 406 Tablet soluble 8mg– – – 5,63 67,7CODEINE with PARACETAMOLA 105

27Tablet 8mg – 500mg 100 – – 88

6–

A 11705

Capsule 8mg – 500mg 50 – – 14,371

–A 117

06Tablet 8mg – 500mg 100 – – 38,3

61–

A 11755

Tablet soluble 8mg – 500mg 24

– – 373

–P 121

5YTablet 30mg–500mg 20 – – 3,120,

54027,078,006A 126

70Tablet 8mg – 500mg 20 – – 26

3–

A 12692

Tablet 8mg – 500mg 100 – – 657

–A 127

36Tablet 30mg–500mg 50 – – 4,42

9–

A 14215

Tablet 8mg – 500mg 50 – – 267

–A 147

88Tablet 8mg–500mg 100 – – 1,86

7–

A 14978

Caplet 15mg – 500mg 50 – – 365

–A 159

94Tablet 8mg – 500mg 50 – – 52

3–

A 17212

Tablet 9.6mg–500mg 48 – – 6,624

–A 172

67Caplet 8mg–500mg 48 – – 8,47

4–

A 17820

Tablet 8mg–500mg 48 – – 2,208

–A 183

74Tablet 8mg – 500mg 48 – – 2,82

0–

A 18375

Tablet 8mg – 500mg 50 – – 167

–A 183

76Tablet 8mg – 500mg 96 – – 15,4

35–

A 18377

Tablet 8mg – 500mg 100 – – 1,399

–A 183

79Tabsule 8mg – 500mg 48 – – 31

6–

A 18380

Tabsule 8mg – 500mg 96 – – 619

–A 187

34Tablet 15mg–500mg 12 – – 91,8

98–

A 19039

Caplet 8mg/500mg 24 – – 859

–A 190

41Tablet 8mg/500mg 24 – – 3,44

5–

P 3316M

Tablet 30mg–500mg 20 – – 128,683

954,109P 417

0LTablet 15mg–500mg 20 – – 19,4

80204,147P 417

1MTablet 8mg–500mg – – 32,1

94370,112P 878

5JTablet 30mg–500mg 60 – – 644,5

3212,770,515

146

N


cost($)

NERVOUS SYSTEMANALGESICSOPIOIDSNATURAL OPIUM ALKALOIDS

N02AA59

N02AA59

DIHYDROCODEINEA 11785 Linctus 200mL 1 – – 21,20

7–

A 12825 Linctus 100mL 1 – – 8,859 –HYDROMORPHONEP 842

0EInjection 2mg in 1mL 5 4.0

0MG 1,791 32,2

95P 8421F

Injection 10mg in 1mL 5 4.00

MG 2,242 127,701P 842

2GInjection 50mg in 5mL 5 4.0

0MG 2,183 288,

183P 8423H


MG 371 79,456P 842

4JOral liquid 1mg per mL 473mL

20.00

MG 2,353 138,066P 854


0MG 742 14,3

73P 8542N

Tablet 4mg 20.00

MG 847 35,828P 854

3PTablet 8mg 20.0

0MG 1,313 105,

778

147

N


cost($)


N02AA08

N02AA03

148

N


cost($)


N02AA01 MORPHINEA 149

31Capsule 20mg (sustained release)

100.00

MG 347 –A 149

35Capsule 100mg (sustained release)

100.00

MG 128 –A 154

15Mixture 200mL 1mg per mL 100.

00MG 267 –

P 1607N

Injection 120mg in 1.5mL 30.00

MG 3,186

292,837P 164

4MInjection 10mg in 1mL 30.0

0MG 47,34

4767,770P 164

5NInjection 15mg in 1mL 30.0

0MG 15,24

3315,429P 164

6PTablet 30mg 100.

00MG 14,40

9281,362P 164

7QInjection 30mg in 1mL 30.0

0MG 28,14

7928,439P 165

3BTablet 10mg (controlled release)

100.00

MG 95,392

2,394,108P 165

4CTablet 30mg (controlled release)

100.00

MG 95,527

4,605,707P 165

5DTablet 60mg (controlled release)

100.00

MG 71,956

5,619,454P 165

6ETablet 100mg (controlled release)

100.00

MG 67,910

7,915,666A 196


0MG 336 –

A 19620


MG 527 –P 212

2QOral solution 2mg per mL 200mL

100.00

MG 20,190

355,519P 212

3ROral solution 5mg per mL 200mL

100.00

MG 33,554

697,715P 212

4TOral solution 10mg per mL 200mL

100.00

MG 36,886

1,109,201P 283

9KCapsule 20mg (sustained release)

100.00

MG 63,003

2,354,041P 284

0LCapsule 50mg (sustained release)

100.00

MG 50,673

3,091,155P 284

1MCapsule 100mg (sustained release)

100.00

MG 39,448

4,906,226P 347

9DInjection 15mg in 1mL 30.0

0MG 11,00

3142,413P 348

0EInjection 30mg in 1mL 30.0

0MG 4,93

070,607P 434

9XTablet 200mg (controlled release)

100.00

MG 211 35,811P 803


100.00

MG 37,852

684,449P 814

6RSachet 30mg (controlled release)

100.00

MG 1,210

48,487P 830

5DSachet 60mg granules for oral suspension

100.00

MG 706 51,468P 830

6ESachet 100mg granules for oral suspension

100.00

MG 447 53,070P 834

9KCapsule 10mg (sustained release) 20

100.00

MG 27,463

588,651P 845


100.00

MG 1,068

394,748P 848

9TTablet 15mg (controlled release) 20

100.00

MG 41,884

1,172,126P 849

0WSachet 20mg granules for oral suspension 20

100.00

MG 2,712

80,583P 849

1XCapsule 30mg (controlled release) 10

100.00

MG 2,630

67,904P 849

2YCapsule 60mg (controlled release) 10

100.00

MG 3,871

154,201P 849

3BCapsule 90mg (controlled release) 10

100.00

MG 2,523

158,723P 849

4CCapsule 120mg (controlled release) 10

100.00

MG 4,288

432,885P 866

9GTablet 10mg 20 100.

00MG 1,19

017,712P 867

0HTablet 20mg 20 100.

00MG 1,22

422,565

A 16418

Tablet 40mg (controlled release) 60

75.00

MG 116

–P 248

1NSuppository 30mg 30.0

0MG 12,7

40852,183P 262

2BTablet 5mg 75.0

0MG 604,8

647,919,365P 519

5KTablet 5mg 75.0

0MG 79

68,588P 838

5HTablet 10mg (controlled release) 20

75.00

MG 304,662

8,330,223P 838

6JTablet 20mg (controlled release) 20

75.00

MG 285,152

13,008,016P 838

7KTablet 40mg (controlled release) 20

75.00

MG 177,717

12,877,798P 838

8LTablet 80mg (controlled release) 20

75.00

MG 99,462

12,979,003P 846


0MG 78,8

31988,428P 850


0MG 77,0

051,424,342P 850


0MG 57,8

451,892,848P 864

4YOral solution 5mg per 5mL 250mL

75.00

MG 6,727

154,507P 868

1XTablet 5mg (controlled release) 20

75.00

MG 121,280

2,945,617

A 17987

Lozenge 200ug 3 – – 399 –P 887

8GTransdermal patch 2.1mg(12 ug per hour) 5

1.20

MG 51,819

2,594,206P 889

1YTransdermal patch 4.2mg (25 ug per hour) 5

1.20

MG 72,768

4,516,625P 889

2BTransdermal patch 8.4mg (50 ug per hour) 5

1.20

MG 49,651

5,488,891P 889

3CTransdermal patch 12.6mg (75 ug per hour) 5

1.20

MG 24,350

3,737,817P 889 Transdermal patch 16.8mg 1.2 MG 28,40 6,225,

PETHIDINE HYDROCHLORIDEA 158

88Injection 100mg in 2mL 10 0.4

0GM 680 –

P 1829G

Injection 100mg in 2mL 5 0.40

GM 6,939

76,709A 189


0GM 7,49

5–

A 19593


GM 2,173

–A 199

82Injection 100mg in 2mL 5 0.4

0GM 27,45

1–

A 16347

Capsule 32.5mg 325mg 20

– – 146,820 –A 164

44Tablet 32.5mg 325mg 20

– – 433,975 –A 166

50Tablet 32.5mg 325mg 20

– – 27,141 –

149

N


cost($)

NERVOUS SYSTEMANALGESICSOPIOIDSNATURAL OPIUM ALKALOIDSN02AA05 OXYCODONE

PHENYLPIPERIDINE DERIVATIVESN02AB03 FENTANYL

N02AB02

DIPHENYLPROPYLAMINE DERIVATIVESN02AC04 DEXTROPROPOXYPHENE NAPSYLATE

P 4081T Capsule 100mg 0.30 GM 25,702 512,536N02AC54 DEXTROPROPOXYPHENE with PARACETAMOL

ORIPAVINE DERIVATIVESN02AE01 BUPRENORPHINE

A 15207

Tablets 2 mg (slow release) 1.20

MG 1,409

–P 886

5NTransdermal patch 5mg (releasing ~5ug/hour) 2

1.20

MG 184,873

5,176,187P 886

6PTransdermal patch 10mg (releasing ~10ug/hour)

1.20

MG 169,246

7,134,058P 886

7QTransdermal patch 20mg (releasing ~20ug/hour)

1.20

MG 93,852

6,659,651

150

A 18386

Tablet 5mg/500mg 24 – – 1,266

–A 190

53Tablet 5mg/500mg 8 – – 4,81

8–

A 195 Capsule 5mg/500mg 10 – – 4,81 –PARACETAMOLA 115

11Elixir 120mg/5 1 3.0

0GM

124

–A 115

12Elixir 200mL 1 3.0

0GM

257

–A 115

15Tablet 500mg 50 3.0

0GM

2,859

–A 115

16Tablet 500mg 100 3.0

0GM

1,401

–A 115

17Tab–sol 500mg 24 3.0

0GM

1,334

–A 115

19Drop 20mL 1 3.0

0GM

968

–A 116

99Suppositories 250mg 20 3.0

0GM

152

–P 174

6XTablet 500mg 3.0

0GM

1,564,418

12,233,046P 174

7YMixture 120mg per 5mL 100mL

3.00

GM

23,917

194,237P 177

0EElixir 240mg per 5mL 200mL

3.00

GM

143,688

1,501,521P 519

6LTablet 500mg 3.0

0GM

245

1,845P 531

9YSuppositories 500mg 24 3.0

0GM

3,149

154,307P 532

0BSuppositories 500mg 24 3.0

0GM

1,136

40,035P 534

3FTablet 665mg (modified release) 9 6

3.00

GM

1,090

13,091P 534

4GTablet 665mg (modified release) 9 6

3.00

GM

249

2,805P 878


0GM

1,424,486

18,319,103P 881

4XTablet 665mg (modified release) 1 92

3.00

GM

638,383

7,508,721

N


cost($)

NERVOUS SYSTEMANALGESICSOPIOIDSOTHER OPIOIDS

N02AX02 TRAMADOLA 179


0GM 11

6–

P 2527B

Tablet 50mg (twice daily sustained release) 20

0.30

GM 45,604

732,050P 348

4JInjection 100mg in 2mL 5 0.3

0GM 17,5

56187,124P 523


0GM 89

37,828P 523

4LTablet 100mg (twice daily sustained release) 20

0.30

GM 237

3,414P 845

5BCapsule 50mg 20 0.3

0GM 189,0

771,659,431P 852

3NTablet 100mg (twice daily sustained release) 20

0.30

GM 451,282

10,355,546P 852

4PTablet 150mg (twice daily sustained release) 20

0.30

GM 221,322

6,803,360P 852

5QTablet 200mg (twice daily sustained release) 20

0.30

GM 365,699

13,710,014P 858

2QInjection 100mg in 2mL 5 0.3

0GM 10,4

55110,946P 861

1FCapsule 50mg 20 0.3

0GM 908,3

418,006,293P 884

3KOral drops 100mg per mL 10mL

0.30

GM 2,494

28,747OTHER ANALGESICS AND ANTIPYRETICS

SALICYLIC ACID DERIVATIVESN02BA01 ASPIRIN

P 1010E Tablet 300mg (dispersible) 3.00 GM 198,4061,480,326ANILIDES

N02BE51 METOCLOPRAMIDE and PARACETAMOL

N02BE01

151

PARACETAMOL with CODEINE with DOXYLAMINEA 108

70Tablet 24 – – 29,039 –

A 12600

Tablet 20 – – 173,229 –A 129

32Capsule 24 – – 6,004 –

A 13102

Tablet 20 – – 164,281 –A 132

00Capsule 20 – – 21

3–

A 13823

Capsule 20 – – 3,661 –A 152

86Tablet 24 – – 99

0–

A 15650

Caplet 500mg–8mg–5mg – – 22,917 –A 172

68Tablet 500mg–9.6mg–5.1mg 20

– – 10,827 –A 183

72Cap 500mg–9.6mg–5.1mg 10 + cap500mg–9.6mg 200

– – 176 –A 183 Tablet 20 – – 16 –PARACETAMOL with PROMETHAZINE with CODEINEA 14779 Syrup 200mL 1 – – 11,445 –A 18358 Syrup 120mg–6.5mg–

5mg in 5mL 100mL– – 6,256 –

P 1323P Injection 1mg in 1mL

4.00 MG 1,532 34,404P 3460D Injection 1mg in

1mL4.00 MG 6,279 97,0

79

N


cost($)

NERVOUS SYSTEMANALGESICSOTHER ANALGESICS AND ANTIPYRETICSANILIDESN02BE51

N02BE51

ANTIMIGRAINE PREPARATIONSERGOT ALKALOIDS

N02CA01 DIHYDROERGOTAMINE

N02CA52 ERGOTAMINE TARTRATE with CAFFEINEA 18569 Suppositories 2mg–100 mg 5 – – 19,708 –

N02CA52 ERGOTAMINE with CAFFEINEA 13550 Tablet 20 – – 84,788 –

N02CA04 METHYSERGIDEP 2826R Tablet 1mg 4.00 MG 8,891 393,545

NARATRIPTANA 161

35Tablet 2.5mg 4 2.5

0MG 27,24

1–

A 20036

Tablet 2.5mg (base) 2 2.50

MG 854 –P 829

8RTablet 2.5mg (base) 4 (2 upto Feb 06)

2.50

MG 75,642

1,867,249P 973 Tablet 2.5mg (base) 4 2.5 MG 8,09 213,

SUMATRIPTANA 141

81Tablet 100mg 50.0

0MG 29,13

6–

A 15210

Tablet 50mg 50.00

MG 128,746

–A 159

87Nasal Spray 10mg per dose 2

20.00

MG 3,239

–A 167

20Injection 6mg in 0.5mL refill 6.0

0MG 2,64

2–

A 16730

Injection 6mg in 0.5mL 6.00

MG 254 –A 174

55Tablet 50mg (base) 4 50.0

0MG 3,32

0–

A 17456


MG 1,532

–A 196

39Tablet 50mg 2 (Fast disintegrating)

50.00

MG 898 –A 196

40Tablet 100mg 2 50.0

0MG 129 –

A 19997

Tablet 50mg 50.00

MG 478 –A 199

98Tablet 100mg 2 50.0

0MG 151 –

P 8144P

Tablet 50mg (base) 4 (2 upto 4 Feb 06)

50.00

MG 239,731

5,828,053P 834

1BNasal Spray 20mg per dose 2

20.00

MG 96,449

1,526,151P 888 Tablet 50mg (base) (fast 50.0 MG 17,82 428,

ZOLMITRIPTANA 200

37Tablet 2.5mg 2 2.5

0MG 1,46

0–

P 8266C

Tablet 2.5mg 4 (2 upto Feb06)

2.50

MG 144,849

3,536,479P 973

6KTablet 2.5mg 4 2.5

0MG 10,59

2274,599

152

N


cost($)

NERVOUS SYSTEMANALGESICSANTIMIGRAINE PREPARATIONSSELECTIVE 5HT RECEPTOR AGONISTSN02CC02

N02CC01

N02CC03

OTHER ANTIMIGRAINE PREPARATIONSN02CX01 PIZOTIFEN MALATE

P 3074T Tablet 500ug (base) 1.50 MG 138,7752,875,266

P 1850J

Tablet 30mg 0.10 GM 16,379

173,707P 185

3MInjection 200mg in 1mL

0.10 GM 146 6,113A 187

51Elixir 15mg/5mL 100mL

100.00

MG 296 –

P 1249R

Tablet 50mg 0.30

GM 7,640

214,959P 187

3NCapsule 30mg 0.3

0GM 21,25

3572,015P 187

4PCapsule 100mg 0.3

0GM 170,1

004,731,623P 269

2QPaediatric oral suspension 30mg per 5mL 500mL

0.30

GM 10,161

257,293

P 1413JCapsule 250mg 1.25

GM 2,464 130,454P 1414K Paediatric syrup 250mg

per 5mL 250mL1.25

GM 3,065 96,872

P 1805B

Tablet 500ug 8.00

MG 35,132

792,980P 180

6CTablet 2mg 8.0

0MG 22,13

7839,317P 180

7DInjection 1mg in 2mL (set containing solution)

8.00

MG 2,663 64,681P 180

8EPaediatric oral drops 2.5mg in 1mL 10mL

8.00

MG 3,704 59,584P 533

7XTablet 500ug 8.0

0MG 26,14

7498,049P 533

8YTablet 2mg 8.0

0MG 12,82

2446,996P 533

9BOral liquid 2.5mg per mL 10mL

8.00

MG 3,626 52,230P 534

0CTablet 500ug 8.0

0MG 11,54

6245,139P 534

1DTablet 2mg 8.0

0MG 5,516 192,

318P 5342E

Oral liquid 2.5mg per mL 10mL

8.00

MG 516 8,804

P 2419H

Tablet 200mg 1.00

GM 142,432

5,064,367P 242

2LTablet 100mg 1.0

0GM 56,48

81,208,375P 242

6QTablet 200mg (controlled release)

1.00

GM 73,964

2,674,199P 242

7ROral suspension 100mg per 5mL 300mL

1.00

GM 26,168

690,744P 243 Tablet 400mg (controlled 1.0 GM 52,72 3,367,

OXCARBAZEPINEP 858


0GM 1,62

5133,710P 858


0GM 5,50

6764,494P 858


0GM 3,32

0677,274P 858

8BOral suspension 60mg per mL 250mL

1.00

GM 674 91,199

153

N


cost($)

NERVOUS SYSTEMANTIEPILEPTICSANTIEPILEPTICSBARBITURATES AND DERIVATIVES

N03AA02 PHENOBARBITONE

N03AA03 PRIMIDONEP 1939C Tablet 250mg 1.25 GM 16,775 854,255

HYDANTOIN DERIVATIVESN03AB02 PHENYTOIN

SUCCINIMIDE DERIVATIVESN03AD01 ETHOSUXIMIDE

BENZODIAZEPINE DERIVATIVESN03AE01 CLONAZEPAM

CARBOXAMIDE DERIVATIVESN03AF01 CARBAMAZEPINE

N03AF02

P 2289L

Tablet 200mg (enteric coated) 20 0

1.50

GM 268,309

9,060,557P 229

0MTablet 500mg (enteric coated) 20 0

1.50

GM 297,187

18,157,915P 229

3QOral liquid 200mg per 5mL 300 mL

1.50

GM 51,768

1,878,547P 229

4RCrushable tablet 100mg 1.5

0GM 52,6

561,622,878P 229 Syrup 200mg per 5mL 1.5 GM 18,1 662,

TIAGABINEP 822

1QTablet 5mg (base) 30.0

0MG 99

097,794P 822

2RTablet 10mg (base) 30.0

0MG 1,06

6180,391P 822 Tablet 15mg (base) 30.0 MG 35 72,3

VIGABATRINP 2667JTablet 500mg 120 2.0

0GM 8,65

11,147,201P 2668K Oral powder sachet

500mg2.00

GM 2,039

187,011

P 1834M

Capsule 300mg 100 1.80 GM 51,329

5,114,446P 183

5NCapsule 400mg 100 1.80 GM 15,8

432,320,461P 459

1PCapsule 100mg 100 1.80 GM 7,60

9233,581P 459

2QCapsule 300mg 100 1.80 GM 28,7

722,578,320P 459

3RCapsule 400mg 100 1.80 GM 4,33

8550,322P 459

4TTablet 600mg 100 1.80 GM 4,31

6812,508P 459

5WTablet 800mg 100 1.80 GM 2,20

1521,009P 838

9MTablet 800mg 100 1.80 GM 9,98

72,543,263P 850

5PCapsule 100mg 100 1.80 GM 12,2

66377,751P 855 Tablet 600mg 100 1.80 GM 12,5 2,394,

LAMOTRIGINEP 284

8XTablet 25mg 0.30 GM 39,5

021,829,523P 284

9YTablet 50mg 0.30 GM 68,5

294,487,563P 285

0BTablet 100mg 0.30 GM 111,2

7411,611,174P 285


4115,331,238P 806 Tablet 5mg 0.30 GM 5,97 183,

LEVETIRACETAMP 865

4LTablet 250mg 60 1.50 GM 6,18

4427,988P 865

5MTablet 500mg 60 1.50 GM 16,2

181,808,431P 865

6NTablet 1gm 60 1.50 GM 5,56

3899,363P 970

8YTablet 250mg 60 1.50 GM 16,0

691,370,071P 970

9BTablet 500mg 60 1.50 GM 49,3

827,083,720P 971

0CTablet 1gm 60 1.50 GM 28,3

865,447,698

154

N


cost($)

NERVOUS SYSTEMANTIEPILEPTICSANTIEPILEPTICSFATTY ACID DERIVATIVES

N03AG01 SODIUM VALPROATE

N03AG06

N03AG04

OTHER ANTIEPILEPTICSN03AX12 GABAPENTIN

N03AX09

N03AX14

A 19043

Capsules 75mg 56 0.30 GM 44,348

–A 190

44Capsules 150mg 56 0.30 GM 23,32

6–

A 190 Capsules 300mg 56 0.30 GM 8,00 –SULTHIAMEP 2099L Tablet 50mg 0.40 GM 1,37

251,908P 2100M Tablet 200mg 0.40 GM 1,60 137,

TOPIRAMATEA 195

61Tablet 25mg 60 0.30 GM 168 –

A 20252

Tablet 50mg 60 0.30 GM 165 –A 202

53Tablet 100mg 60 0.30 GM 225 –

A 20254

Tablet 200mg 60 0.30 GM 184 –P 816

3PTablet 25mg 0.30 GM 16,46

4844,833P 816

4QTablet 50mg 0.30 GM 19,44

61,416,397P 816

5RTablet 100mg 0.30 GM 17,13

01,938,008P 816

6TTablet 200mg 0.30 GM 10,04

81,933,295P 837

1NCapsule 15mg 0.30 GM 554 29,0

52P 8372P

Capsule 25mg 0.30 GM 676 36,648P 852

0KCapsule 50mg 0.30 GM 847 73,6

04P 9701N

Capsule 15mg 60 0.30 GM 781 44,166P 970

2PCapsule 25mg 60 0.30 GM 952 60,8

64P 9703Q

Capsule 50mg 60 0.30 GM 1,071

107,938P 970

4RTablet 25mg 60 0.30 GM 8,70

8515,141P 970

5TTablet 50mg 60 0.30 GM 11,45

8923,190P 970

6WTablet 100mg 60 0.30 GM 12,95

81,565,050P 970

7XTablet 200mg 60 0.30 GM 7,85

41,612,062

155

N


cost($)

NERVOUS SYSTEMANTIEPILEPTICSANTIEPILEPTICSOTHER ANTIEPILEPTICS

N03AX16 PREGABALIN

N03AX03

N03AX11

P 1109JTablet 2mg 10.00 MG 12,379

151,113P 1110K Tablet 5mg 10.00 MG 5,721 83,346

P 2225D

Capsule 100mg–25mg 0.60

GM 36,020

1,377,511P 222

6ECapsule 200mg–50mg 0.6

0GM 18,29

9949,738P 222

7FCapsule 50mg–12.5mg 0.6

0GM 23,10

8501,896P 222

8GTablet 200mg–50mg 0.6

0GM 37,79

72,024,194P 222

9HTablet 100mg–25mg 0.6

0GM 52,57

92,060,043P 223

1KCapsule 100mg–25mg (sustained release)

0.60

GM 12,155

506,081P 821

8MDispersible tablet 50mg 12.5mg

0.60

GM 6,900

157,819P 821 Dispersible tablet 100mg 0.6 GM 7,95 335,

LEVODOPA with CARBIDOPAP 124

2JTablet 100mg–25mg 0.6

0GM 183,1

077,745,781P 124

5MTablet 250mg–25mg 0.6

0GM 45,35

12,198,225P 125 Tablet 200mg–50mg 100 0.6 GM 29,70 2,211,

LEVODOPA,DECARBOXYLASE INHIBITOR and COMT INHIBITORP 879

7BTablet 50mg–12.5mg–200mg

0.45

GM 1,512

477,516P 879

8CTablet 100mg–25mg–200mg 0.4

5GM 9,78

73,365,214P 879

9DTablet 150mg–37.5mg–200mg

0.45

GM 8,528

3,178,210

156

N


cost($)

NERVOUS SYSTEMANTI–PARKINSON DRUGSANTICHOLINERGIC AGENTSTERTIARY AMINES WITH CARBON CHAIN

N04AA01 BENZHEXOL HYDROCHLORIDE

N04AA02 BIPERIDEN HYDROCHLORIDEP 2544X Tablet 2mg 10.00MG 14,289 265,730

ETHERS OF TROPINE OR TROPINE DERIVATIVESN04AC01 BENZTROPINE MESYLATE

P 2362H

Tablet 2mg 60 2.00 MG 61,843

696,024P 303

8XInjection 2mg in 2mL 2.00 MG 1,210 28,2

92P 3457Y

Injection 2mg in 2mL 2.00 MG 5,152 107,874DOPAMINERGIC AGENTS

DOPA AND DOPA DERIVATIVESN04BA02 LEVODOPA with BENSERAZIDE

N04BA02

N04BA03

ADAMANTANE DERIVATIVESN04BB01 AMANTADINE HYDROCHLORIDE

P 3016R Capsule 100mg 0.20 GM 15,496 650,564

P 6104G Injection 10mg in 1 mL

20.00

MG 200 228,048P 9607P Injection 20mg in 2 20.0 MG 156 239,

BROMOCRIPTINE MESYLATEP 144

3YCapsule 2.5mg (base) 40.0

0MG 12,31

2438,374P 144

5CCapsule 10mg 40.0

0MG 1,32

1270,562P 144 Capsule 5mg 40.0 MG 5,28 357,

CABERGOLINEP 839

3RTablet 1mg 30 3.00 MG 34,80

02,595,317P 839

4TTablet 2mg 30 3.00 MG 31,28

53,096,322P 839 Tablet 4mg 30 3.00 MG 24,17 2,931,

PERGOLIDEP 280

8TTablet 50ug (base) 3.00 MG 1,45

384,512P 280

9WTablet 250ug (base) 3.00 MG 4,90

2342,606P 281 Tablet 1mg (base) 3.00 MG 2,64 671,

ROPINIROLEA 18889 Tablet 0.5mg 28 6.00 MG 6,73

0–

A 18890 Tablet 2mg 28 6.00 MG 3,000

–

157

N


cost($)

NERVOUS SYSTEMANTI–PARKINSON DRUGSDOPAMINERGIC AGENTSDOPAMINE AGONISTS

N04BC07 APOMORPHINE

N04BC01

N04BC06

N04BC02

N04BC04

MONOAMINE OXIDASE TYPE B INHIBITORSN04BD01 SELEGILINE HYDROCHLORIDE

P 1973W Tablet 5mg 100 5.00 MG 6,975 386,543OTHER DOPAMINERGIC AGENTS

N04BX02 ENTACAPONEP 8367J Tablet 200mg 1.00 GM 17,651

4,998,415

P 1195X

Injection 50mg in 2 mL 0.10

GM 892 13,331P 119

6YTablet 10mg 0.3

0GM 9,589 79,7

67P 1197B

Tablet 25mg 0.30

GM 42,695

417,607P 119

9DTablet 100mg 0.3

0GM 27,84

7377,977P 120

1FMixture 25mg per 5mL 100mL

0.30

GM 4,929 72,478P 345

5WInjection 50mg in 2mL 0.1

0GM 3,980 56,2

99

P 1001Q

Injection 50mg in 2mL 1.00 MG 4,322

153,263P 104

6CInjection 12.5mg in 0.5mL

1.00 MG 2,287

40,032P 309 Injection 25mg in 1mL 1.00 MG 4,86 118,

PROCHLORPERAZINEP 236

9QInjection 12.5mg in 1mL

50.00

MG 7,443

114,669P 289

3GTablet 5mg 100.

00MG 810,8

536,694,103P 289

4HSuppositories 5mg 5 100.

00MG 5,29

294,932P 289

5JSuppositories 25mg 5 100.

00MG 20,87

9436,306P 347 Injection 12.5mg in 50.0 MG 12,02 172,

TRIFLUOPERAZINE HYDROCHLORIDEP 218

5BTablet 1mg (base) 20.0

0MG 15,38

6153,282P 218

6CTablet 5mg (base) 20.0

0MG 17,20

3197,684P 238

6NTablet 2mg (base) 20.0

0MG 7,17

276,187

P 3052P Tablet 2.5mg 50.00 MG 42,567

379,491P 3053Q Tablet 10mg 50.00 MG 17,01 221,

THIORIDAZINE HYDROCHLORIDEA 202

85Tablet 50mg 100 0.30 GM 119 –

P 2163W

Tablet 10mg 0.30 GM 2,648 25,186P 216

4XTablet 50mg 0.30 GM 5,130 76,7

02P 2165Y

Tablet 100mg 0.30 GM 4,556 106,106P 235

9ETablet 25mg 0.30 GM 5,237 59,6

85

158

N


cost($)

NERVOUS SYSTEMPSYCHOLEPTICSANTIPSYCHOTICSPHENOTHIAZINE WITH DIMETHYLAMINOPROPYL GROUP

N05AA01 CHLORPROMAZINE HYDROCHLORIDE

PHENOTHIAZINE WITH PIPERAZINE STRUCTUREN05AB02 FLUPHENAZINE DECANOATE

N05AB04

N05AB06

PHENOTHIAZINE WITH PIPERIDINE STRUCTUREN05AC01 PERICYAZINE

N05AC02

BUTYROPHENONE DERIVATIVESN05AD01 HALOPERIDOL

P 2761H

Tablet 500ug 100 8.00

MG 49,476

432,823P 276

3KOral liquid 2mg per mL 100 mL

8.00

MG 1,868 28,258P 276

5MI.M. injection equivalent to 50mg haloperidol

3.30

MG 2,098 51,058P 276

6NI.M. injection equivalent to 150mg haloperidol

3.30

MG 1,888 81,848P 276

7PTablet 1.5mg 8.0

0MG 15,62

4143,779P 276

8QInjection 5mg in 1mL 8.0

0MG 6,893 148,

479P 2770T

Tablet 5mg 8.00

MG 21,349

213,054

159

P 3456X


MG 4,055 82,044

159

A 19954

Capsule 20mg 60 80.00 MG 13,879

–P 907

0JCapsule 20mg 60 80.00 MG 1,67

7179,223P 907

1KCapsule 40mg 60 80.00 MG 2,98

6583,105P 907

2LCapsule 60mg 60 80.00 MG 663 187,

670P 9073M

Capsule 80mg 60 80.00 MG 3,874

1,397,948

P 2255Q

Injection oily I.M. 20mg in 1mL

4.00

MG 5,485 96,026P 225

6RInjection oily I.M. 40mg in 1mL

4.00

MG 3,208 76,920P 225

7TInjection oily I.M. 100mg in 1mL

4.00

MG 4,932 208,458

P 6101D

Tablet 25mg 0.30 GM 4,832

312,634P 610

2ETablet 100mg 0.30 GM 23,6

968,064,709P 641

7RTablet 50mg 100 0.30 GM 1,18

5114,987P 641 Tablet 200mg 100 0.30 GM 3,65 1,644,

OLANZAPINEA 183

56Vial 10mg (solvent required)

10.00

MG 110

–P 817

0BTablet 2.5mg 30 10.0

0MG 144,4

099,558,904P 818


0MG 238,5

2830,597,762P 818

6WTablet 7.5mg 30 10.0

0MG 60,2

3212,648,687P 818


0MG 297,3

9994,749,622P 843

3WWafer 5mg 28 10.0

0MG 45,4

025,675,765P 843 Wafer 10mg 28 10.0 MG 49,1 15,329

QUETIAPINEP 845

6CTablet 25mg (base) 60 0.40 GM 106,9

157,021,166P 845

7DTablet 100mg (base) 90 0.40 GM 74,2

2111,401,643P 845

8ETablet 200mg (base) 60 0.40 GM 88,6

8923,583,161P 858

0NTablet 300mg (base) 60 0.40 GM 57,2

0019,998,318

N


cost($)

NERVOUS SYSTEMPSYCHOLEPTICSANTIPSYCHOTICSINDOLE DERIVATIVES

N05AE04 ZIPRASIDONE

THIOXANTHENE DERIVATIVES

N05AF01 FLUPENTHIXOL

N05AF05 ZUCLOPENTHIXOLP 8097E Oily I.M. injection 200mg in 1mL 15.00MG 23,033

537,680DIPHENYLBUTYLPIPERIDINE DERIVATIVES

N05AG02 PIMOZIDEA 11421 Tablet 2mg 50 4.00 MG 549 –

DIAZEPINES, OXAZEPINES AND THIAZEPINESN05AH02 CLOZAPINE

N05AH03

N05AH04

160

P 8594H


GM 20,771

1,022,775P 859

5JTablet 200mg 60 0.4

0GM 29,58

64,523,501P 859


0GM 34,12

89,360,042P 873

6TOral solution 100mg per mL 60mL 2

0.40

GM 237 45,530

P 3059B Tablet 250mg 200 889.00

MG 101,870

1,407,118P 8290H Tablet 450mg (slow

release) 200889.00

MG 31,646

934,344

P 8717T


MG 28,753

5,004,557P 871


0MG 31,3

137,803,957P 871


0MG 12,8

343,664,520P 872 Tablet 30mg 30 15.0 MG 19,7 6,877,

RISPERIDONEP 316

9TTablet 1mg 5.0

0MG 91,6

897,090,793P 317

0WTablet 2mg 5.0

0MG 65,9

039,770,422P 317

1XTablet 3mg 5.0

0MG 32,3

846,788,075P 317

2YTablet 4mg 5.0

0MG 27,0

347,506,111P 810

0HOral solution 1mg per mL 100mL

5.00

MG 4,628

612,731P 878

0DPdr for I.M. injection 25mg/2mL diluent syringe

1.80

MG 34,171

10,862,832P 878

1EPdr for I.M. injection 37.5mg/2mL diluent syringe

1.80

MG 31,562

13,938,062P 878

2FPdr for I.M. injection 50mg/2mL diluent syringe

1.80

MG 38,721

19,524,308P 878

7LTablet 0.5mg 60 5.0

0MG 68,4

882,733,921P 878

8MTablet 0.5mg (orally disintegrating)56

5.00

MG 12,137

463,859P 878

9NTablet 1mg 60 5.0

0MG 53,7

444,040,691P 879

0PTablet 1mg (orally disintegrating) 56

5.00

MG 4,583

326,077P 879

1QOral solution 1mg per mL 30mL

5.00

MG 6,672

321,340P 879

2RTablet 1mg (orally disintegrating) 56

5.00

MG 5,056

358,419P 879

4WTablet 2mg (orally disintegrating) 56

5.00

MG 5,378

728,415P 886

9TTablet 0.5mg 60 5.0

0MG 29,6

231,176,166P 887

0WTablet 0.5mg (orally disintegrating) 56

5.00

MG 5,185

196,292P 907

5PTablet 3mg (orally disintegrating) 56

5.00

MG 778

134,492P 907

6QTablet 4mg (orally disintegrating) 56

5.00

MG 572

127,322P 907

9WTablet 2mg 60 5.0

0MG 8,44

41,172,277P 908

0XTablet 2mg (orally disintegrating) 56

5.00

MG 914

111,417

N


cost($)

NERVOUS SYSTEMPSYCHOLEPTICSANTIPSYCHOTICSBENZAMIDES

N05AL05 AMISULPRIDE

LITHIUMN05AN01 LITHIUM CARBONATE

OTHER ANTIPSYCHOTICSN05AX12 ARIPIPRAZOLE

N05AX08

161

P 2130D

Tablet 250ug 1.00 MG 79,777

830,460P 213

1ETablet 500ug 1.00 MG 187,6

702,603,803P 213

2FTablet 1mg 1.00 MG 217,2

884,633,665P 811 Tablet 2mg 1.00 MG 131,7 4,048,

BROMAZEPAMP 4150K Tablet 3mg 10.00 MG 18,30

2472,984P 4151L Tablet 6mg 10.00 MG 27,60

2867,908

A 13803


MG

224

–A 154

50Elixir 0.1% 100mL 10.0

0MG

3,604

–P 255

8PInjection 10mg in 2mL 10.0

0MG

5,018

59,008P 316

1JTablet 2mg 10.0

0MG

245,749

1,782,981P 316

2KTablet 5mg 10.0

0MG

1,896,974

14,197,205P 345

8BInjection 10mg in 2mL 10.0

0MG

11,541

125,564P 507

1XTablet 2mg 10.0

0MG

578

3,987P 507

2YTablet 5mg 10.0

0MG

3,771

25,730P 535


0MG

548

4,578P 535


0MG

3,738

34,720P 535


0MG

217

1,915P 535 Tablet 5mg 50 10.0 M 1,95 21,2

LORAZEPAMA 138

07Tablet 1mg 50 2.50 M

G76,084

–A 138 Tablet 2.5mg 50 2.50 M 33,1 –OXAZEPAMP 313

2WTablet 15mg 50.0

0MG

216,232

1,411,632P 313

3XTablet 30mg 50.0

0MG

1,146,504

7,717,366P 313

4YTablet 15mg 50.0

0MG

10,100

83,288P 313

5BTablet 30mg 50.0

0MG

14,296

121,747P 519

3HTablet 30mg 50.0

0MG

217

1,431P 537


0MG

564

4,538P 537


0MG

1,375

11,511P 537


0MG

171

1,606P 537


0MG

880

9,176

N


cost($)

NERVOUS SYSTEMPSYCHOLEPTICSANXIOLYTICSBENZODIAZEPINE DERIVATIVES

N05BA12 ALPRAZOLAM

N05BA08

N05BA09 CLOBAZAMA 10898 Tablet 10mg 50 20.00MG 22,762 –

N05BA01 DIAZEPAM

N05BA06

N05BA04

AZASPIRODECANEDIONE DERIVATIVESN05BE01 BUSPIRONE HYDROCHLORIDE

P 4144D Tablet 5mg 50 30.00 MG 2,692 127,241P 4145E Tablet 10mg 50 30.00 MG 3,771 282,817

A 11021

Ampoule 15mg/3mL 5 15.00

MG

307

–A 126

45Ampoule 5mg/mL 10 15.0

0MG

6,515

–A 137


0MG

1,731

–A 168

38Ampoule 5mg/5mL 5 15.0

0MG

249

–A 179


0MG

253

–A 185


0MG

581

–A 185 Ampoule 5mg/5mL 10 15.0 M 25 –NITRAZEPAMP 272

3HTablet 5mg 25 5.00 M

G630,276

4,510,215P 273

2TTablet 5mg 50 5.00 M

G13,504

129,742P 535

9CTablet 5mg 50 5.00 M

G1,361

12,338P 536 Tablet 5mg 50 5.00 M 57 7,0

TEMAZEPAMA 183

40Capsule 10mg 20.0

0MG

118

–A 185


0MG

882

–P 208

8XTablet 10mg 20.0

0MG

78,712

723,505P 208


0MG

2,706,112

19,366,662P 522

1TTablet 10mg 20.0

0MG

1,124

7,785P 537


0MG

5,694

52,746P 537 Tablet 10mg 50 20.0 M 1,95 21,0

TRIAZOLAM

162

N


cost($)

NERVOUS SYSTEMPSYCHOLEPTICSHYPNOTICS AND SEDATIVESALDEHYDES AND DERIVATIVES

N05CC01 CHLORAL HYDRATEA 18744 Syrup 1g/10mL 200mL 1.00 GM 1,743 –

BENZODIAZEPINE DERIVATIVESN05CD03 FLUNITRAZEPAM

P 4216X Tablet 1mg 30 1.00 MG 53,124 901,222N05CD08 MIDAZOLAM

N05CD02

N05CD07

N05CD05A 13374 Tablet 0.125mg 50 0.25 MG 4,986 –

ZOLPIDEMA 168

09Tablet 10mg 7 10.00 MG 26,46

6–

A 17644

Tablet 10mg 20 10.00 MG 299,817

–A 197

63Tablet 6.25mg 21 10.00 MG 20,30

5–

A 19764

Tablet 12.5mg 7 10.00 MG 419 –A 197

65Tablet 12.5mg 21 10.00 MG 165,0

75–

A 19787

Tablet 10mg 20 10.00 MG 16,422

–A 198

03Tablet 10mg 7 10.00 MG 933 –

A 19804

Tablet 10mg 20 10.00 MG 44,627

–A 198

17Tablet 10mg 7 10.00 MG 4,24

0–

A 19818

Tablet 10mg 20 10.00 MG 103,107

–A 198

93Tablet 10mg 20 10.00 MG 13,80

9–

A 19899

Tablet 10mg 20 10.00 MG 8,860

–A 199

74Tablet 10mg 20 10.00 MG 2,18

7–

A 201 Tablet 10mg 20 10.00 MG 430 –ZOPICLONEA 14925 Tablet 7.5mg 10 7.50 MG 6,11

1–

P 4522B Tablet 7.5mg 7.50 MG 88,668

2,011,769

N


cost($)

NERVOUS SYSTEMPSYCHOLEPTICSHYPNOTICS AND SEDATIVESBENZODIAZEPINE RELATED DRUGS

N05CF02

N05CF01

N


cost($)

NERVOUS SYSTEMPSYCHOANALEPTICSANTIDEPRESSANTSNON SELECTIVE MONOAMINE REUPTAKE INHIBITORS

N06AA09 AMITRIPTYLINE HYDROCHLORIDEA 197

35Tablet 25mg 75.0

0MG 375 –

P 2417F


MG 374,719

2,718,127P 241


0MG 534,7

233,923,180P 242


0MG 401,7

033,231,304N06AA0

4CLOMIPRAMINE HYDROCHLORIDEP 1561E Tablet 25mg 50 100.

00MG 65,63

12,415,115N06AA1

6DOTHIEPIN HYDROCHLORIDEP 1357K Capsule 25mg 50 150.

00MG 262,3

922,167,485P 1358L Tablet 75mg 50 150.

00MG 359,3

753,306,524N06AA1

2DOXEPIN HYDROCHLORIDEP 1011F Capsule 10mg (base)50

100.00

MG 68,841

534,978P 1012G Tablet 50mg (base)

50100.00

MG 144,990

1,327,955P 1013H Capsule 25mg

(base)50100.00

MG 171,966

1,461,743A 14246 Tablet 75mg 30 100.

00MG 124 –

N06AA02

IMIPRAMINE HYDROCHLORIDEP 2420J Tablet 10mg 50 100.

00MG 45,77

2333,718P 2421K Tablet 25mg 50 100.

00MG 129,4

371,061,558N06AA1

0NORTRIPTYLINE HYDROCHLORIDEP 2522R Tablet 10mg (base) 50

75.00

MG 20,202

246,352P 2523T Tablet 25mg (base)

5075.00

MG 62,625

1,110,750N06AA0

6TRIMIPRAMINE MALEATEA 14531 Tablet 25mg (base) 150.

00MG 2,10

8–

A 16468 Capsule 50mg 50 150.00

MG 11,297

–

CITALOPRAMP 822

0PTablet 20mg (base) 28 20.0

0MG

1,560,358

52,018,615P 870

2BTablet 10mg (base) 28 20.0

0MG

24,684

479,366P 870 Tablet 40mg (base) 28 20.0 M 92,7 3,953,

ESCITALOPRAMP 870

0XTablet 10mg (base) 28 10.0

0MG

773,655

22,498,361P 870

1YTablet 20mg (base) 28 10.0

0MG

543,459

21,622,540P 884

9ROral solution 10mg (base) per mL 28mL

10.00

MG

1,714

64,998P 970 Oral solution 10mg (base) 10.0 M 27 16,5

FLUOXETINE HYDROCHLORIDEP 1434L Capsule 20mg

(base)2820.00

MG

850,812

29,179,103P 8270G Tablet 20mg (base) 20.0 M 257,9 7,941,

FLUVOXAMINEP 8174F Tablet 100mg 30 0.1

0GM

329,922

13,572,744P 8512B Tablet 50mg 30 0.1

0GM

131,329

3,202,951

P 2236Q

Tablet 50mg (base) 30 50.00

MG

1,356,188

40,211,141P 223

7RTablet 100mg (base) 30

50.00

MG

1,306,731

46,066,364P 883

6CTablet 50mg (base) 30 50.0

0MG

91,865

2,674,539P 883

7DTablet 100mg (base) 30

50.00

MG

86,185

2,760,876

N


cost($)

NERVOUS SYSTEMPSYCHOANALEPTICSANTIDEPRESSANTSSELECTIVE SEROTONIN REUPTAKE INHIBITORS

N06AB04

N06AB10

N06AB03

N06AB08

N06AB05 PAROXETINEP 2242B Tablet 20mg (base) 30 20.00MG 1,127,052 42,901,897

N06AB06 SERTRALINE

MONOAMINE OXIDASE INHIBITORS, NON–SELECTIVEN06AF03 PHENELZINE SULPHATE

P 2856H Tablet 15mg (base) 100 60.00MG 7,082 884,140N06AF04 TRANYLCYPROMINE SULPHATE

P 2444P Tablet 10mg (base) 50 10.00MG 17,682 950,886MONOAMINE OXIDASE TYPE A INHIBITORS

N06AG02 MOCLOBEMIDEP 190

0BTablet 150mg 60 0.30 GM 51,71

61,114,715A 202

58Tablet 150mg 60 0.30 GM 563 –

A 20259

Tablet 300mg 60 0.30 GM 176 –P 800

3FTablet 300mg 60 0.30 GM 133,2

905,123,770

BUPROPIONP 8465M Tablet 150mg

(sustained release)0.30

GM 58,333

4,538,214P 8710K Tablet 150mg 0.3 GM 35,3 6,011,

MIANSERIN HYDROCHLORIDEP 1627P Tablet 10mg 50 60.0

0MG 21,6

58327,700P 1628Q Tablet 20mg 50 60.0 MG 46,4 1,638,

MIRTAZAPINEP 851

3CTablet 30mg 30 30.0

0MG 871,8

0531,837,846P 885

5CTablet 15mg (orally disintegrating) 30

30.00

MG 50,666

1,178,110P 885

6DTablet 30mg (orally disintegrating) 30

30.00

MG 47,210

1,647,735P 885

7ETablet 45mg (orally disintegrating) 30

30.00

MG 16,709

868,195P 888


0MG 73,7

093,796,800

N


cost($)

NERVOUS SYSTEMPSYCHOANALEPTICSANTIDEPRESSANTSOTHER ANTIDEPRESSANTS

N06AX12

N06AX03

N06AX11

N06AX18 REBOXETINEP 8583R Tablet 4mg (base) 60 8.00 MG 97,094 3,762,542

N06AX16 VENLAFAXINEA 196

00Tablet 75mg (base) 100.

00MG

333

–P 830

1XCapsule 75mg (base) modified release 28

100.00

MG

1,162,077

54,115,527P 830

2YCapsule 150mg (base) modified release 28

100.00

MG

1,266,494

80,059,487P 886

8RTablet 37.5mg (base) (modified release) 28

100.00

MG

140,888

3,749,150

A 18484


MG 875 –A 184


0MG 1,773 –

A 18488


MG 3,885 –A 184


0MG 6,513 –

P 9092M

Capsule 10mg base 56

80.00

MG 751 170,680P 909

3NCapsule 18mg base 56

80.00

MG 968 208,639P 909

4PCapsule 25mg base 56

80.00

MG 1,912 417,474P 909

5QCapsule 40mg base 56

80.00

MG 3,198 699,735P 909

6RCapsule 60mg base 56

80.00

MG 2,678 578,419

A 17704

Capsule controlled release 20mg

30.00

MG 23,196

–A 177

05Capsule controlled release 30mg

30.00

MG 24,299

–A 177

06Capsule controlled release 40mg

30.00

MG 25,907

–P 217

2HTablet CR 27mg 30 30.0

0MG 4,44

9324,083P 238

7PTablet C R 18mg 30 30.0

0MG 22,90

01,327,226P 238

8QTablet C R 36mg 30 30.0

0MG 59,78

74,109,965P 243

2BTablet C R 54mg 30 30.0

0MG 45,81

33,598,283P 883 Tablet 10mg 100 30.0 MG 112,5 2,052,

MODAFINILA 176

24Tablet 100mg 30 0.3

0GM 3,95

4–

A 17626


GM 209 –P 881


0GM 2,45

6771,899

N


cost($)

NERVOUS SYSTEMPSYCHOANALEPTICSPSYCHOSTIMULANTS AND NOOTROPICSCENTRALLY ACTING SYMPATHOMIMETICS

N06BA09 ATOMOXETINE

N06BA02 DEXAMPHETAMINE SULPHATEP 1165H Tablet 5mg 15.00MG 257,6415,828,619

N06BA04 METHYLPHENIDATE

N06BA07

DONEPEZILP 8495D Tablet 5mg 28 7.5

0MG 61,1

779,672,208P 8496E Tablet 10mg 28 7.5 MG 173,8 26,882

GALANTAMINEP 877

0NTablet 8mg (base) (prolonged release) 28

16.00

MG 25,396

3,544,393P 877

1PTablet 16mg (base) (prolonged release) 28

16.00

MG 73,670

11,626,427P 877 Tablet 24mg (base) 16.0 MG 15,6 2,926,

RIVASTIGMINEP 849

7FCapsule 1.5mg 56 9.0

0MG 3,04

0490,029P 849

8GCapsule 3mg 56 9.0

0MG 5,41

3859,396P 849

9HCapsule 4.5mg 56 9.0

0MG 2,75

8428,933P 850


0MG 3,64

5565,130P 856

3QOral solution 2mg (base) per mL 120mL

9.00

MG 658

109,283

N


cost($)

NERVOUS SYSTEMPSYCHOANALEPTICSANTI–DEMENTIA DRUGSANTICHOLINESTERASES

N06DA02

N06DA04

N06DA03

OTHER ANTI–DEMENTIA DRUGS N06DX01 MEMANTINE HYDROCHLORIDE

A 18031 Tablet 10mg 56 – – 13,984 –

P 1959D

Tablet 60mg 180.00

MG 11,285

655,364P 260

8GTablet 180mg (sustained release)

180.00

MG 2,076 239,819P 272

4JTablet 10mg 180.

00MG 2,827 74,7

28

P 4571N

Transdermal patch 7 cm releasing ~7mg/24hr 7

MG 407 28,798P 457

2PTransdermal patch 14 cm releasing ~14mg/24hr 7 14.00

MG 852 60,405P 457

3QTransdermal patch 21 cm releasing ~21mg/24hr 7 14.00

MG 3,053 215,733P 457

6WTransdermal patch releasing 5mg/16hr 7

MG 272 13,405P 457

7XTransdermal patch releasing 10mg/16hr 7

MG 517 27,505P 457

8YTransdermal patch releasing 15mg/16hr 7

MG 711 42,038

N07BB03

ACAMPROSATEP 8357W Tablet 333mg (enteric coated)

2.00

GM 27,760

4,577,664N07BB0

1DISULFIRAMA 16345 Effervescent Tablet 200mg 30

– – 3,909

–N07BB04

NALTREXONEP 8370M Tablet 50mg 30 50.0

0MG 19,78

93,179,676

P 6307Y

Sublingual tablet 0.4mg (base)

8.00

MG 1,189

–P 630

8BSublingual tablet 2mg (base) 8.0

0MG 2,07

4–

P 630 Sublingual tablet 8mg (base) 8.0 MG 9,80 –BUPRENORPHINE HYDROCHLORIDE with NALOXONE HYDROCHLORIDEP 6470M Sublingual tablet 2mg

(base) – 0.5mg (base) 28– – 6,59

3–

P 6471N Sublingual tablet 8mg – – 9,37 –METHADONE HYDROCHLORIDEP 160

6MInjection 10mg in 1mL 25.0

0MG 549 85,6

52P 1609Q

Tablet 10mg 25.00

MG 92,532

3,099,129A 175

13Syrup 25mg per 5mL 200mL 25.0

0MG 49,04

1–

P 5399E

Syrup 25mg per 5mL 200mL 75.00

MG 1,054

23,538P 540

0FSyrup 25mg per 5mL 200mL 75.0

0MG 733 19,7

19P 6171T

Syrup 25mg per 5mL 200mL 25.00

MG 8,340

–P 617

2WSyrup 25mg per 5mL 1 L 25.0

0MG 1,80

8–

N


cost($)

NERVOUS SYSTEMOTHER NERVOUS SYSTEM DRUGSPARASYMPATHOMIMETICSANTICHOLINESTERASES

N07AA02 PYRIDOSTIGMINE BROMIDE

CHOLINE ESTERSN07AB02 BETHANECHOL

CHLORIDEP 1062X Tablet 10mg 45.00MG 6,235 135,226

DRUGS USED IN ADDICTIVE DISORDERSDRUGS USED IN NICOTINE DEPENDENCE

N07BA01 NICOTINE

DRUGS USED IN ALCOHOL DEPENDENCE

DRUGS USED IN OPIOID DEPENDENCEN07BC01 BUPRENORPHINE

N07BC51

N07BC02

170

N


cost($)

NERVOUS SYSTEMOTHER NERVOUS SYSTEM DRUGSANTIVERTIGO PREPARATIONSANTIVERTIGO PREPARATIONSN07CA01 BETAHISTINE

A 16064 Tablet 16mg 25 24.00 MG 160,406 –A 18064 Tablet 16mg 10 24.00 MG 27

7–

OTHER NERVOUS SYSTEM DRUGSOTHER NERVOUS SYSTEM DRUGS

N07XX02 RILUZOLEP 8664B Tablet 50mg 56 0.10 MG 6,375 4,333,764

N07XX06 TETRABENAZINEP 1330B Tablet 25mg 0.10 GM 5,018 1,845,730

171

P 1621H

Tablet 400mg 2.00

GM 354,244

3,513,135P 162

6NTablet 400mg 2.0

0GM 1,72

513,460P 163

0TOral suspension 320mg per 5mL

2.00

GM 29,570

440,246P 163

6DTablet 200mg 2.0

0GM 135,1

57984,765P 164

2KSuppositories 500mg 10 2.0

0GM 1,42

136,036P 333

9RTablet 200mg 2.0

0GM 68,66

7498,661P 334

1WOral suspension 320mg per 5mL

2.00

GM 867 12,560P 515

5HTablet 400mg 2.0

0GM 58,55

5576,705P 515

9MTablet 400mg 2.0

0GM 130 924

P01BA01 CHLOROQUINEA 15137 Tablet equivalent to 150mg (approx.)

0.50

GM 4,490

–P01BA02 HYDROXYCHLOROQUINE SULPHATE

P 1512N Tablet 200mg 0.52

GM 147,464

5,170,920BIGUANIDES

P01BB51 ATOVAQUONE with PROGUANILA 16050 Tablet 12 – – 21,79

7–

A 18864 Tablet 12 – – 1,481

–

A 14495

Tablet 250mg 8 1.00 GM 15,572

–QUININEP 197

2TTablet 300mg 1.50 GM 55,03

8597,036P 197

5YTablet 300mg 1.50 GM 134,9

831,474,737

P


cost($)

ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLANTSANTIPROTOZOALSAGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASESNITROIMIDAZOLE DERIVATIVES

P01AB01 METRONIDAZOLE

P01AB02 TINIDAZOLE

P 1465D Tablet 500mg 2.00 GM 138,0171,145,747ANTIMALARIALSQUINOLINE DERIVATIVES

P01BB01 PROGUANILA 15224 Tablet 100mg 0.20 GM 451 –

METHANOLQUINOLINESP01BC02 MEFLOQUINE

P01BC01

DIAMINOPYRIMIDINESP01BD01 PYRIMETHAMINE

P 1966L Tablet 25mg – – 305 3,913

P 8459F

Tablet 400mg 4.00 GM 536 92,468P 850

3MTablet 200mg 6 0.40 GM 1,664 53,9

87P 9047E

Tablet 200mg 6 0.40 GM 639 20,230

P 3047JTablet 125mg (base) 0.75 GM 649 4,452P 3048K Tablet 250mg

(base)0.75 GM 3,183 26,1

51

172

P


cost($)

ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLANTSANTHELMINTICSANTITREMATODALSQUINOLINE DERIVATIVES

P02BA01 PRAZIQUANTEL

A 13814 Tablet 600mg 8 3.00 GM 360 –ANTINEMATODAL AGENTSBENZIMIDAZOLE DERIVATIVESP02CA03 ALBENDAZOLE

P02CA01 MEBENDAZOLEP 4325P Tablet 100mg 0.20 GM 174 3,167

TETRAHYDROPYRIMIDINE DERIVATIVESP02CC01 PYRANTEL EMBONATE

AVERMECTINESP02CF01 IVERMECTIN

P 8359Y Tablet 3mg 4 12.00MG 4,604 182,494

173

P


cost($)

ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLANTSECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLANTSECTOPARASITICIDES, INCL. SCABICIDESPYRETHRINES, INCL. SYNTHETIC COMPOUNDS

P03AC04 PERMETHRINP 3054R Cream 50mg per g (5%) 30g – – 53,805 817,475

OTHER ECTOPARASITICIDES, INCL. SCABICIDESP03AX01 BENZYL BENZOATE

A 13227 Lotion 25% 200mL 1

– – 486 –A 19826 Lotion 25% 200mL

1– – 241 –

A 10690

Nasal spray pump 15mL 1 0.40

MG 269 –P 437

7JNasal drops 500ug per mL (0.05%) 15 mL

0.40

MG 138 2,075P 437

8KNasal spray 500ug per mL (0.05%) 15 mL

0.40

MG 2,400 36,246P 437

9LNasal spray 500ug per mL (0.05%) 18 mL

0.40

MG 377 6,030

R01AD01

BECLOMETHASONE DIPROPIONATEA 17056 Aqueous nasal spray 50ug per dose 200 dose 0.40

MG 4,536

–R01AD05

BUDESONIDEA 17200 Nasal spray aqueous(pump) 32ug per dose 60 doses 0.30

MG 783 –A 17201 Nasal spray aqueous(pump) 32ug per dose 120 doses 0.30

MG 954 –A 17850 Nasal spray aqueous(pump) 64ug per dose 240 doses 0.30

MG 96,934

–A 17952 Nasal spray aqueous(pump) 64ug per dose 120 doses 0.30

MG 155,037

–P 4092JNasal spray aqueous(pump) 64ug per dose 120 doses 0.30

MG 46,178

1,230,119R01AD0

8FLUTICASONEA 17840 Aqueous Nasal unit dose instillation 400ug 28 0.20

MG 802 –R01AD09

MOMETASONE FUROATEA 16441 Aqueous Nasal spray 50ug per dose 0.20

MG 451,319

–A 18043 Aqueous Nasal spray 50ug per dose 65 doses 0.20

MG 28,497

–

174

R


cost($)

RESPIRATORY SYSTEMNASAL PREPARATIONSDECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USESYMPATHOMIMETICS, PLAIN

R01AA05 OXYMETAZOLINE

R01AA07 XYLOMETAZOLINEA 11436 Nasal spray 15mL 1 0.80 MG 1,142 –

ANTIALLERGIC AGENTS,EXCL.CORTICOSTEROIDSR01AC02 LEVOCABASTINE

P 4311X Nasal spray 500ug per mL (0.05) 10mL 0.60 MG 2,966 49,317R01AC01 SODIUM CROMOGLYCATE

P 4468E Nasal spray metered dose pump 20mg per mL (2%) 40.00 MG965 17,979

CORTICOSTEROIDS

OTHER NASAL PREPARATIONSR01AX03 IPRATROPIUM BROMIDE

A 16829

Aqueous nasal spray(pump pack) 42ug per dose 10mL

0.24

MG 222 –P 408

9FAqueous nasal spray(pump pack) 21ug per dose

0.24

MG 10,369

214,043P 409

0GAqueous nasal spray(pump pack) 42ug per dose

0.24

MG 10,783

289,507

R01BA52

BROMHEXINE with GUAIPHENESIN with PSEUDOEPHEDRINEA 19678 Liquid 100mL 1 – –

1,342 –R01BA52

BROMHEXINE with PSEUDOEPHEDRINEA 19485 Liquid 200mL – – 73

6–

R01BA52

CHLORPHENIRAMINE with DEXTROMETHORPHAN with PARACETAMOL with PSEUDOEPHERINEA 19965 Tablets 2mg chlor/500mg pseud 6+

– –322

–

175

R


cost($)

RESPIRATORY SYSTEMNASAL PREPARATIONSNASAL DECONGESTANTS FOR SYSTEMIC USESYMPATHOMIMETICS

R01BA52 BROMHEXINE with PSEUDOEPHEDRINEA 19651 Liquid 200mL 1 – – 2,931 –

R01BA52 CHLORPHENIRAMINE with DEXTROMETHORPHAN with PSEUDOEPHEDRINEA 19681 Mixture 100mL 1 – – 361 –

R01BA52 CHLORPHENIRAMINE with PARACETAMOL with CODEINE PSEUDOEPHERINEA 19971 Tab2mg chlor/500mg para/

30mg pseud8+/9mg codeine – – 4,634 –R01BA52 CHLORPHENIRAMINE with PSEUDOEPHEDRINE with PARACETEMOL

A 19538 Tablet 24 – – 2,460 –R01BA52 CODEINE with PARRACETAMOL with PSEUDOEPHEDRINE with TRIPROLIDINE

A 19481 Tablet 24 – – 73,120 –R01BA52 DEXTROMETHORPHAN with

DOXYLAMINE with PARACETAMOL with PSEUDOEPHEDRINEA 19483 Capsule 24 – – 31,100 –A 19484 Capsule 20 – – 2,466 –

R01BA52 DEXTROMETHORPHAN with PARACETAMOL with PSEUDOEPHEDRINEA 19482 Capsule 24 – – 2,168 –A 19503 Tablet 24 – – 1,333 –

R01BA52 DEXTROMETHORPHAN with PARACETAMOLE with PSEUDOEPHEDRINEA 19541 Tablet 24 – – 1,102 –

R01BA52 DEXTROMETHORPHAN with PSEUDOEPHEDRINEA 19511 Syrup 100mL – – 2,204 –A 19533 Tablet 6 – – 40,929 –A 19922 Capsules 10mg/30mg 24 – – 543 –

R01BA52 IBUPROFEN WITH PSEUDOEPHEDRINEA 19663 Tablets 20 – – 618 –

R01BA52 IBUPROFEN with PSEUDOEPHEDRINEA 19513 Tablet 24 – – 2,563 –

R01BA52 IBUPROFEN with PSEUDOEPHEDRINE with PSEUDOEPHEDRINEA 19492 Tablet 24 – – 12,540 –

R01BA52 LORATADINE with PSEUDOEPHEDRINEA 19534 Tablet 6 – – 23,272 –

A 11894

Tablet 10 – – 4,849 –A 190

49Sachet, 10 – – 62

4–

A 19478

Tablet 24 – – 2,484 –A 195

04Tablet 24 – – 11,764 –

A 19515

Tablet 24 – – 6,857 –

176

R


cost($)

RESPIRATORY SYSTEMNASAL PREPARATIONSNASAL DECONGESTANTS FOR SYSTEMIC USESYMPATHOMIMETICS

R01BA52 PARACETAMOL with PSEUDOEPHEDRINE

R01BA52 PARACETAMOL with PSEUDOEPHEDRINE with CHLORPHENIRAMINEA 11897 Tablet 10 – – 6,148 –

R01BA52 PARACETAMOL with PSEUDOEPHEDRINE with TRIPROLIDINEA 19514 Tablet 24 – – 7,412 –A 19516 Tablet 20 – – 4,725 –

R01BA52 PSEUDEPHEDRINE with FEXOFENADINEA 19052 Tablet 120mg–60mg 10 – – 535 –A 19644 Tablet 120mg–60mg 6 – – 17,373 –

R01BA02 PSEUDOEPHEDRINEA 11948 Elixir 30mg/5mL 1 0.24 GM 2,260 –A 17458 Tablet 60mg 60 0.24 GM 309 –A 18518 Tablet 60mg 30 0.24 GM 167 –A 19683 Tablets 60mg 12 – – 4,478 –A 19962 Tablets substained release 120mg 6 0.24 GM 8,427

–P 4420P Tablet 60mg 0.24 GM 16,612 245,654

R01BA52 PSEUDOEPHEDRINE with GUAIPHENESINA 19921 Capsules 30mg/100mg 24 – – 1,224 –

P 8136F

Capsule contain powder oral inhalation 12ug

24.00

UG

17,466

640,478P 823

9PPowder oral inhalation breath actuated 6ug

24.00

UG

11,974

293,916P 824 Powder oral inhalation breath 24.0 U 70,9 2,574,

R03AC02 SALBUTAMOLP 109

9WCapsule 200 ug (base) (oral inhalation)

0.80

MG

4,033

82,755A 162

97Oral pressurised inhalation 100 ug per

0.80

MG

181

–P 200

0GNebuliser solution single dose 2.5mg(base)

10.00

MG

107,284

2,497,019P 200

1HNebuliser solution single dose 5mg(base)

10.00

MG

501,984

12,513,099P 200

3KNebuliser solution 5mg (base) per mL(0.5%)

10.00

MG

237

3,307P 349

5YOral pressurised inhalant 100ug (base) CFC-free

0.80

MG

17,987

203,353P 349

6BNebuliser solution single dose 2.5mg(base)

10.00

MG

6,367

95,642P 349

7CNebuliser solution single dose 5mg(base)

10.00

MG

9,815

152,807P 828

8FOral pressurised inhalant 100ug (base) CFC-free

0.80

MG

3,021,120

49,707,716P 835

4QOral pressurised inhalant breath actuated 100ug

0.80

MG

86,740

3,109,081R03AC1

2SALMETEROLP 3027H Oral pressurised inhalation 25ug (base) 0.10

MG

59,716

2,038,373P 8141L Powder inhal in breath actu

dev 50ug/dose 60 doses 0.10MG

24,180

842,139R03AC0

3TERBUTALINE SULPHATEP 1251W Nebuliser solution single dose 5mg in 2mL

MG

3,005

87,462P 1252X Pdr for inhalation in breath

actu dev 500ug/doseMG

348,232

5,636,436

A 18544

Pdr oral inhal in breath actu dev400ug–12ug/dose 60 – – 37

8–

P 8625Y

Pdr oral inhal in breath actu dev200ug–6ug/dose 120 – – 559,7

8632,263,855P 875

0MPdr oral inhal in breath actu dev400ug–12ug/dose 60 – – 291,7

4825,048,040P 879

6YPdr oral inhal in breath actu dev6ug–100ug/dose 120 – – 27,1

911,446,475

177

R


cost($)

RESPIRATORY SYSTEMDRUGS FOR OBSTRUCTIVE AIRWAY DISEASESADRENERGICS, INHALANTSSELECTIVE BETA–2–ADRENOCEPTOR AGONISTS

R03AC13 EFORMOTEROL

ADRENERGICS AND OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASESR03AK07 EFORMOTEROL with BUDESONIDE

R03AK04 SALBUTAMOL with IPRATROPIUM BROMIDEP 4283K Oral press inhal 20ug (anhydrous)–100 ug per dose – –

482 22,365R03AK06 SALMETEROL and FLUTICASONE

P 8430Q

Pdr oral inhal in breath actu dev 50ug/100ug 60

– – 89,037

4,025,332P 843

1RPdr oral inhal in breath actu dev 50ug/250ug 60

– – 715,271

41,707,903P 843

2TPdr oral inhal in breath actu dev 50ug/500ug 60

– – 681,127

53,605,189P 851

7GOral Press inhal 25ug–50ug 120

– – 96,142

4,343,619P 851

8HOral Press inhal 25ug–125ug 120

– – 272,428

15,842,251

178

P 8519J

Oral Press inhal 25ug–250ug 120

– – 984,510

76,516,504

P 8406K

Oral press inhal 50ug/dose(200 doses) CFC free

0.80

MG 13,612

238,869P 840

7LOral press inhal 100ug/dose(200 doses)CFC

0.80

MG 73,299

2,283,786P 840

8MOral press inhal in breath actv dev 50ug CFC free

0.80

MG 3,051

78,605P 840 Oral press inhal in breath actu 0.8 MG 30,27 1,107,

BUDESONIDEP 206

5QNebuliser suspn single dose units 500ug in 2mL 30

1.50

MG 6,237

331,149P 206

6RNebuliser suspn single dose units 1mg in 2mL 30

1.50

MG 14,741

1,098,212P 207

0YPder for oral inhal in breath actu dev 100ug/dose

0.80

MG 10,589

226,802P 207

1BPder oral inhal in breath actu dev 200ug/dose

0.80

MG 70,590

2,035,202P 207 Pder oral inhal in breath actu 0.8 MG 149,0 6,507,

CICLESONIDEP 8853Y Oral pressurised inhalation

80ug/dose 120 doses0.16

MG 10,266

244,635P 8854B Oral pressurised inhalation 0.1 MG 46,65 1,840,

FLUTICASONEA 173

14Oral pressurised inhalation 50ug/dose 120 doses

0.60

MG 182 –P 814

7TPowder for oral inhalation 100ug/dose 60 doses

0.60

MG 11,442

177,495P 814

8WPowder for oral inhalation 250ug/dose 60 doses

0.60

MG 60,019

1,719,488P 814

9XPowder for oral inhalation 500ug/dose 60 doses

0.60

MG 20,355

1,022,983P 834

5FOral pressurised inhalation 125ug/dose 120 doses

0.60

MG 128,628

3,661,274P 834

6GOral pressurised inhalation 250ug/dose 120 doses

0.60

MG 132,653

6,407,293P 851

6FOral pressurised inhalation 50ug/dose 120 doses

0.60

MG 128,882

1,993,512

P 1541D

Nebuliser solution 250ug per mL (0.025%)

0.30

MG 957

18,983P 154

2ENebuliser solution single dose 250ug/mL 30

0.30

MG 46,697

2,083,457P 823

8NNebuliser solution single dose 500ug in 1mL 30

0.30

MG 245,186

12,895,779P 867

1JOral pressurised inhalation 21ug/dose 200 doses

0.12

MG 116,178

4,565,928

179

R


cost($)

RESPIRATORY SYSTEMDRUGS FOR OBSTRUCTIVE AIRWAY DISEASESOTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,INHALANTSGLUCOCORTICOIDS

R03BA01 BECLOMETHASONE DIPROPIONATE

R03BA02

R03BA08

R03BA05

ANTICHOLINERGICSR03BB01 IPRATROPIUM BROMIDE

R03BB04 TIOTROPIUM BROMIDEP 8626B Capsule 18ug (base)(oral inhalation) 3018.00 UG 1,376,925 104,392,442

ANTIALLERGIC AGENTS, EXCL. CORTICOSTEROIDSR03BC03 NEDOCROMIL

P 8365G Oral pressurised inhalation 2mg/dose 112 doses 8.00 MG63,961 2,150,084

R03BC01 SODIUM CROMOGLYCATEP 112

4ENebuliser solution ampoule 20mg/2ml

80.00

MG 1,250

71,762A 200

17Nebuliser solution 20 mg per 2 mL, ampoule

80.00

MG 153 –P 287

2EOral pressurised inhalation 1mg/dose 200 doses

40.00

MG 537 14,970P 287

8LCapsule 20mg (oral inhalation)

80.00

MG 2,560

82,776P 833

4POral pressurised inhalation 5mg/dose 112 doses

40.00

MG 36,666

1,240,028

180

P 8767K

Oral pressurised inhalation 1mg/dose 200 doses

40.00

MG 5,921

166,311

R03DA02

CHOLINE THEOPHYLLINATEA 16083 Elixir 50mg per 5mL 500mL

0.60

GM 5,578 –R03DA54

CHOLINE THEOPHYLLINATE with GUAIPHENESINA 10362 Expectorant 500mL 1

– – 10,743

–R03DA04

THEOPHYLLINEP 2614N Syrup 80mg per 15mL 500mL

0.40

GM 14,386

136,848P 2634P Tablet 250mg (sustained

release)0.40

GM 21,856

258,988P 8230E Tablet 200mg (sustained

release)0.20

GM 16,957

181,442P 8231F Tablet 300mg (sustained

release)0.40

GM 16,925

223,545

A 16115

Chewable tablet 10mg 28

10.00

MG 42,841

–P 862

7CChewable tablet 4mg (base) 28

10.00

MG 63,007

2,897,244P 862

8DChewable tablet 5mg (base) 28

10.00

MG 84,530

3,889,233

181

R


cost($)

RESPIRATORY SYSTEMDRUGS FOR OBSTRUCTIVE AIRWAY DISEASESADRENERGICS FOR SYSTEMIC USESELECTIVE BETA–2–ADRENOCEPTOR AGONISTS

R03CC02 SALBUTAMOLP 1103C Syrup 2mg (base) per 5mL 300mL 12.00 MG 49,692

619,464R03CC03 TERBUTALINE SULPHATE

P 1034K

Injection 500ug in 1mL

15.00

MG 144 34,198A 172

36Elixir 0.3mg/mL 300mL

2.00 MG 29,795

–P 349

1RInjection 500ug in 1mL

15.00

MG 3,832 108,798OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES

XANTHINES

LEUKOTRIENERECEPTOR ANTAGONISTSR03DC03 MONTELUKAST

R03DC01 ZAFIRLUKASTA 16282 Tablet 20mg 56 40.00MG 886 –

180

R05CA CAMPHOR COMPOUNDA 15831 Linctus 100mL – – 532 –

R05CA10 GUAIPHENESIN with PSEUDOEPHEDRINE

A 13545 Syrup sf100m– – 2,675 –

A 19461 Syrup 100m 1 – – 2,741 –R05CA10 SENEGA and AMMONIA

A 19447 Mixture 200mL – – 2,428 –P 4074K Mixture 200mL – – 12,06

796,378MUCOLYTICS

P 1214X

Tablet 30mg 100.00

MG 68,433

1,190,383A 128

17Linctus 0.5% 100mL 1

100.00

MG 1,559

–A 165 Tablet 30mg 100 100. MG 725 –CODEINE with PARACETAMOL with PSEUDOEPHEDRINEA 10584 Tablet 24 – – 37,26

9–

A 19469 Tablet 24 – – 21,963

–

A 14751 Elixir sugar free 200mL

– – 202

–A 17186 Elixir sugar and colour – – 2,875 –DEXTROMETHORPHAN with DIPHENHHYDRAMINEA 18877 Linctus 100mL 1 – – 78

8–

A 18878 Linctus 200mL 1 – – 55 –DEXTROMETHORPHAN with DIPHENHHYDRAMINE with PSEUDOEPHEDRINE

R


cost($)

RESPIRATORY SYSTEMCOUGH AND COLD PREPARATIONSEXPECTORANTS,EXCL COMBINATIONS WITH ANTITUSSIVESEXPECTORANTS

R05CB01 ACETYLCYSTEINEP 8747J Sterile inhalation solution 200mg per mL(20%) 5mL 1.60 GM 6,887 934,187

R05CB02 BROMHEXINE HYDROCHLORIDEA 10212 Elx 4mg/5mL 1 24.00 MG 10,741 –A 13662 Tablet 8mg 100 24.00 MG 3,234 –

COUGH SUPPRESSANTS, EXCL.COMBINATIONS WITH EXPECTORANTSOPIUM ALKALOIDS AND DERIVATIVES

R05DA04 CODEINE

R05DA20

R05DA20 CODEINE with PSEUDOEPHEDRINEA 12608 Linct 100mL 1 100.00 MG 291 –

R05DA20 CODEINE with PSEUDOEPHEDRINE with PHENYLEPHRINEA 19650 Mixture 100mL 1 – – 2,407 –

R05DA20 DEXTROMETHORPHAN with BROMPHENIRAMINE with PHENYLEPHRINE

R05DA20

R05DA20A 19463 Syrup 100mL – – 1,565 –

181

A 10723

Linctus 200mL 1 50.00

MG 1,996 –A 126

11Linctus 200mL 1 50.0

0MG 705 –

A 12921

Expectorant 200mL 1 50.00

MG 650 –A 138

09Linctus 1mg per mL (0.1%) 100mL

50.00

MG 1,402 –P 407

1GLinctus 1mg per mL (0.1%) 100mL

50.00

MG 7,951 97,628

R


cost($)

RESPIRATORY SYSTEMCOUGH AND COLD PREPARATIONSCOUGH SUPPRESSANTS, EXCL.COMBINATIONS WITH EXPECTORANTSOPIUM ALKALOIDS AND DERIVATIVES

R05DA08 PHOLCODINE

R05DA20 PHOLCODINE with PSEUDOEPHEDRINEA 13367 Mixture 200mL 1 50.00MG 1,699 –

COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONSOPIUM DERIVATIVES AND EXPECTORANTS

R05FA02 AMMONIA with CODEINE with GUAIPHNESIN with PHENYLEPHRINE with PSEUDOEPHEDRINEA 19682 Mixture 100mL – – 210 –

R06AA02

DIMENHYDRINATEA 10684 Syrup 2.5mg/mL 50mL 300.

00MG 55

3–

R06AA02

DIPHENHYDRAMINEA 15912 Capsule 50mg 8 200.

00MG 4,914 –

R06AA52

DIPHENHYDRAMINE with AMMONIUM CHLORIDEA 10194 Mixture 100mL 1

– – 3,470 –A 10196 Mixture 500mL 1 – – 21

7–

A 13099 Mixture 200mL 1 – – 4,691 –R06AA52

DIPHENHYDRAMINE with PHENYLEPHA 11694 200mL 1 – – 1,109 –

R06AA09

DOXYLAMINEA 13003 Tablet 25mg 20 – – 32,840 –A 14123 Capsule 25mg 20 – – 14,349 –

R06AB01

BROMPHENIRAMINEA 16130 Drops 50mL 1 – – 9,499 –

R06AB51

BROMPHENIRAMINE COMBINATIONSA 10665 Drop 30mL 1 24.0

0MG 9,860 –

A 10713 Elixir 200mL 1 24.00

MG 280

–A 14816 Drop 50mL – – 2,014 –

182

R


cost($)

RESPIRATORY SYSTEMANTIHISTAMINES FOR SYSTEMIC USEANTIHISTAMINES FOR SYSTEMIC USEAMINOALKYL ETHERS

SUBSTITUTED ALKYLAMINES

R06AB54 CHLORPHENIRAMINE with CODEINE with PARACETAMOL with PSEUDOEPHRINEA 19679 Tablets 24 – – 49,621

– R06AB54 CHLORPHENIRAMINE with CODINE with PARACETAMOL WITH PSEUDOEPHEDRINE A 19479 Tablet 24 – –

7,164 –A 19480 Capsule 24 – – 14,825 –

R06AB54 CHLORPHENIRAMINE with DEXTROMETHORPHAN WITH PARACETAMOL WITH PSEUDOEPHEDRINEA 19486 Sachets 10 – – 1,227 –A 19489 Tablets 24 – – 1,024 –

R06AB54 CHLORPHENIRAMINE with DEXTROMETHORPHAN with PARACETAMOL with PSEUDOEPHRINEA 19547 Capsules 24 – – 1,354 –

R06AB54 CHLORPHENIRAMINE with PARACETAMOLA 18516 Tablets 2mg/500mg 24 – – 1,960 –

R06AB54 CHLORPHENIRAMINE with PARACETAMOL with PSEUDOEPHEDRINEA 19475 Tablet 24 – – 4,408 –A 19502 Tablets 24 – – 249 –A 19506 Tablets 24 – – 2,111 –

R06AB54 CHLORPHENIRAMINE with PHENYLEPHRINEA 106

04Syrup 100mL 1 – – 22

0–

A 10605

Syrup 200mL 1 – – 279

–A 160

69Syrup 100mL 1 – – 53

1–

A 160 Syrup Infant 50mL 1 – – 24,586 –R06AB54 CHLORPHENIRAMINE with PHOLCODEINE with PSEUDOEPHRINE

A 19542 Syrup 100mL – – 213

–A 19543 Syrup 200mL – – 35

8–

R06AB54

CHLORPHENIRAMINE with PSEUDOEPHEDRINEA 13477 Syrup infant 50mL 1

– – 10,992 –R06AB54

CHLORPHENIRAMINE with PSEUDOEPHRINEA 19532 Tablets 12

– – 43,544 –R06AB02

DEXCHLORPHENIRAMINEA 11602 Syrup 2mg/5mL 1 6.0

0MG 16,257 –

A 12592 Tablet 6mg 20 6.00

MG 12,928 –A 12822 Tablet 2mg 50 6.0

0MG 18,281 –

A 19058 Tablet 2mg 25 6.00

MG 26,427 –A 19059 Tablet 6mg 40 6.0

0MG 5,174 –

R06AB52

DEXCHLORPHENIRAMINE with PHENYLEPHRINEA 10608 Tablet 18

– – 299

–R06AB05

PHENIRAMINEA 10066 Tablet 50mg 10 75.0

0MG 97

2–

A 13917 Tablet 50mg 75.00

MG 4,380 –

183

R


cost($)

RESPIRATORY SYSTEMANTIHISTAMINES FOR SYSTEMIC USEANTIHISTAMINES FOR SYSTEMIC USESUBSTITUTED ALKYLAMINES

PHENOTHIAZINE DERIVATIVES

R06AD02 PROMETHAZINE

A 12553

Elixir 100mL 1 25.00

MG 502 –A 158

10Tablet 25mg 30 25.0

0MG 3,963 –

P 1948M


MG 11,669

265,204P 348

8NInjection 50mg in 2mL 25.0

0MG 13,74

7259,568P 407

2HTablet 10mg 25.0

0MG 36,30

8476,088P 407

3JTablet 25mg 25.0

0MG 56,53

6854,269P 532


0MG 2,730 39,6

78P 5326H


MG 3,758 63,481P 532

7JOral liquid 5mg per 5mL 100mL

25.00

MG 26,464

483,609P 532


0MG 1,204 15,7

85P 5329L


MG 1,937 35,326P 533

0MOral liquid 5mg per 5mL 100mL

25.00

MG 11,000

7,765R06AD5

2PROMETHAZINE with PHOLCODINEA 12066 Linctus 100mL 1 – – 1,986 –

184

R06AD01

TRIMEPRAZINEA 12156 Syrup 7.5mg/5 1 30.0

0MG 3,631 –

A 12157 Syrup 30mg/5 1 30.00

MG 2,437 –

A 14363

Tablet 10mg 10.00

MG 6,682 –A 161

21Oral drops 10mg per mL 20mL

10.00

MG 284 –A 161

22Oral solution 1mg/mL 75mL

10.00

MG 2,589 –P 417


0MG 16,47

9614,165

185

R


cost($)

RESPIRATORY SYSTEMANTIHISTAMINES FOR SYSTEMIC USEANTIHISTAMINES FOR SYSTEMIC USEPIPERAZINE DERIVATIVESR06AE07 CETIRIZINE

R06AE CETIRIZINE AND PSEUDOEPHEDRINEA 19920 Tablet 6 – – 1,383 –

OTHER ANTIHISTAMINES FOR SYSTEMIC USER06AX02

CYPROHEPTADINE HYDROCHLORIDEP 1798P Tablet 4mg 12.0

0MG 83,13

51,028,587R06AX2

7DESLORATADINEA 18720 Tablet 5mg 28 5.0

0MG 133 –

A 18721 Tablet 5mg 7 5.00

MG 420 –R06AX26

FEXOFENADINEA 161

41Tablet 120mg 10 0.1

2GM 368 –

A 16142


GM 2,539

–A 162

66Tablet 180mg 30 0.1

2GM 1,35

7–

A 18893


GM 257 –A 188

94Tablet 180mg 10 0.1

2GM 433 –

A 18895


GM 176 –P 423

7BCapsule 60mg 0.1

2GM 6,11

7279,000P 423

8CTablet 120mg 0.1

2GM 13,01

6507,795R06AX13 LORATADINE

A 13978

Tablet 10mg 10.00

MG 10,052

–A 145

13Syrup 100mL 10.0

0MG 3,30

5–

A 18283


MG 457 –A 196

85Tablet 10mg 10.0

0MG 713 –

A 19687


MG 113 –P 431

3BTablet 10mg 10.0

0MG 41,65

11,774,907R06AX13 LORATADINE with PSEUDOEPHEDRINE

A 15405 Tablet 10 10.00

MG 161 –A 16281 Tablet 10 10.0

0MG 134 –

P 1171P

Eye ointment 10mg per g (1%) 4g

– – 551,521

4,694,520A 146

70Eye drops Minims 0.5% 20 – – 160 –

P 2360F

Eye drops 5mg per mL (0.5%) 10mL

– – 1,171,383

9,455,863P 505

5CEye drops 5mg per mL (0.5%) 10mL

– – 218 1,158S01AA1

1GENTAMICIN SULPHATEP 1441W Eye drops 3mg (base) per mL (0.3%) 5mL

– – 12,424

217,168S01AA1

2TOBRAMYCINP 2328M Eye drops 3mg per mL (0.3%) 5mL

– – 72,113

1,257,644P 2329N Eye ointment 3mg per g

(0.3%) 3.5g– – 19,58

7394,835

P 1217C

Eye drops 3mg per mL (0.3%) 5mL

– – 15,786

449,630A 173

03Eye drops 3mg per mL (0.3%) 5mL

– – 336 –A 173


– – 209 –

S01BA01

DEXAMETHASONEP 1288T Eye drops 1mg per mL (0.1%) 5mL

– – 190,934

1,760,640S01BA0

7FLUOROMETHOLONEP 1204J Eye drops 1mg per mL (0.1%) 5mL

– – 264,340

2,436,603P 1438Q Eye drops 1mg per mL

(0.1%) 5mL– – 59,13

5545,882S01BA0

2HYDROCORTISONEP 1497T Eye ointment 5mg per g (0.5%) 5g

– – 21,469

226,351A 19589 Eye drops 10mg per

mL (1%) 10mL– – 212 –

P 2441L Eye ointment 10mg per g (1%) 5g

– – 44,308

475,383S01BA0

4PREDNISOLONEA 14678 Minims 0.5% 20 – – 2,71

7–

186

S


cost($)

SENSORY ORGANSOPHTHALMOLOGICALSANTIINFECTIVESANTIBIOTICS

S01AA01 CHLORAMPHENICOL

SULFONAMIDESS01AB04 SULPHACETAMIDE

P 2063N Eye drops 100mg per mL (10%) 15mL – – 23,142278,460

ANTIVIRALSS01AD03 ACICLOVIR

P 1002R Eye ointment 30mg per g (3%) 4.5g – – 42,3831,300,521

OTHER ANTIINFECTIVESS01AX13 CIPROFLOXACIN

S01AX11 OFLOXACINP 8383F Eye drops 3mg per mL (0.3%) 5mL – – 15,481

409,123ANTIINFLAMMATORY AGENTSCORTICOSTEROIDS, PLAIN

CORTICOSTEROIDS AND SYMPATHOMIMETICS IN COMBS01BB02 PREDNISOLONE ACETATE with PHENYLEPHRINE HYDROCHLORIDE

187

P 3112T Eye drops 10mg–1.2mg per mL (1%–0.12%) 10mL – –265,476 5,717,102

S01EA03

APRACLONIDINEP 8083K Eye drops 5mg (base) per mL (0.5%) 10mL

1.50

MG 6,745

251,079S01EA0

5BRIMONIDINEP 8351M Eye drops 2mg per mL (0.2%) 5mL

0.40

MG 196,963

3,836,979S01EA0

2DIPIVEFRINEP 1351D Eye drops 1mg per mL (0.1%) 10mL

0.20

MG 8,355

176,842

A 19844

Eye drops 30mg per mL (3%) 15mL

12.00

MG 343 –A 198

45Eye drops 30mg per mL (3%) 15mL

12.00

MG 333 –A 202


2.00

MG 168 –P 259

5NEye drops 10mg per mL (1%) 15mL

4.00

MG 13,038

148,951P 259

6PEye drops 20mg per mL (2%) 15mL

8.00

MG 32,729

414,315P 259

8REye drops 40mg per mL (4%) 15mL

16.00

MG 28,554

444,133P 277

8FEye drops 5mg per mL (0.5%) 15mL

2.00

MG 4,174 47,359P 277

9GEye drops 60mg per mL (6%) 15mL

24.00

MG 4,131 82,764

188

S


cost($)

SENSORY ORGANSOPHTHALMOLOGICALSANTIINFLAMMATORY AGENTSANTIINFLAMMATORY AGENTS, NON–STEROIDS

S01BC03 DICLOFENACA 15226 Eye drops 0.1% – – 546 –A 19829 Eye drops 5mg/5mL (0.1%)

1 .3mL, 5– – 19,81

6–

S01BC04

FLURBIPROFENP 8699W Eye drops 300ug per mL(0.03%) single dose 0.4mL 5

– – 2,261 31,635S01BC0

5KETOROLAC TROMETAMOLA 16800 Eye drops 0.5% 5mL – – 37,02

6–

ANTIGLAUCOMA PREPARATIONS AND MIOTICSSYMPATHOMIMETICS IN GLAUCOMA THERAPY

PARASYMPATHOMIMETICS

S01EB01 PILOCARPINE

CARBONIC ANHYDRASE INHIBITORSS01EC01

ACETAZOLAMIDEP 1004W Tablet 250mg 0.7

5GM 33,97

6659,862S01EC0

4BRINZOLAMIDEP 8483L Eye drops 10mg per mL (1%) 5mL

2.00

MG 155,860

3,043,552S01EC0

3DORZOLAMIDEP 8488R Eye drops 20mg per mL (2%) 5mL

6.00

MG 56,593

1,105,122

P 2811Y Eye drops 2.5mg (base) per mL(0.25%) 5mL

0.50 MG 94,580

1,246,650P 2825Q Eye drops 5mg (base)

per mL (0.5%) 5mL1.00 MG 47,7

72629,890S01ED5

1BRIMONIDINE TARTRATE with TIMOLOL MALEATEP 8826M Eye drops 2mg–5mg (base) per

– 101,825

2,789,545S01ED5

1LATANOPROST with TIMOLOL MALEATEP 8895E Eye drops 50ug 5mg per mL (0.005%–0.5%), 2.5 mL –

– 281,277

12,196,961S01ED0

3LEVOBUNOLOLP 1819R Eye drops 2.5mg per mL (0.25%) 5mL 0.50

MG 25,119

304,407S01ED0

1TIMOLOL MALEATEP 1278G Eye drops 2.5mg (base) per mL (0.25%) 5mL 0.50

MG 48,728

590,309P 1279H Eye drops 5mg (base) per mL

(0.5% ) 5mL 1.00MG 302,3

293,980,377P 1925H Eye drops (gellan gum solution)

2.5mg (base) 0.50MG 25,3

81308,273P 1926J Eye

drops (gellan gum solution) 5mg (base) 1.00MG 156,6

342,066,923P 8803H Eye gel 1mg (base) per g

(0.1%) 5g –– 57,9

61703,542S01ED5

1TIMOLOL MALEATE with PILOCARPINE HYDROCHLORIDEP 8567X Eye drops 5mg–20mg per mL

– 264,414

7,257,633S01ED5

1TRAVAPROST WITH TIMOLOL

S01FA01

ATROPINE SULPHATEP 1093M Eye drops 10mg per mL (1%) 15mL

– – 17,959

176,886S01FA0

4CYCLOPENTOLATEA 10596 Eye drops 1%15mL 1 – – 140 –

S01FA05

HOMATROPINE HYDROBROMIDEA 19627 Eye drops 50mg per mL (5%) 15mL

– – 122 –P 2541R Eye drops 20mg per mL (2%) 15mL

– – 13,300

211,910S01FA0

6TROPICAMIDEA 11192 Eye drops 0.5% 1 – – 251 –A 11193 Eye drops 1% 1 – – 127 –

189

S


cost($)

SENSORY ORGANSOPHTHALMOLOGICALSANTIGLAUCOMA PREPARATIONS AND MIOTICSBETA BLOCKING AGENTS

S01ED02 BETAXOLOL HYDROCHLORIDE

P 9057Q Eye drops 0.04–5mg (base) per mL(0.004–0.5%)2.5mL – – 45,663 1,980,356

PROSTAGLANDIN ANALOGUESS01EE03

BIMATOPROSTP 8620Q Eye drops 300ug per mL (0.03%) 3mL

30.00

UG

283,503

10,347,374S01EE0

1LATANOPROSTP 8243W Eye drops 50ug per mL (0.005%) 2.5mL

5.00

UG

1,485,055

54,193,542S01EE0

4TRAVOPROSTP 8597L Eye drops 0.040mg per mL (0.004%)

– – 137,801

5,026,522MYDRIATICS AND CYCLOPLEGICS

ANTICHOLINERGICS

SYMPATHOMIMETICS EXCL. ANTIGLAUCOMA PREPARATIONS S01FB01 PHENYLEPHRINE

190

A 13252 Eye drops 0.12% 1 – – 165 –

188

P 4031E Eye drops 5mg (sulphate)–250ug (nitrate)

– – 4,222 52,426P 4032F Eye drops 5mg

(phosphate)–500ug– – 120 1,4

84S01GA01

NAPHAZOLINEP 4035J Eye drops 1mg per mL (0.1%) 15mL

– – 2,353 28,774S01GA5

1NAPHAZOLINE COMBINATIONSP 4355F Eye drops 250ug–3mgper mL (0.025%–0.3%) 15mL

– – 3,277 41,524

P 1371E Solution for intravitreal injection 3mg in 0.3mL

– – 7,726

15,944,397P 1382R Solution for intravitreal

injection 3mg in 0.3mL– – 9,94

220,425,802

S


cost($)

SENSORY ORGANSOPHTHALMOLOGICALSDECONGESTANTS AND ANTIALLERGICSSYMPATHOMIMETICS USED AS DECONGESTANTS

S01GA51 ANTAZOLINE with NAPHAZOLINE

S01GA55 PHENYLEPHRINE HYDROCHLORIDE with ZINC SULPHATEP 4034H Eye drops 2.5mg–1.2mg per mL (0.25%–0.12%) 15mL – –

675 7,843OTHER ANTIALLERGICS

S01GX08 KETOTIFENA 187

22Eye drops 250mg (base) per mL 2.5mL

– – 1,087 –A 187

23Eye drops 250mg (base) per mL 5mL

– – 5,149 –A 197


– – 7,366 –A 197


– – 263 –S01GX02

LEVOCABASTINEP 4310W Eye drops 500ug per mL (0.05%) 4mL

– – 3,848 63,882S01GX0

5LODOXAMIDEA 19726 Eye drops 0.1% 10mL – – 653 –

S01GX01

SODIUM CROMOGLYCATEP 1127H Eye drops 20mg per mL (2%) 10mL

– – 32,691

440,593OCULAR VASCULAR DISORDER AGENTS

ANTINEOVASCULARISATION AGENTSS01LA04 RANIBIZUMAB

S01LA01 VERTEPORFINP 1349B Powder for I.V. infusion 15mg– – 234 532,600

189

P 8564R Ocular lubricating gel 2mg–3mg per g (0.2%–0.3%)

– – 108,407

1,012,602P 8676P Eye drops 4mg–3mg per mL – – 374,3 3,476,

CARBOMER 940P 8384G Ocular lubricating gel 2mg

per g (0.2%) 10g– – 171,7

021,612,313P 8514D Ocular lubricating gel 3mg

per g (0.3%) 30– – 18,75

0652,571

S


cost($)

SENSORY ORGANSOPHTHALMOLOGICALSOTHER OPHTHALMOLOGICALSOTHER OPHTHALMOLOGICALS

S01XA20 ARTIFICIAL TEARS and OTHER INDIFFERENT PREPARATIONS

S01XA20

S01XA20 CARBOMER 980P 8578L Eye drops 2mg per g (0.2%) single dose units – – 5,287

185,949S01XA20 CARMELLOSE SODIUM

P 2324H

Eye drops 10mg per mL (1%) single dose units

– – 17,063

602,928P 233

8CEye drops 5mg per mL (0.5%) single dose units

– – 86,114

3,031,258P 854

8XEye drops 5mg per mL (0.5%) 15mL

– – 445,524

4,138,618P 859

3GEye drops 10mg per mL (1%) 15mL

– – 132,812

1,233,567P 882

3JEye drops 2.5mg per mL (0.25%) single dose 0.6mL

– – 6,255

243,126P 882

4KOcular lub gel 10mg per mL (1%) single unit 0.6mL

– – 2,003

64,377S01XA20 HYPROMELLOSE

P 1509K

Eye drops 3mg–1mg per mL (0.3%–0.1%) 15mL

– – 570,706

5,313,244P 295

6NEye drops 5mg per mL (0.5%) 15mL

– – 25,538

236,834P 828

7EEye drops 3mg–1mg per mL (0.3%) 15mL

– – 166,042

1,541,920S01XA2

0HYPROMELLOSE with DEXTRANP 8299T Eye drops (0.3%–0.1%) single dose 0.4mL 28

– – 53,123

1,846,260S01XA2

0PARAFFINP 1750D Compound eye ointment 7g – – 151,9

973,083,839P 1754H Compound eye ointment

3.5g– – 20,93

6406,192S01XA2

0POLYVINYL ALCOHOLP 2681D Eye drops 30mg per mL (3%) 15mL

– – 27,252

253,484P 2682E Eye drops 14mg per mL

(1.4%) 15mL– – 116,2

911,080,608P 8831T Eye drops 14mg per mL

(1.4%) 15mL– – 1,81

716,567P 8832W Eye drops 30mg per mL

(3%) 15mL– – 1,05

29,784

190

S


cost($)

SENSORY ORGANSOTOLOGICALSANTIINFECTIVESANTIINFECTIVES

S02AA10

ACETIC ACIDA 10103 Ear drops 35mL 1 – – 196 –

S02AA01

CHLORAMPHENICOLP 1172Q Ear drops (aqueous) 5mg per mL (0.5%) 5mL

– – 17,890

174,318S02AA1

5CIPROFLOXACINP 2480M Eye drops 3mg per mL (0.3%) 5mL 1

– – 16,200

298,073S02AA3

0NEOMYCIN UNDECENOATE with BACITRACIN ZINCP 2296W Ear ointment 12mg (3.5mg

– – 123,194

917,192CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION

CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATIONS02CA06

DEXAMETHASONE with FRAMYCETIN SULPHATE and GRAMICIDINP 2781J Ear drops

4,117,965S02CA0

2FLUMETHASONE PIVALATE with CLIOQUINOLA 15097 Ear drops 200ug–10mg per mL (0.02%–1%)

– – 51,603–

S02CA03

HYDROCORTISONE with CIPROFLOXACINP 4528H Ear drops 2mg/10mg per mL(0.2–1%) 10mL

– – 106,2842,959,733S02CA0

4TRIAMCINOLONE ACETONIDE with NEOMYCIN SULPHATE GRAMICIDINand NYSTATINP 2971J Ear drops 1mg–2.5mg (base)–250ug–per mL – –

1,042,015P 2974M Ear ointment 1mg–2.5mg (base)–250ug– per

mL – – 340,3962,419,311OTHER OTOLOGICALS

ANALGESICS AND ANESTHETICSS02DA PHENAZONE with BENZOCAINE

A 10094 Ear drops 10mL 1 – – 1,782 –INDIFFERENT PREPARATIONS

S02DC

S02DCA 10803 Ear drops non–nhs 15mLCARBAMIDE PEROXIDE

– – 156 –

P 4176T Ear drops 65mg per mL (6.5%) 10mL

– – 4,446 57,246S02DC DICHLOROBENZENE CHLORBUTOL and

TURPENTINEP 4180B Ear drops 20mg–

50mg–0.1mL per mL (2%–

OIL

– – 5,498 69,464S02DC DOCUSATE SODIUM

P 4199B Ear drops 50mg per mL (5%) 10mL

– – 11,911

154,720

191

S


cost($)

SENSORY ORGANSOPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONSANTIINFECTIVESANTIINFECTIVES

S03AA FRAMYCETIN SULPHATEP 1440T Eye and ear drops 5mg per mL (0.5%) 8 mL – – 69,769

564,744

192

V


cost($)

VARIOUSALLERGENSALLERGENSALLERGEN EXTRACTS

V01AA07 INSECT ALLERGEN EXTRACT –HONEY BEE VENOMP 2886X Injection set containing 550ug – – 2,738 557,477

V01AA07 INSECT ALLERGEN EXTRACT –PAPER WASP VENOMP 2918N Injection set containing 550ug – – 430 87,763

P 1753G


1FInjection 800ug in 2mL – – 2,187 212,

876P 3482G

Injection 2mg in 5mL – – 5,650 359,401

P 6500D Tablet 250mg (dispersible) 28

– – 254 235,720P 9600G Tablet 500mg

(dispersible) 28– – 954 1,786,

577

P 2308L

Tablet 15mg 60.00

MG 6,464

710,623P 587

0YInjection equiv to 300mg folinic acid in 30mL

60.00

MG 411 91,765P 588

6TInjection equiv to 100mg folinic acid in 10mL

60.00

MG 2,561

374,437P 589

0BInjection equiv to 50mg folinic acid in 5mL

60.00

MG 5,224

410,036P 874

0BInjection equiv to 50mg folinic acid in 5mL

60.00

MG 12,722

1,974,877P 881

2TInjection equiv to 100mg folinic acid in 10mL

60.00

MG 6,060

1,643,077P 904 Injection equiv to 300mg 60.0 MG 237 61,1

MESNAP 596

1RSolution for I.V. injection 1g in 10mL

– – 295 13,112P 807

8ESolution for I.V. injection 400mg in 4mL

– – 152 9,216P 807

9FSolution for I.V. injection 1g in 10mL

– – 1,205

173,382

193

V


cost($)

VARIOUSALL OTHER THERAPEUTIC PRODUCTSALL OTHER THERAPEUTIC PRODUCTSANTIDOTES

V03AB15 NALOXONE HYDROCHLORIDE

IRON CHELATING AGENTSV03AC03 DEFERASIROX

V03AC01 DESFERRIOXAMINEP 6113R Powder for injection 500mg vial – – 112 32,513

DRUGS FOR TREATMENT OF HYPERKALEMIAV03AE02 SEVELAMER

P 2142R Sevelamer hydrochloride tablet 800mg 180 6.40 GM 556201,314

V03AE01 SODIUM POLYSTYRENE SULPHONATEP 4470G Oral powder 454g – – 4,344 287,712

DETOXIFYING AGENTS FOR CYTOSTATIC TREATMENTV03AF03 CALCIUM FOLINATE

V03AF01

DRUGS FOR TREATMENT OF HYPERCALCEMIAV03AG SODIUM ACID PHOSPHATE

P 2946C Tablet containing 500mgP–469mgNa–123mgK – – 3,392301,085

Pharmaceutical Benefits Scheme (PBS) | Home · Web viewA 17988 Capsule 50mg 50 0.30 GM 116 – P 2527B Tablet 50mg (twice daily sustained release) 20 0.30 GM 45,604 732,050 P 3484J

Documents